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Abstract 
Human embryonic stem cell (hESC)-based therapies will only become viable once we eliminate the 
use of animal-derived material during ESC scale-up. Some groups have demonstrated the expansion 
of hESCs in xeno-free systems but the effect on downstream self-renewal and differentiation is poorly 
understood. Heparan sulfate (HS) is a master regulator of cellular behavior but the role of HS during 
ESC expansion is unclear, as is the exogenous source of HS in cultures. It has been shown that 
mESCs synthesise low levels of low-sulfated HS, but it is unclear if culture condition has any impact.  
In the studies here, three discrete culture conditions were employed for E14 mESC expansion along 
with immunostaining and RT-qPCR to study marker expression for differentiation to the three 
lineages and corresponding BM synthesis. SAX-HPLC was used to characterise soluble HS from 
cells/medium/serum. A varierty of polymers were tested as synthetic alternatives for ESC expansion. 
It was found that HS-deficient embryoid bodies (EBs) (derived from EXT1
-/-
 mESCs in normal 
culture conditions) remained in a pluripotent state and lacked a typical differentiation pattern. 
Furthermore, HS-deficient mESCs could not be maintained in the absence of serum, highlighting a 
link between serum and HS. EBs derived from E14 mESCs cultured in the absence of serum 
displayed unusual differentiation patterns, which were rescued by exogenous porcine mucosal heparin 
(PMH). Feeder cells displayed cell-surface HS but feeder-cell conditioned medium (CM) was 
predominantly an unsulfated structure. An array of low and highly sulfated HS structures were 
identified in serum-alone. 10-fold more HS was purified from serum-free feeder-free (-F –FBS) CM 
compared to the other mESC CM (with/without feeders but in the presence of serum; +/-F +FBS). 
Furthermore, unlike +/-F +FBS conditions, highly sulfated HS disaccharide UA2S–GlcNS6S was the 
major constituent in –F-FBS and Sulf2 levels were significantly reduced. Poly-Ɛ-lysine macroporous 
substrates supported mESC and kidney-derived stem cells (KSCs-GFP) adherence and proliferation, 
further enhanced by adsorbing RGD or per-sulfated HS structures to the surface of the poly-Ɛ-lysine.  
The key conclusions from these studies were that serum is a source of HS, without which, mESCs 
behave uncharacteristically; that synthetic HS-mimetic structures could represent an alternative to 
serum; and poly-Ɛ-lysine shows great promise to replace current animal-derived coating materials for 
ESC expansion. 
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1. Introduction 
1.1 Embryonic Stem Cells 
Embryonic stem cells are pluripotent cells that can differentiate to become any cell type 
whilst maintaining the ability to replicate indefinitely. As a result, embryonic stem cells have 
massive potential in medicine, both therapeutically in repairing damaged/diseased tissue, for 
example, in Parkinson’s disease or diabetes, and for implementation in drug screening. 
However, before stem cell-based therapies can be developed or employed clinically, it is 
necessary to understand how embryonic stem cells are regulated, both in maintenance of their 
pluripotency and direction of their differentiation.  
1.1.1 Origins of ESCs 
Since 1970, four different classes of pluripotent cells have been isolated; embryonic stem cells 
(ESCs), embryonic germ (EG) and epiblast stem cells (EpiSCs) from the embryo, and embryonic 
carcinoma (EC) cells isolated from adults. All three have the capacity for self-renewal and 
differentiation but discrete differences underpin their respective therapeutic potential. 
 Embryonic stem cells (ESCs) 
Embryonic stem cells (ESCs) are derived from the inner cell mass (ICM) of a pre-implanted 
blastocyst (Evans and Kaufman 1981; Martin 1981) and represent pluripotent cells with the 
ability to replicate indefinitely in an undifferentiated state, whilst maintaining the ability to 
give rise to all cell lineages once stimulated correctly, such is the ability of ESCs to generate 
high cell numbers.  
Embryonic germ (EG) cells 
Embryonic germ (EG) cells are derived from primordial germ cells (PGC) of the post-
implanted embryo, destined to form eggs or sperm. In the human, EG cells can be isolated 
from the gonadal ridge of the fetus post-fertilisation (5 – 10 week), analogous to derivation 
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from PGCs in the mouse embryo at 8.5 day post-coitum (Labosky, Barlow et al. 1994; 
Donovan and de Miguel 2003).  
Epiblast Stem Cells (EpiSCs) 
Epiblast-derived stem cells (EpiSCs) are derived from the very early (pre-implanted 
blastocyst stage) embryo but pre-gastrulation. 
Embryonal carcinoma (EC) cells 
A teratoma represents an encapsulated tumour composed of various tissues foreign to their 
site of origin, of which there are two classifications; malignant and benign. Benign teratomas 
have limited growth ability and are represented by well-differentiated somatic tissues. 
Malignant teratomas (teratocarcinomas) in contrast, contain undifferentiated stem cells with 
an unlimited proliferative ability and tendency to metastasize. Teratocarcinomas, first formed 
experimentally in adult mice by grafts of early mouse embryonic tissues, represent the origin 
of EC cells. Most EC cell lines, despite retaining some capacity to differentiate, display poor 
differentiation in vivo and typically form tumours (Stevens 1970; Damjanov, Damjanov et al. 
1987). 
Consequently, EC cells do not present much potential in any clinical capacity, largely owing 
to their tumourigenic nature. Furthermore, EC cells are aneuploid and cannot proceed through 
meiosis to produce mature gametes, unlike ESCs which stably retain euploid chromosome 
constitution, crucial for meiosis and underpins genetic manipulation technology. Although 
EG cells form chimeras following injection into the blastocyst and give rise to the three germ 
layers (Stewart, Gadi et al. 1994), their genomic imprint can be erased, therefore negating the 
ability to employ them as therapeutic agents (Smith 2001). Subsequently, ESCs represent the 
class of embryonic stem cell isolated from the embryo with real potential. 
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1.1.2. Early embryonic development 
ESCs, owing to their defining pluripotent characteristic, theoretically can mimic in vivo 
development in an in vitro model. Embryonic development is a complex, highly sequential 
process whereby the zygote diversifies into every cell type, as a consequence of 
differentiation, proliferation and growth, which begins with cleavage (mitotic divisions after 
fertilisation) and gastrulation (polarisation of the embryo), outlined in Figure. 1.1.  
 
1.1. Early embryonic development Schematic outlining the early embryonic development cascade 
which gives rise to extraembryonic and embryonic tissues (from stemcells.nih.gov) 
 
Given that ESCs are isolated at the ICM stage of embryonic development, they possess the 
ability to give rise to all three germ layers; endoderm, ectoderm and mesoderm, underpinning 
the massive clinical potential, since every cell type in the adult human originates from one of 
three primary germ layers. 
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Ectoderm (outer layer): 
 Outer surface  - epidermal (skin) 
 CNS   - neuron of brain 
 Neural crest - pigment cell 
Mesoderm (middle layer): 
 Dorsal  - notochord 
 Paraxial  - bone tissue 
 Intermediate - tubule cell of kidney 
 Lateral  - red blood cells 
 Head  - facial muscle 
Endoderm (inner layer): 
 Digestive tube - stomach cell 
 Pharynx  - thyroid cells 
 Respiratory tube - lung cell 
 
Consequently, any population of ESCs theoretically can be directed to differentiate and 
become a specific cell type to suit specific clinical applications; for example, ESCs 
stimulated to become neurons for a Parkinson’s disease-based application (Marchetto, 
Brennand et al.; Zhang, Duan et al.) or ESCs stimulated to become insulin-producing cells for 
diabetes treatment (Soria, Roche et al. 2000).  
However, any clinical application will initially require the expansion of ESCs to suitably high 
cell numbers, therefore, understanding and foremost exploiting pluripotency is crucial. 
1.1.2 Human ESCs (hESCs) and mouse ESCs (mESCs) 
Any embryonic stem cell-based clinical application requires human-derived embryonic stem 
cells at its origin, however, owing to the ethics and limitations surrounding human embryonic 
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stem cell (hESC) research, mouse embryonic stem cells (mESCs) are often used as a model 
(de Wert and Mummery 2003).  
hESCs were isolated as recently as 1998 from the ICM of a pre-implanted blastocyst at the 4-
5 day stage (Thomson, Itskovitz-Eldor et al. 1998), almost 20 years after the derivation of 
mESCs from 3.5-4 day embryo (Stevens 1970). Consequently, much of the research, 
speculation and prospects of hESCs is founded on the well defined and deeply investigated, 
murine model. Furthermore, the difference in timing of ESC isolation in the embryo (4-5 day 
for hESCs compared to 7.5day for mESCs) is likely to underpin some of the major 
differences in ESC behaviour. Nonetheless, many similarities are apparent, justifying the 
usage of mESCs throughout this project. 
In culture, like mESCs, hESCs express the pluripotency marker and transcription factor, Oct4 
(Smith 2001) and similar antigens, SSEA-1 for example (Ginis, Luo et al. 2004; Zeng, Miura 
et al. 2004), although hESCs display a relatively slow proliferation rate compared to that of 
mESCs. hESCs do not respond to the leukaemia inhibitory factor (LIF), the major factor 
maintaining mESC pluripotency in vitro, and furthermore, it is unclear if the STAT pathway, 
so crucial in mESCs pluripotency, governs any part of hESC pluripotency. In the developing 
embryo, trophectoderm cells, which give rise to the placenta, do not differentiate in the 
mouse model, as identified in the human model. 
1.1.3 ESC pluripotency 
As mentioned, ESCs are characterised by their ability to self-renew, a property governed by 
extracellular signals coupled to a complex, timely activated intracellular signalling cascade, 
to activate transcription programs (summarised in Fig. 1.2.). 
1.1.4.1 Transcriptional regulators of ESC pluripotency  
Oct4  
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Oct-4, a 352 amino acid protein belonging to class V of POU transcriptional factors, is 
initially expressed in all blastomeres of the developing embryo, constantly expressed in ICM 
cells and maintained throughout the epiblast (Pesce and Scholer 2001; Sterneckert, Hoing et 
al. 2012). Targeted disruption of Oct4 was shown to result in an ICM lacking pluripotent 
properties (Nichols, Zevnik et al. 1998) therefore Oct4 has long been identified as a marker 
of ESC pluirpotency. Steady-state expression of Oct4 is shown to be crucial; high-expressing 
Oct4 ESCs are driven towards mesoderm and endoderm differentiation, whilst low-level Oct4 
expressing ESCs become trophectoderm (Niwa, Miyazaki et al. 2000; Niwa 2001). 
 
1.2. mESC pluripotency Schematic representing extracellular and intracellular factors governing 
mESC pluripotency 
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Nanog 
Nanog, a homeobox-containing protein has more recently been identified as a marker of 
pluripotency (Chambers, Colby et al. 2003; Mitsui, Tokuzawa et al. 2003) expressed in 
mESCs and hESCs and EC and EG cells (Yamaguchi, Kimura et al. 2005). Nanog-null 
embryos fail to survive beyond implantation due to failure to specify the pluripotent epiblast 
and Nanog deletion in mESCs was shown to result in ESC differentiation (Mitsui, Tokuzawa 
et al. 2003; Ivanova, Dobrin et al. 2006), highlighting the importance of Nanog in mESC 
pluripotency. Interestingly, unlike Oct4, Nanog functions independently of the LIF-STAT3 
pathway since over-expression of mESCs renders ESCs independent from STAT3 
stimulation, but cannot abrogate the requirement for Oct4 (Orkin, Wang et al. 2008; Silva, 
Nichols et al. 2009).  
Sox2, Klfs and other regulators of ESC pluripotency 
Genome-wide studies have highlighted co-localisation of Sox2 with Oct4 and Nanog in ESC 
chromatin (Chambers and Tomlinson 2009) in an organised transcriptional network to 
maintain pluripotency. Sox2 (SRY (sex determining region-Y)-box 2) is another transcription 
factor thought to regulate pluripotency, largely attributed to its interaction with Oct4 (Masui, 
Nakatake et al. 2007; Kashyap, Rezende et al. 2009). 
Krüppel-like factors (Klfs) are evolutionarily conserved zinc finger-containing transcription 
factors, shown to participate in the maintenance of mESC pluripotency (Bourillot and 
Savatier). Klf2, Klf4 and Klf5 have more recently been particularly highlighted as influential, 
since triple knockdown of Klf2/Klf4/Klf5 was shown to induce ESC differentiation (Jiang, 
Chan et al. 2008; Parisi, Passaro et al. 2008; Hall, Guo et al. 2009). Klf2 and Klf4 are more 
efficient at reprogramming cells into iPS cells than Klf5 though, suggesting a hierarchical 
relationship (Guo, Yang et al. 2009). Interestingly, Klf2, Klf4 and Klf5 can activate the 
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expression of Oct4, Nanog and Sox2, however disparity occurs in activation of Klfs; Klf2 is 
activated by Oct4 whilst Klf4 and Klf5 are activated by Nanog (Bourillot, Aksoy et al. 2009) 
and furthermore Klf4 and Klf5 (not Klf2) are regulated by STAT3, suggesting these link 
extrinsic regulators to the core pluripotency nectwork (Schulz, Kolde et al. 2009). 
Neural repressor REST and Sall4 are two more transcription factors shown to be of great 
importance in maintenance of ESC pluripotency. Deletion of REST results in loss of ESC 
pluripotency (Ballas, Grunseich et al. 2005; Singh, Kagalwala et al. 2008) and mutation in 
Sall4 leads ESCs to re-specify to trophoblast cells, since Sall4 is known to activate Oct4 
(Elling, Klasen et al. 2006; Sakaki-Yumoto, Kobayashi et al. 2006).  
1.1.4.2. Mechanisms and signalling pathways maintaining mESC pluripotency 
LIF/STAT3 pathway 
The leukaemia inhibitory factor (LIF) was the first purified factor shown to govern the 
undifferentiated state of mESCs in vitro (Moreau, Donaldson et al. 1988; Smith, Heath et al. 
1988; Williams, Hilton et al. 1988), originally identified as a macrophage maturation-
inducing factor during the inhibition of leukaemia (Patterson 1994), hence the name. 
LIF is a glycoprotein, which belongs to the IL – 6 cytokine family shown to function via the 
binding to LIF receptors, gp190 (LIFR) and gp130. LIF binds LIFR and forms a 
heterodimeric complex with gp130, recruiting tyrokinase JAK on its cytoplasmic domain, in 
turn, upon phosphorylation, creating sites for signal transducer and activator of transcription 
(STAT) proteins (Boeuf, Hauss et al. 1997; Niwa, Burdon et al. 1998; Turkson, Ryan et al. 
2001). The LIF-STAT3 pathway has specifically been identified as critical in mESC self-
renewal (Niwa, Burdon et al. 1998; Niwa, Ogawa et al. 2009). Activation of STAT3 is shown 
to be sufficient in maintaining mESC self-renewal (Matsuda, Nakamura et al. 1999). 
However, as mentioned, even in the presence of LIF, mESCs can spontaneously differentiate 
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into primitive endoderm, although visceral and parietal endoderm is inhibited (Shen and 
Leder 1992; Murray and Edgar 2001). LIF could therefore facilitate mESC pluripotency via 
inhibition of visceral endoderm differentiation, supported by Mountford et al., who 
demonstrated that a lack of primitive endoderm, attributed to transfection with Oct4 promoter 
gene, results in maintained pluripotency, despite the lack of LIF (Mountford, Nichols et al. 
1998).   
Activin/Nodal pathway 
The transforming growth factor beta (TGF-β) is a superfamily, including 30 proteins, with a 
broad array of biological functions, of which Activin and Nodal are members. They signal 
upon formation of heteromeric complexes of type I and II receptors; active type II receptor 
kinase, phosphorylates type I receptor, thus activating intracellular signalling cascades, 
SMAD being an important example (Miyazawa, Shinozaki et al. 2002).  
It has been demonstrated that these signalling pathways are important in maintaining an 
mESC niche (Ramalho-Santos, Yoon et al. 2002; Chng, Vallier et al. 2011). Nodal-null mice 
result in limited Oct4 expression (Conlon, Lyons et al. 1994) and inhibition of Activin/Nodal 
signalling by Smad7 expression, resulted in decreased mESC propagation (Ogawa, Saito et 
al. 2007), emphasising the importance of Activin/Nodal signalling in ESC pluripotency. 
Bone Morphogenic Protein (BMP) 
The bone morphogenic proteins (BMPs) were originally identified as facilitators of ESC 
differentiation (discussed in greater detail later), initially discovered during bone and 
cartilage development. However, more recently, it has been reported that BMPs induce the 
expression of Id (Inhibition of differentiation) genes via the Smad pathway to co-operate with 
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the LIF pathway to maintain the ESCs self-renewal (Ying, Nichols et al. 2003). In the 
absence of LIF however, BMPs function to facilitate ESC differentiation. 
Wnt 
Unlike LIF/STAT3 and BMP, Wnt signalling, thus far, is the only signalling pathway thought 
to be active in maintaining pluripotency in both human and mouse ESCs (Sato, Meijer et al. 
2004; Sokol 2011). Wnt proteins were originally identified during wing development in 
Drosphilia studies, owing to the name. Wnts represent a group of secreted, lipid-modified 
proteins shown to function to maintain mESC pluripotency via inactivation of a serine kinase 
GSK-β (a consequence of activation of cytoplasmic signal protein, Disheveled) to stabilise β-
catenin (cell-cell adhesion gene regulator) (Sato, Meijer et al. 2004; Miki, Yasuda et al. 
2011). 
1.1.4 In vitro expansion of mESCs (maintenance of pluripotency) 
 
Since the 1960s, in vitro cell propagation has been achieved via expansion of certain cell 
populations on tissue culture plastic (polystyrene) dishes (Curtis, Forrester et al. 1983), 
corresponding to tailored culture conditions. Expansion of pluripotent mESCs and hESCs, 
has long been achieved using serum supplementation and a fibroblast feeder cell layer as 
substrate (Heath and Smith 1988; Smith, Heath et al. 1988; Brook and Gardner 1997) and 
more recently, leukaemia inhibitory factor (LIF) supplementation for the maintenance of 
mESCs pluripotency (Niwa, Burdon et al. 1998; Sun and Shi 1998). 
mESCs typically form compact colonies, and display high nuclear:cytoplasmic ratio. 
However, despite the presence of LIF, mESCs positioned at the periphery of the colonies 
spontaneously differentiate. Furthermore, mESCs undergo spontaneous apoptosis if cell 
24 
 
density is low enough, furthermore highlighting the importance of a proper experimental 
niche for the maintenance and proliferation of ESCs.  
1.1.5 Embryoid Body (EB) 
An interesting feature of mESCs is that, once grown in suspension culture, they clump 
together to form aggregates known as embryoid bodies (EBs). EBs represent a well-
established model system of early development (Robertson 1987), since the three-
dimensional structure mimics a developing embryo at the egg cylinder stage in vivo (Denker 
2004), demonstrating differentiation to all three primary germ layers; endoderm, ectoderm 
and mesoderm, as discussed previous. 
EB development persists once ESCs aggregate to form clusters by day 2. This is followed by 
differentiation of extraembryonic primitive endoderm (PE) at the periphery of the EB by day 
3 (Murray and Edgar 2000). At day 4, visceral and parietal endoderm cells are present, a 
result of differentiation from their PE precursors. PE cells deposit a BM at their basal surface, 
resembling that of the BM which is present between the primitive endoderm and epiblast in 
the early embryo. Parietal endoderm cells deposit a thick BM similar to Reichert’s 
membrane, which is found between parietal endoderm and trophectoderm in the early 
embryo, although the BM in the blastocyst between the ICM and PE cells is much thinner 
(Inoue, Leblond et al. 1983) since the parietal endoderm cells cannot migrate away from core 
of the EB as they would normally do from the ICM. BM deposition initiates polarisation of 
inner cells forming primitive ectoderm epithelium, separating pluripotent inner cells from 
differentiated outer cells. Some inner ESCs differentiate to epiblast to form columnar epiblast 
epithelium (CEE), whilst other inner ESCs undergo programmed cell death (Coucouvanis and 
Martin 1995), representing the start of cavitation, a phenomenon typically seen by day 7. 
CEE cells then further differentiate to definitive endoderm, ectoderm and mesoderm, such as 
neuronal cells (summarised in Figure 1.3.). 
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1.1.7 Lineage commitment of mESCs 
1.1.7.1 Transcriptional regulators of ESC differentiation during lineage commitment 
ESC differentiation is dependent on silencing the self-renewing, highly complex signaling 
cascade described previously and the response of ESCs to specific environmental cues to 
make fate decisions. In vitro, ESCs can be directed to differentiate, instead of undergoing self 
renewal, via a combination of aggregation culture and the removal of LIF (Keller 1995; 
Smith 2001), the method employed throughout this study, although two other methods also 
exist both consistent with the removal of LIF. One involves expansion of ESCs on stromal 
cells (Nakano, Kodama et al. 1994), while the other entails expansion of ESCs on ECM 
proteins (Nishikawa, Nishikawa et al. 1998). Upon differentiation in vitro, analogous to ESC 
differentiation in vivo, a specific patterning exists correlating to a specific order of 
transcriptional networks. Throughout this project, key markers of these transcriptional 
networks operating, are monitored. 
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1.3. EB development Schematic diagram outlining the important stages of EB development once 
ESCs are grown in suspension. Aggregation of ESCs occurs at day 2, followed by differentiation of 
cells on the periphery of EB to extraembryonic primitive endoderm by day 3. Visceral and parietal 
endoderm develop from primitive endoderm precursors by day 4. Parietal endoderm cells contribute 
to thick BM deposition, specifically a Reichert’s-like BM. Some inner ESCs differentiate to epiblast 
and upon contact with BM become polarised and become columnar primitive ectoderm (CEE), whilst 
epiblast cells that do not deposit BM undergo programmed cell death, resulting in cavitation of EB. 
Primitive ectoderm undergoes further differentiation to mesoderm, definitive endoderm and definitive 
ectoderm, although this process is chaotic. 
Mesoderm differentiation 
Mesoderm, as outlined briefly, forms all tissues of the adult human with the exception of the 
nervous system, skin epidermis and epithelia and can be categorized into paraxial, 
intermediate and lateral plate. Accordingly, a vast array of transcription factors and activated 
signaling cascades occur according to patterning stage, some of which are used in this 
project.  
Mesoderm differentiation in the early developing embryo is initially identified by the 
epithelial to mesenchymal transition (EMT), a pivotal point during gastrulation and formation 
of the germ layers (Lehembre, Yilmaz et al. 2008), thought to be associated with a loss of E-
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cadherin expression (Frame and Inman 2008). Brachyury, a T-box transcription factor (Inman 
and Downs 2006) marks the specification of mesoderm at the time of gastrulation and is 
transiently expressed from E7 to 8.5 in the mouse intermediate and axial mesoderm 
(Wilkinson, Bhatt et al. 1990; Kispert and Herrmann 1994), and is therefore a useful marker 
of mesoderm differentiation in vitro. Mutations in the Bry gene result in eventual embryonic 
lethality, owing to insufficient mesoderm and absence of the notochord, although 
development is normal up to the primitive streak (Herrmann 1992; Herrmann and Kispert 
1994).  Paraxial, intermediate and lateral plate mesoderm differentiation occurs as a 
consequence of successful patterning due to somite divisions into sclerotom, dermatome and 
myotome. In the mouse, the first genes known to be asymmetrically identified at this stage 
are members of the TGFβ family member Nodal, around the node (Jones, Kuehn et al. 1995; 
Beddington and Robertson 1999; Gritsman, Talbot et al. 2000), followed by Lefty2, 
and Pitx2 in the left LPM and Lefty1 in the left floor plate of the neural tube (Lowe, Yamada 
et al. 2001; Brennan, Norris et al. 2002; Saijoh, Oki et al. 2003). The paraxial mesoderm 
develops via the formation of two cylinders of tissue either side of the notochord and after 
weeks 4 and 5, blocks of this tissue called somites bud off to the cranial end, to begin 
governing segmentation. The t-box transcription factor Tbx-6 is known to work downstream 
of Nodal and has important roles in the presomitic mesoderm and formation of the somite 
borders (Chapman, Agulnik et al. 1996; Hadjantonakis, Pisano et al. 2008). Scleratome, 
which gives rise to vertebral body and arch surrounding neural tube is thought to be initiated 
and maintained by sonic hedgehog (Shh) and Noggin, molecules produced by the neural tube 
(Dockter and Ordahl 1998; Dockter 2000), functioning to antagonize BMP4 (Hirsinger, 
Duprez et al. 1997). Epithelial-mesenchymal conversion of the dermatome, which contributes 
to skin on the dorsal side of the body and the myotome, which develops to form skeletal 
musculature of the neck, trunk and limbs, is thought to depend on signals from the neural 
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tube (Brill, Kahane et al. 1995). The intermediate mesoderm gives rise to the gonads, kidneys 
and adrenal cortex (Evseenko, Zhu et al.); Pax-2 and Osr1 are important transcription factors 
first seen after gastrulation in the mediolateral mesoderm (James and Schultheiss 2005) and 
the forkhead transcription factors Foxc1 and Foxc2 are crucial (Wilm, James et al. 2004), 
demonstrated by Foxc1-deficient mice lacking mesoderm differentiation (Aitola, Carlsson et 
al. 2000).  
Despite the complexity, mesoderm differentiation is the most well studied and well 
categorized of the three germ lineages, perhaps underpinned by some default mechanism, 
given the ease of differentiating mESCs to hematopoetic, vascular and cardiac lineages 
(Doetschman, Eistetter et al. 1985). Differentiation of ESCs to mesoderm in the EB model is 
often achieved using combinations of exogenous proteins (Liu, Wang et al.; Torres, Prieto et 
al.) and provides little information on positional information for cell types (Era); therefore 
much work is still needed to optimize for mesoderm-derived cells using this model.  
Endoderm-differentiation 
Endoderm is classically defined as the inner layer of the embryo, whose main derivative is 
the epithelia of the digestive tract, from which organs such as the liver and pancreas develop. 
Analogous to endoderm development in the EB model, in vivo endoderm develops in close 
association with mesoderm in vertebrates, and most endoderm cells are derived from the 
primitive streak (Lawson, Meneses et al. 1991; Wells and Melton 1999). Extraembryonic 
endoderm structures, referred to in this project, are defined as primitive endoderm, parietal 
endoderm and visceral endoderm and differ from definitive endoderm, although they do share 
many transcriptional markers.  
Extraembryonic primitive endoderm cells give rise to endoderm-derived cell lineages in a 
precise spatial pattern, outlined in the murine model whereby cells within the ICM proliferate 
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and segregate to form an outer layer detected by E4.0 shortly before implantation (Gardner 
1982). Likewise during EB development, endoderm differentiation persists via the 
differentiation of cells on the EB periphery to extraembryonic primitive endoderm (PE), as 
outlined previously.  
GATA factors have been identified as key regulators of both extraembryonic and definitive 
endoderm differentiation, via regulation of primitive endoderm differentiation (Murakami, 
Okumura et al. 2005; Okumura, Matsumoto et al. 2005). GATA factors are evolutionarily 
conserved transcriptional regulators, comprised of six members (Gata1 - 6). Gata1-3 are 
generally expressed in hematopoietic lineages; for instance Gata2 and Gata3 have been 
suggested to play a role in early embryonic patterning in Xenopus and Zebrafish (Zon, 
Mather et al. 1991), specifically detected at the pre-primitive streak stage in the chick (Sheng 
and Stern 1999). Gata4-6 in contrast are mainly found in mesoderm and endoderm lineages 
(Molkentin 2000; Ralston and Rossant 2005) evidently crucial in early development (Simon 
1995) and Gata6 specifically, is employed in this project.  
Gata6 is a key regulator of endoderm differentiation, demonstrated neatly since Gata6-null 
embryos lack primitive endoderm differentiation, and visceral and parietal endoderm are 
consequently lacking also (Morrisey, Tang et al. 1998; Cai, Capo-Chichi et al. 2008). 
Moreover, ectopic Gata6 expression can bypass the requirement of Grb2, crucial in Nanog 
repression and primitive endoderm differentiation (Hamazaki, Kehoe et al. 2006; Wang, 
Smedberg et al. 2011), further highlighting the importance of Gata6 in primitive endoderm 
differentiation. 
Alpha-fetoprotein (AFP), Sall4, Sox7, Sox17 and HNF-4 (Duncan, Manova et al. 1994) 
represent key factors also crucial in extraembryonic endoderm differentiation, many of which 
interact with GATA factors to stimulate endoderm differentiation. AFP is the most abundant 
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protein of the mammalian embryo identified in the embryonic yolk sac and fetal liver 
(Tomasi 1977; Spear and Tilghman 1990), although expression is shown to substantially 
decrease after birth. AFP is thought to be secreted by the visceral endoderm (Dziadek 1978), 
although it is proposed that synthesis and expression may depend on interactions of visceral 
endoderm with underlying ectoderm tissue. Hepatocyte nuclear factor 4 (HNF-4) is a 
transcription factor identiﬁed in liver extracts as a DNA binding protein (Sladek 1994), of 
which primitive endoderm differentiation is thought to depend, attributed to its interaction 
with Gata6 (Duncan, Nagy et al. 1997; Morrisey, Tang et al. 1998). Sall4, a component of the 
spalt-like zinc-finger family of transcription factors, is also demonstrated to be crucial in 
differentiation to primitive endoderm (Elling, Klasen et al. 2006), and proposed to be 
specifically important for the Nanog repression step of primitive endoderm differentiation 
(Frankenberg, Gerbe et al. 2011). Sox7 and Sox17 are thought to govern parietal endoderm 
differentiation through interactions with GATA factors (Futaki, Hayashi et al. 2004), and one 
proposed model is that Sox7 competes with Gata4 for FGF3 binding (Murakami, Shen et al. 
2004). Interestingly Sox7 and Sox17 are thought to depend and affect BM formation, 
specifically attributed to Laminin alpha 1 (LamA1) interactions (Niimi, Hayashi et al. 2004).  
Ectoderm 
In vertebrates, ectoderm is dissected into the external (or surface) ectoderm, the neural crest, 
and the neural tube. Cell lineages derived from the ectoderm differentiate to form the 
epidermis; skin, hair, and nails, the brain, and the nervous systems. Formation of these neural 
tissues commence when the notochord, derived from the mesoderm, induce over-lapping 
areas of ectoderm to form the neural plate. The neural plate subsequently folds to form the 
neural tube and dorsal/lateral polarity is established. Within the neural tube, neuroepithelial 
cells proliferate and differentiate into a variety of ectodermal cell lineages. These cells will 
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form the adult nervous system. Specific ectodermal lineages include oligodendrocytes, type-1 
and -2 astrocytes, and neuron progenitors. 
The relationship and interactions between BMP4, Noggin and Chordin is thought to largely 
underpin ectoderm differentiation, specifically inhibition of BMP4-Noggin-Chordin 
interactions is thought to be required for folding of the neural plate (Piccolo, Sasai et al. 
1996; Zimmerman, De Jesus-Escobar et al. 1996). Pax2 and Pax6 are transcription factors 
that contain paired box DNA binding domains, and are evolutionarily conserved in ectoderm 
development. Eye development is a classic demonstration of the importance of Pax6 for 
example; Pax6 mutants lose functionality of the eye, consistent with Drosophila, mice and 
humans (Hogan, Horsburgh et al. 1986; Quiring, Walldorf et al. 1994). Pax6 
expression is detected in a number of regions of the developing mouse central nervous 
system, including the presumptive retina from the headfold stage onwards (Walther and 
Gruss 1991; Walther, Guenet et al. 1991; Stoykova and Gruss 1994; Grindley, Davidson et al. 
1995) and therefore represents a useful marker of differentiation to ectoderm in the EB 
model. 
1.1.7.2 Basement membrane 
Basement membranes (BM) represent the earliest extracellular matrices produced during 
embryogenesis. In the early embryo, primitive endoderm cells deposit BM at their basal 
surface, present between the PE and epiblast. Parietal endoderm cells deposit a thick BM 
similar to Reichert’s membrane, which is found between parietal endoderm and 
trophectoderm in the early embryo (Austria and Couchman 1991).  
BMs are synthesised to provide structural support onto which epithelial tissues grow and for 
compartmentalisation, as a specialised type of extracellular matrix (ECM) localised between 
epithelial and mesenchymal tissues (Amenta, Clark et al. 1983; Martinez-Hernandez and 
Amenta 1983; Paulsson 1992; Engvall 1995; LeBleu, Macdonald et al. 2007). In many 
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instances, BMs function as semi-permeable membrane, controlling the passage of 
macromolecules by size and charge and more recently, it has been shown that BMs influence 
cell behaviour; certain BM components are shown to promote cell adhesion and proliferation 
in the early stages of blood vessel development (Navaratnam 1991) and direct definitive 
endoderm differentiation in mESCs (Higuchi, Shiraki et al. 2010).  
Components of BM largely underpin their structure and function; laminin and collagen IV are 
major constituents (Kleinman, Cannon et al. 1985; Liotta, Rao et al. 1986; Martin and Timpl 
1987) along with proteoglycans and nidogen (Carlin, Jaffe et al. 1981; Timpl, Fujiwara et al. 
1984; Leivo and Engvall 1988). BMs are connected to local cells via a network of integrins, 
who preferentially bind laminin and collagen IV in mass molecular self-assembly 
(Yurchenco, Tsilibary et al. 1986; Timpl and Brown 1996). Throughout this project, 
identification and analysis of laminin expression, is employed as a method of assessing EB 
development and mESC differentiation. 
Laminin 
Laminin, a family of extracellular matrix heterotrimeric glycoproteins, are the major non-
collagenous constituent of BMs. In mammals they have been shown to be involved in diverse 
developmental processes including cell adhesion, differentiation, migration and metastasis, to 
name a few. 
Laminins are composed of three non-identical chains (alpha, beta, gamma) as a laminin 
heterodimer in a cross-shaped structure. Three short arms are formed by a different chain and 
one long arm is composed of the three assembled coiled chains (Figure 1.4; Yurchenco and 
Mathus, 2000.). Of the three chains which make up the laminin heterodimer, beta 1 and 
gamma 1 are detected at the 2-cell stage, whilst alpha 1 is detected at the 8-16 cell stage 
(Cooper and MacQueen 1983; Dziadek and Timpl 1985). 
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1.4. Laminin-1 Schematic diagram outlining the structure of laminin-1 as a model for other laminins, 
outlining the relationship of the 3 chains; α, β and γ joined together in a coiled-coil to form a crucifix 
shape. The heparin-binding domain (G) extends from the coil. Roman numberals indicate regions that 
vary between structures (Yurchenco and Mathus, 2000). 
Mammals possess 15 different heterotrimers (compared to 2 or 3 in invertebrates) formed via 
combinations of 5 alpha, 4 beta and 3 gamma (Aumailley, Bruckner-Tuderman et al. 2005). 
Synthesis of the laminin heterodimer is thought to occur initially with dimerisation between 
beta and gamma chains intracellularly, followed by incorporation of the alpha subunits, to 
facilitate secretion. Ultimately, this model predicts that the alpha subunit dictates 
extracellular secretion (Morita, Sugimoto et al. 1985; Kumagai, Kadowaki et al. 1997; Goto, 
Aoki et al. 2001). Interestingly, research has shown that while the alpha subunit can be 
secreted alone as a monomer, secretion of beta and gamma chains requires simultaneous 
expression of all three chains and their heterotrimeric assembly (Yurchenco, Quan et al. 
1997). 
Upon secretion, laminins interact with each other via the small arms in order to undergo self 
assembly into a BM meshwork. During development, this process is more complicated and 
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requires the long arm to be tethered to receptors on cell surface (Urbano, Torgler et al. 2009). 
Laminins interact with many different receptors, including integrins, α dystroglycan and 
sulphated carbohydrates (sulphatides, heparin, heparan sulphates and HNK-1) (Miner and 
Yurchenco 2004). The importance of such interactions are not fully defined, but it appears 
that laminins employ integrins as a predominant method of mediating cellular response 
(Martin-Bermudo and Brown 1999; Urbano, Torgler et al. 2009). 
The importance of laminin in development is well-documented and different laminin 
isoforms have proven crucial during different development stages. Laminin-111 (alpha 1, 
beta 1 and gamma 1) deficient mice lack BM formation and embryogenesis fails to persist 
beyond pre-implantation (Smyth, Vatansever et al. 1999; Scheele, Falk et al. 2005); moreover 
conditional laminin-111 knockout (to bypass embryonic lethality) displayed defects in 
cerebellum development in mice (Heng, Lefebvre et al. 2011). Laminin-511 (alpha 5, beta 1, 
gamma 1) deficient mice lack a normal developing intestine (Mahoney, Stappenbeck et al. 
2008). 
1.1.7.3 Signalling pathways important in lineage commitment 
 Bone Morphogenic Protein (BMP) 
The bone morphogenic proteins (BMPs) as mentioned, were discovered over 40 years ago as 
orchestrators of bone formation (Urist 1965) and play a crucial role in ESC differentiation (as 
well as self renewal described previous). Since then, twenty BMPs have been identified, of 
which many have been discovered to be essential in early embryonic development, often 
linked to activation of Nodal signaling (Mishina 2003). BMP4 is highly expressed in 
extraembryonic ectoderm and primitive streak before gastrulation (Winnier, Blessing et al. 
1995; Lawson, Dunn et al. 1999; Ying and Zhao 2001). Furthermore, BMP-4 has been shown 
to be necessary for mesoderm differentiation and interestingly, was also found to be 
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necessary for visceral endoderm differentiation (Sirard, de la Pompa et al. 1998; Yang, Li et 
al. 1998).  BMP2 is also expressed in extraembryonic tissues and although BMP2-null mice 
can gastrulate, there is evidence of abnormal embryonic development (Zhang and Bradley 
1996; Kishigami and Mishina 2005). Likewise, BMP6 and BMP7 null mice do not display 
restricted patterning during embryonic development (Dudley, Lyons et al. 1995; Luo, 
Hofmann et al. 1995).   
Fibroblast growth factor (FGF) signaling pathway 
There are 22 members of the fibroblast growth factors (FGFs) family and 4 identified FGF 
receptors (Ornitz and Itoh 2001; Reuss and von Bohlen und Halbach 2003), representing 
extracellular signalling proteins that act through receptor tyrosine kinase activity. Tyrosine 
phosphorylation occurs upon ligand stimulation and has been shown to activate MAPK 
pathways (Chen, Li et al. 2000; Li, Wang et al. 2007; Suwinska and Ciemerych 2011). The 
importance of FGF during development has long been highlighted, since mutations in 
different FGF species are shown to be embryo lethal after pre-implantation (Feldman, 
Poueymirou et al. 1995; Arman, Haffner-Krausz et al. 1998). Furthermore, an FGF docking 
adaptor protein, FRS2a, is shown to control intracellular response of mESCs to FGF (Hadari, 
Gotoh et al. 2001; Gotoh, Manova et al. 2005). 
The role of FGFs in ESC behaviour however is inconsistent. Some studies suggest that FGFs 
have a role in ESC self-renewal (De Felici, Farini et al. 2009; Lanner and Rossant 2010; 
Hsieh, Intawicha et al. 2011). For instance, FGF4, specifically has been shown to be 
regulated by Oct4 and Sox2, markers of ESC pluripotency (Yuan, Corbi et al. 1995) and, 
basic FGF (FGF2) is shown to support hESC self-renewal via stabilisation of the signalling 
above a certain threshold (Levenstein, Ludwig et al. 2006; Eiselleova, Matulka et al. 2009) 
and are similarly important in mESCs (Diecke, Quiroga-Negreira et al. 2008). However, in 
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contrast, a more long-standing idea is that FGF influences differentiation. This is supported 
by recent data suggesting that the role of LIF in maintenance of mESC pluripotency is to 
block FGF signaling downstream of ERK (Silva and Smith 2008; Ying, Wray et al. 2008).  
Ornitz et al., identified that many FGFs are crucial in early development (Ornitz 2000; Wang, 
Ai et al. 2004); FGF2 has been shown to be crucial in brain development (Qiao, Meyer et al. 
2003) and blood vessel formation (Sperinde and Nugent 2000), furthermore, FGF4-null 
mESCs were shown to fail to respond to differentiation inducers (Ids), suggesting a specific 
role for FGF4 in mESC differentiation (Wilder, Kelly et al. 1997; Kunath, Saba-El-Leil et al. 
2007). 
Overall, much is already known of the intrinsic factors that regulate ESC self-renewal and 
differentiation, but much less is known about the role of extracellular factors, such as growth 
factors and the extracellular matrix (ECM), in regulating ESC behaviour.  
One master extrinsic regulator however, is heparan sulfate (HS), a polysaccharide synthesised 
by all mammalian cells shown to mediate many signalling pathways responsible for cell 
proliferation, migration, differentiation and apoptosis throughout early development 
(Delehedde, Deudon et al. 1996; Guimond and Turnbull 1999; Harmer 2006). 
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1.2 Heparan Sulfate  
Heparan Sulfate (HS) is a linear polysaccharide and a class of glycosaminoglycan (GAG), 
made by virtually all mammalian cells. In biological terms, it is often referred to as heparan 
sulfate proteoglycan (HSPG), since this GAG is commonly found attached to a protein. 
Interest in HSPGs has grown massively of late with the realisation that this complex 
macromolecule plays fundamental roles in growth factor signalling and morphogenesis. 
1.2.1 Glycosaminoglycans (GAGs) 
Glycosaminoglycans (GAGs) are large linear polysaccharides, of which there are five 
classifications: 
 Hyaluronan 
 Chondroitin Sulfate (CS) 
 Dermatan Sulfate (DS) 
 Heparin/heparin sulphate (HS) 
 Keratan Sulfate (KS) 
Hyaluronan, a major carbohydrate component of the ECM and found in abundance in load-
bearing joints, is unique since it is the only GAG which is unsulfated and not found attached 
to a protein (Laurent 1989; Chen and Abatangelo 1999). KS, fibrous filaments found in the 
cornea, does not contain a uronic acid disaccharide component, unlike the other GAGs. DS is 
the predominant GAG found in skin (Trowbridge and Gallo 2002; Trowbridge, Rudisill et al. 
2002), and more recently has been linked to cardiovascular disease and tumourgenesis 
(Tollefsen). Chondroitin and heparin/HS are the most abundant GAGs. CS, commonly found 
as the proteoglycan aggregan, is a major component of cartilage, loss of which results in 
osteoarthritis (Miller and Clegg). Of all the GAGs, HS is the most deeply investigated, often 
described as a master extrinsic regulator of cellular behaviour. 
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The biological activity and significance of HS, like any GAG, is attributed to its structure and 
biochemical make-up; one classic example is that all GAGs function in part to maintain ECM 
hydration, attributed to their hydrophilicity and net negative charge (Prydz and Dalen 2000). 
1.2.2 HS structure 
HS is not a single molecule but instead a diverse family of related molecules, consisting of 
repeating uronic acid-glucosamine disaccharide subunits, arranged in sulfated (NS) and 
unsulfated (NA) regions with spacers between; Figure 1.5. Variability in substitution of the 
disaccharide subunits with N-sulfate, N-acetyl and O-sulfate groups means that theoretically 
48 disaccharides could exist, although to date, only 24 have been identified. Generally, the 
same set of disaccharides exist in most tissues but their relative content varies quantitatively 
(Esko and Lindahl 2001); HS and heparin being an exemplar. HS and heparin display 
identical building blocks but the disaccharide subunits are present in different proportions; 
SO4 content is lower in HS than heparin, therefore resulting in a fine structure that can encode 
for higher diversity of information (Rabenstein 2002).  
 
1.5. GAG repeating unit Schematic diagram outlining the molecular structure of the HS disaccharide 
building blocks. A disaccharide repeat of uronic acid and glucosamine, and corresponding potential 
sites of sulfation (red; R1, O-sulfation at C2 of uronic acid; R2, O-sulfation at C6 of glucosamine; R3, 
either SO3 or acetate) indicate the potential diversity and heterogenous nature of HS.  
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1.2.3 HS Biosynthesis 
Biosynthesis of HS occurs sequentially in the Golgi apparatus, where a Xyl-Gal-Gal-GlcA 
linker oligosaccharide is initially built up, attached to the serine residues of proteins (which 
become the core proteins). The HS chain is then produced via the activation of membrane-
bound enzymes. These enzymes are present in multiple isoforms, where expression is 
spatially and temporarily regulated giving rise to different GAGs during different stages of 
development (Raman, Sasisekharan et al. 2005; Nairn, Kinoshita-Toyoda et al. 2007). 
Elongation of the HS chain occurs via alternating addition of N-acetyl-glucosamine 
(GlcNAc) residues followed by D-glucuronic acid (GlcA), mediated by two copolymerase 
enzymes (GlcNAc transferase II and GlcA transferase II) products of EXT1 and EXT2 genes. 
The HS chain is then transported across the Golgi apparatus and the nascent chain is modified 
by several enzymes (summarised in Table 1.1); firstly replace NDSTs which can replace N-
acetyl with N-sulfate, then O-sulfates can be added at C2 by 2-O-glucuronic/iduronic 
sulfotransferase (2OST), and finally further O-sulfation of HS can occur at C6 and C3 
positions of glucosamine residues if 6-O-sulfotransferase and 3-O- sulfotransferase are 
present, respectively (Whitelock and Iozzo 2005). Modifications are not template-driven 
though, and therefore these reactions do not modify the entire chain to completion, resulting 
in structural heterogeneity (Figure 1.6).  
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1.6. HS biosynthesis Schematic outline of HS biosynthesis. Chain polymerisation occurs by 
alternating addition of GlcNAc and GlcUA monosaccharides to the tetrasaccharide linker (GlcA-Gal-
Gal-Xyl) which is attached to serine residues of the core protein, followed by sequential chain 
modification; deacetylation and sulfation according to the presence of NDSTs, C-5 epimerase and 2-
O, 6-O and 3-O sulfotransferases.  
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Table 1.1 HS biosynthetic enzymes and their respective roles 
Enzyme Name Function 
EXT1 Exostosin1 
 
First step of chain initiation; adds alternating units 
of glucuronic acid (GlcA) and GlcNAc to the non-
reducing end of the chain (Busse, Feta et al. 2007; 
Presto, Thuveson et al. 2008) 
EXT2 Exostosin 2 
 
First step of chain initiation; adds alternating units 
of glucuronic acid (GlcA) and GlcNAc to the non-
reducing end of the chain (Busse, Feta et al. 2007) 
HS20ST Heparan sulfate 2-O 
sulfotransferase 
 
Transfers the sulfo group from 3'-
phosphoadenosine 5'-phosphosulfate (PAPS) to the 
2-OH position of the uronic acid adjacent to N-
sulfated glucosamine (Xu, Song et al. 2007) 
HS30ST1-6 Heparan sulfate 3-O 
sulfotransferases (6 isoforms) 
Transfers the sulfo group from 3'-
phosphoadenosine 5'-phosphosulfate (PAPS) to the 
3-OH position of the glucosamine which are N-
sulfated  
HS60ST1-3 Heparan sulfate 6-O 
sulfotransferases (1-3) 
 
Transfers the sulfo group from 3'-
phosphoadenosine 5'-phosphosulfate (PAPS) to the 
6-OH position of the glucosamine which is N-
sulfated or N-acetylated (if adjacent to an N-
sulfated glucosamine) 
NDST1-3 N-deactylase/N sulfotransferases 
1-3 
 
Replaces acetyl groups with sulfate groups at the 
N-position of the glucosamine 
Sulf1 6-O-endosulfatase Removes 6-O sulfate groups (Dhoot, Gustafsson et 
al. 2001; Morimoto-Tomita, Uchimura et al. 2002) 
Sulf2 6-O-endosulfatase 
 
Removes 6-O sulfate groups (Morimoto-Tomita, 
Uchimura et al. 2002; Holst, Bou-Reslan et al. 
2007) 
C-5 
epimerase 
C-5 epimerase Conversion of glucuronic (GlcA) acid to iduronic 
acid (IdoA) (Feyerabend, Li et al. 2006) 
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Ultimately, HS biosynthesis dictates the resultant HS molecule, which largely governs HS-
protein interactions, according to sulfation pattern. A simple demonstration of this is how 
increased HS sulfation of HS is typically correlated with increased signalling activity 
(Baldwin, ten Dam et al. 2008). However, the core protein represents a method of classifying 
overall HSPGs as an alternative to degree of sulfation, and often underpins their functionality 
in development, since the core proteins carry the chains for display at specific locations. 
1.2.4 Core proteins 
Commonly, HS GAGs are attached to a core protein, of which there are three basic types, 
each representing a different mode of cell-interaction and therefore determines if that specific 
HSPG is expressed on the cell surface or in the ECM (Gandhi and Mancera 2008);  
 Syndecans  
 Glypicans 
 Basement membrane proteins  
Syndecans are classified into four subfamilies; syndecan1, 2, 3 and 4, based on distinct gene 
products which vary on the size of the extended extracellular domain onto which associated 
GAG is attached. They contain a conserved transmembrane domain and a characteristically 
small cytoplasmic domain (Lopes, Dietrich et al. 2006). Syndecans are detected on 
blastomere surfaces at the morula stage but restricted in the blasteol cavity (Jokimaa, Inki et 
al. 1998; San Martin, Soto-Suazo et al. 2004). 
Glypicans are categorised into three subfamilies; Gpc1 and 2, Gpc3 and 4 and Gpc5 and 6; 
all distinct gene products with 14 highly conserved cysteine residues which form an extended 
region (2 or 3 Ser-Gly sequences) near the plasma membrane; the glycosylphosphatidyl 
inositol anchor (GPI) (Bernfield, Gotte et al. 1999).  
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ECM proteins, as the name suggests, represent ECM constituents, given that these HSPGs, 
unlike syndecans and glypicans, are secreted from the cell into the ECM. They are thought to 
have a multi-domain structure (Lindblom, Carlstedt et al. 1989; Kallunki and Tryggvason 
1992) and there are three predominant sub-types (Iozzo, Cohen et al. 1994; Murdoch, Liu et 
al. 1994); 
 Agrin 
 Perlecan 
 Collagen XVIII 
Agrin is responsible for the formation, maintenance and regeneration of the neuromuscular 
junction, widely expressed in the central nervous system (CNS) (Kroger and Schroder 2002) 
and accumulating evidence suggests it has a major role in Alzheimers disease (Cole and 
Halfter 1996; Bezakova and Ruegg 2003). Perlecan is more broadly expressed throughout 
early embryonic development, identified in underlying uterine epithelia and trophoblast. In 
the pre-implanted mouse embryo, expression is transient before the morula stage and by the 
blastocyst stage, perlecan expression is enhanced (Rohde, Janatpore et al. 1998; Abraham, 
Riggs et al. 2010). It is also expressed in interstitial matrix tissue of cartilage and bone 
(Schofield, Gallagher et al. 1999; Farach-Carson, Hecht et al. 2005). The C-terminal domain 
of Collagen XVIII, endostatin, is reported to have angiogenesis properties and promotes 
tumour growth via inducing apoptosis of endothelial tissues (Seppinen and Pihlajaniemi; 
Marneros and Olsen 2005). Proteoglycans are therefore diverse molecules, depending on the 
number of GAG chains, type of core protein and class of GAG side chain (Turnbull and 
Gallagher 1991; Lyon, Deakin et al. 1994; Maccarana, Sakura et al. 1996). 
Unlike HS biosynthetic enzyme knockout studies, mutations in HSPG core proteins generally 
stimulate mild defects, suggesting that core proteins are more dispensable and/or can be 
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compensated for. Syndecan4 knockout mice display defective fetal blood vessel formation 
(Ishiguro, Kadomatsu et al. 2000) and are more susceptible to renal damage (Ishiguro, 
Kadomatsu et al. 2001). Syndecan-3 null mice demonstrate defects in muscular development 
(Cornelison, Wilcox-Adelman et al. 2004), development of the digestive system (Westphal, 
Murch et al. 2000) and display impaired nervous system development (Kaksonen, Pavlov et 
al. 2002). Syndecan-1 null mice display defects in respiratory system development; 
specifically hypo-responsiveness (Xu, Park et al. 2005) and impairment in immune system 
function (Park, Pier et al. 2001; Gotte, Joussen et al. 2002). Gpc3 null mice result in 
overgrowth (Cano-Gauci, Song et al. 1999; Chiao, Fisher et al. 2002) and display skeletal 
problems attributed to a lack of BMP interaction (Paine-Saunders, Viviano et al. 2000). 
Perlecan-null mice display defects in fetal tissue development (Costell, Gustafsson et al. 
1999). 
1.2.5 Heparin: a close relative of HS 
Heparin is a close structural relative or subset of the HS family, and unlike HS, which is 
found synthesised by all mammalian cells, heparin is restricted to mast cells, where its 
primary function is to store histamine and proteases (Montgomery, Lidholt et al. 1992). 
Heparin and HS share the same polysaccharide backbone, as described previous; a repeating 
uronic-glucosamine disaccharide. The two molecules differ only in the degree of sulfation, 
and although the same pathway is used during biosynthesis, heparin undergoes more 
extensive sulfation and uronic acid epimerization. More than 85 % of GlcNAc residues are 
N-deacetylated and N-sulfated and more than 70 % of the uronic acid is converted to IdoA. 
Consequently, heparin is a more sulphated, homogeneous molecule, typically represented by 
approximately 2.4-2.6 sulfates/disaccharide, compared to heterogenous HS sulfation 
represented by 0.8 - 1.8 sulfates/disaccharide. Taken together, heparin is well-studied and 
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understood, and is therefore a long standing model or proxy molecule for HS (Rabenstein 
2002; Carlsson, Presto et al. 2008).  
1.3 Heparan sulfate in development 
1.3.1 Early embryonic development 
The importance of HS in development is outlined neatly by Lin et al., who demonstrate that 
EXT1
-/-
 mouse mutants, deficient in HS synthesis, do not survive beyond gastrulation, 
thought to be attributed to an inability to implant into the uterine wall (Lin, Wei et al. 2000). 
Similarly, EXT2 null mice display arrested growth by day 6 and fail to develop (Stickens, 
Zak et al. 2005). Defects in other HS biosynthetic enzymes further emphasize the importance 
of HS sulfation in development. NDST1-deficient mice, display immature lung development, 
eye defects and defects in vascular development (Pallerla, Pan et al. 2007; Ringvall and 
Kjellen 2010); similarly NDST2-deficient mice display defective embryonic development 
(Forsberg and Kjellen 2001) and disruption in 2-O sulfation (HS2OST), was shown to result 
in principally the lack of kidney organogenesis (Bullock, Fletcher et al. 1998; Turnbull, 
Powell et al. 2001). HS sulfation is vital in throughout development and is conserved across 
many species (Gorsi and Stringer 2007), elegantly demonstrated since the loss of sulfation 
has been shown to affect Wingless (Wg), FGF and Hedgehog (Hh) (Lin, Buff et al. 1999; 
Toyoda, Kinoshita-Toyoda et al. 2000; Luders, Segawa et al. 2003), discussed in greater 
detail later. Furthermore, a loss of 6-O sulfation (HS60ST) is correlated with a lack of FGF, 
Wnt and BMP signalling (Kamimura, Fujise et al. 2001; Irie, Habuchi et al. 2003; Sedita, 
Izvolsky et al. 2004). 
Aside from facilitating differentiation during development, it is thought that HS is also 
crucial to maintaining an ESC niche (Nurcombe and Cool 2007; Grunert, Nurcombe et al. 
2008), emphasised by studies suggesting that HS is necessary for ESCs to sustain 
46 
 
pluripotency (Sasaki, Okishio et al. 2008). Furthermore self renewal of mesenchymal stem 
cells from human adult bone marrow is shown to be enhanced via supplementation with 
embryonic form of HS (HS-2)(Helledie, Dombrowski et al. 2011). 
1.3.2 HS-protein interactions 
Heparan sulfate-interacting proteins include growth factors, morphogens, ECM components 
and many more, of which most have been identified as functionally significant throughout 
development. 
1.3.2.1. Heparin: an important anticoagulant 
As mentioned, HS and heparin are structurally, very closely related. Understanding and 
studying heparin as a model for HS, has led to the idea that specific HS motifs and sulfation 
patterns facilitate specific protein binding, in turn governing signalling pathways. The classic 
example is the discovery of the antithrombin (AT)-binding pentasaccharide sequence in 
heparin (Petitou, Casu et al. 2003). Heparin was discovered in 1916 and over 20 years later 
was shown to have anticoagulant properties, providing a plasma cofactor was present 
(Abildgaard 1968). It has since been proven that the AT-binding region specifically consists 
of three GlcN residues (two of which are required to be N-sulfated), one GlcA and one IdoA, 
furthermore binding is enhanced upon the presence of two O-sulfated groups, a 6-O sulfate 
and a 3-O sulfate (Petitou, Casu et al. 2003).  Alongside the AT-binding site, the requirement 
for a specific 3-O sulfated HS structure in the binding of herpes simplex protein to cell 
surface HS during infection (Shukla, Liu et al. 1999) exemplifies the important of specific 
sulfation pattern. Likewise it appears that 6-O sulfates may contribute importantly to specific 
protein binding and selectivity of recognition (Ashikari-Hada, Habuchi et al. 2004; Powell, 
Yates et al. 2004; Mahalingam, Gallagher et al. 2007). The relationship between HS sulfation 
pattern, conformation and activity has been difficult to establish fueling a debate within the 
glycomics field as to whether the important of HS sulfation pattern is actually an artifact of 
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HS conformation. Support for this, amongst many examples, is that the activation of the 
serpin protease inhibitor AT, by binding to this pentasaccharide is a consequence of 
conformational change which increases the rate of inactivation of proteases involved in 
coagulation (Factors IIa and Xa for example). The glycosidic linkage geometry is more 
recently proving crucial, both influencing and being influenced by the degree and position of 
sulfation. Biophysical techniques have shown that conformation stability of the glucosamine 
varies according to varying degrees of sulfation (Molloy, 1993 and Yates, 1996). Likewise, in 
one study, eight systematically sulfated HS structures were shown to alter the uronic acid 
conformation and upon conversion to different cation forms (Na
+
, K
+
, Mg2
+
, Ca2
+ 
and Cu2
+
 
for example) resulted in distinct conformations and varying degrees of flexibility. 
Additionally Cu2+ and K+ conversions of HS modififed activated a previously inactive 
FGF2-FGFR1c signal (Rudd and Yates, 2007) exemplifying the influence conformation has 
on functionality.  
1.3.2.2. HS-growth factor interactions 
Growth factors are a class of soluble proteins that stimulate a wide range of cellular 
responses, for many of which HS mediates the function. The HS-FGF interaction is the most 
extensively studied. 
 HS-FGF complex 
FGF signalling, as outlined previously, is crucial in early embryonic development. The 
integrity of FGF signalling is dependent on tight regulation of FGF activity and receptor 
specificity, which has been shown to depend on HS and the existence of a HS-FGFR-FGF 
complex (Pye, Vives et al. 1998; Guimond and Turnbull 1999), supported by the 
identification of a heparin-binding domain within the FGF structure (Eriksson, Cousens et al. 
1991; Kan, Wang et al. 1993) and evidence that HS is thought to stabilise FGFs against 
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degradation and act as a storage reservoir for ligands (Hacker, Nybakken et al. 2005; 
Beenken and Mohammadi 2009).  
The proposed signalling complex is thought to consist of an FGF dimer, bound to two 
receptors with an HS oligosaccharide. However, the physical orientation of the ligands, 
receptors and HS chains remains controversial (Plotnikov, Schlessinger et al. 1999; 
Plotnikov, Eliseenkova et al. 2001).  In the instance of FGF1, Wu et al., propose that HS 
interacts both with FGF and FGFR and furthermore, since molar ratio of HS, FGF1 and 
FGFR1 were shown to be independent of HS size, suggested the complex must take place on 
the cell surface (Wu, Zhang et al. 2003). Powell et al., showed that both FGFR1 and FGFR2 
bind to HS, albeit with different binding affinities owing to their kinetic, dynamic interactions 
with FGF (Powell, Fernig et al. 2002). Another study suggests that FGF and FGFR act 
together to identify suitable, unique HS motifs once bound together (Mohammadi, Olsen et 
al. 2005). Interestingly regarding the importance of HS sulfation, 6-O desulfated heparin was 
shown to display reduced selectivity for several different FGF-FGFR complexes, supporting 
the idea of tissue-specific nature of HS-FGF interactions (Zhang, Zhang et al. 2009). HS is 
shown to increase the binding affinity of FGF-2 by 10-fold therefore high concentrations of 
FGF can signal in a HS-free environment although high affinity signalling is limited to full 
ligand-receptor-HS structure (Pellegrini 2001). HS interaction with FGF-2 is shown to 
control cell-proliferation in the adult brain (Mercier and Arikawa-Hirasawa 2011), and is 
similarly important in breast carcinoma development (Qiao, Meyer et al. 2003). 
Despite controversy surrounding the dynamics of the formation and structure of HS-FGF-
FGFR interaction complex, there is growing evidence to suggest that the sulfated regions of 
HS underpin HS-FGF interactions. Although ionic interactions will encourage and dictate a 
general affinity for FGF-HS binding (Pye, Vives et al. 1998), more evidence exists for 
specific HS-FGF binding depending on specific arrangements of NA and NS segments 
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(Faham, Hileman et al. 1996; Ford-Perriss, Guimond et al. 2002) and since none of the amino 
acid residues in the HS binding region of FGF are conserved (Faham, Linhardt et al. 1998), it 
is likely that different FGFs have different affinities for different HS structures.  
In Drosophila, the sulfateless gene (Sfl) resulted in unmodified HS, which could not activate 
FGF (Lin, Buff et al. 1999) and additionally, 2-O sulfation is shown to be required for 
FGF/FGFR binding and additional 6-O-sulfation is required for mitogenic activity (Rapraeger 
1995; Pye, Vives et al. 1998; Guimond and Turnbull 1999). 
HS-VEGF complex 
The vascular endothelial growth factors (VEGFs) are a family of endothelial cell mitogens 
with potent permeability properties, crucial in vascular system development and angiogensis 
(Folpe, Veikkola et al. 2000; Veikkola, Karkkainen et al. 2000). VEGFs have also been 
shown to play a role in early embryonic development and surrounding tissues, since high 
levels of VEGF are detected in the early egg sac and hemangioblasts within the yolk sac by 
E8-11, as well as in multiple fetal tissues including lung, kidney and heart (Jakeman, 
Armanini et al. 1993; Cheung 1997). 
Alternative splicing of VEGF gives rise to at least six isoforms, categorised by heparin-
binding ability; VEGF121 does not bind heparin, VEGF165 binds with moderate affinity and 
VEGF189 binds heparin strongly (Robinson and Stringer 2001). As in HS-FGF binding, there 
is evidence that HS binding is necessary to mediate VEGF function, for example many 
studies have demonstrated the importance of HS in the binding of VEGF165 to VEGFR2 for 
mitogenic activity (Gitay-Goren, Soker et al. 1992; Gengrinovitch, Berman et al. 1999), and 
furthermore, a lack of HS-VEGF binding has been shown to disrupt VEGF concentration 
gradients in the ECM and display uncharacteristic extracellular localisation of VEGF, 
strongly implicating that HS plays an important role for HS in controlling VEGF diffusion. 
50 
 
Other HS-growth factor interactions (reviewed by Ori (Ori, Wilkinson et al. 2008), Zhang 
(Zhang 2010)) include hepatocyte  growth factor (Lyon, Deakin et al. 1998; Rahmoune, 
Rudland et al. 1998), epidermal growth factor (EGF) (Dluz, Higashiyama et al. 1993), 
platelet-derived growth factor (PDGF) (Feyzi, Lustig et al. 1997; Feyzi, Trybala et al. 1997; 
Rolny, Spillmann et al. 2002) and transforming growth factor beta (TGFβ) (Lyon, Deakin et 
al. 1994; Mulloy and Rider 2006; Rider 2006).  
HS-ECM components 
HSPGs perlecan, agrin and collagen XVIII, as described previously, are major components of 
the ECM and owing to their residency in the ECM, interact with many other ECM 
components including fibronectin (Haugen, Letourneau et al. 1992), laminin (Dow and 
Riopelle 1990; Riopelle and Dow 1990; Battaglia, Mayer et al. 1992; Mayer, Kohfeldt et al. 
1998), and collagens (LeBaron, Hook et al. 1989; Specks, Mayer et al. 1992) to contribute to 
ECM assembly and function. The importance of HS-ECM interactions was demonstrated 
since cells grown in sodium chlorate, a well known GAG-inhibitor, lacked the ability to 
produce a BM, attributed to a reduced capacity to bind laminin (Brauer, Keller et al. 1990). 
Furthermore, like many HS-protein interactions, HS-ECM interactions display a degree of 
specificity attributed to HS sulfation (Perrimon and Bernfield 2000). 
HS-morphogen interactions 
Morphogens are signalling molecules that re-locate from an original tissue to generate a 
gradient of morphogen concentration which functions to induce cellular responses via 
concentration-dependent activation of genes.  
The distribution of morphogens during development determines cell fate and has often been 
shown to be regulated by HS, neatly demonstrated by Drosophila wing formation. Wingless 
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(Wg) (Wnt protein), Decapentaplegic (Dpp) a BMP protein and Hedgehog (Hh), three 
particularly important morphogens in wing patterning (Strigini and Cohen 1999) are shown to 
depend on adequate HS binding, since disruptions in HS biosynthetic enzymes was shown to 
affect Hh diffusion (Bellaiche, The et al. 1998), Wg and Hh functionality (bornemann 2004, 
takei 2004).  
Interestingly, like HS-FGF, HS sulfate motifs have been demonstrated to be of great 
importance in HS-morphogen interactions; for example mutations in the sulfateless gene in 
Drosphillia (Slf) which competes with PAPs to prevent sulfation, is shown to disrupt Wg 
signalling (Binari, Staveley et al. 1997; Hacker, Lin et al. 1997). Furthermore, FGFs acting as 
morphogens, for example during mesoderm patterning from the cardiac tissue to foregut and 
endoderm in liver and lung development (Serls, Doherty et al. 2005), are dependent on HS 
sulfation, exemplified by the requirement for FGF8 gradient in the embryo stimulating 
downstream phosphorylation with consequential embryo development (Dubrulle and 
Pourquie 2004). 
1.3.2.3 HS Tissue specificity 
HS purified from different tissues/cell types has led to identification of structural differences 
depending on tissue of origin (Naimy, Leymarie et al.; Warda, Toida et al. 2006). HS has 
been isolated and purified from a wide variety of animals from C.elegans to humans (Gomes 
and Dietrich 1982; Dietrich, Nader et al. 1983; Warda, Toida et al. 2006) and substantial 
differences in HS structure have been identified (Linhardt, Turnbull et al. 1990; Medeiros, 
Mendes et al. 2000; Toyoda, Kinoshita-Toyoda et al. 2000; Warda, Mao et al. 2003; 
Vongchan, Warda et al. 2005). 
Allen et al., neatly demonstrated that HS is tissue-specific using the HS-FGF complex as a 
model tool. Mice embryos responded to different FGFs depending on developmental stage; 
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for example FGF4 was not shown to recognise HS in the heart and major blood vessels but 
was apparent in all other tissues (Allen, Filla et al. 2001). Furthermore, FGF10-FGFR-HS 
complex is detected in varying stages of development for the activation of specific pathways 
at specific times (Avivi, Yayon et al. 1993; Yan, Fukabori et al. 1993; Igarashi, Finch et al. 
1998; Patel, Knox et al. 2007). Tissue-specific differences in HS is likely to exist because of 
affinity and binding ability attributed to specific HS structures (Faham, Linhardt et al. 1998). 
This is supported by work which highlights the specificity of different FGFs for different 
FGFRs; FGF4 affinity for FGFR1 and FGFR2 depends on HS concentration (Aviezer, Safran 
et al. 1999). Furthermore, specific patterns of HS N-sulfation and O-sulfation have been 
shown to activate different FGFs; 1, 2 and 4 for instance (Guimond and Turnbull 1999; 
Kreuger, Jemth et al. 2005; Harmer 2006). 
Moreover, HSPGs have been shown to undergo structural changes during progressive 
pathological events (Lindahl and Lindahl 1997; Rykova and Grigorieva 1998). Collectively, 
these results support the idea that structure and function of HS is hugely diverse of HS across 
organs, species, developmental stages and disease status. 
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1.4 Biomaterials  
Considering the complex nature of the ECM in vivo, as demonstrated extensively in previous 
sections, it is unsurprising that bioengineers are struggling to meet the demands for an 
artificial ECM. As mentioned, any ESC-based clinical application requires a standardised 
system of generating high ESC numbers. Therefore a biomaterial demonstrating 
biocompatibility, mechanically stability, cost efficacy and ease of surface modification is 
required for cell expansion. Materials with all these properties are currently elusive. 
1.4.1 Overview of biomaterials 
Biomaterials represent synthetic materials with excellent biocompatibility defined as ‘the 
ability of a material to perform with an appropriate host response in a specific application’ 
(Williams 2003). Biomaterials were in some capacity exploited in the early 1900’s, when 
bone plates were successfully implemented to stabilise bone fractures and to accelerate their 
healing. By the 1950’s, blood vessel replacement using polymers was in clinical trials 
(Chlupac, Filova et al. 2009) and artificial heart valves and hip joints were in development 
from the 1970s. 
Biomaterials are generally classified into three groups and subcategorised according to 
application, whereby they display different mechanical properties, outlined in Table 1.2. 
Several classes of biomaterials can be used in any one application such is the demand of 
biomaterials to function seamlessly and dynamically, as natural materials would. 
Orthopaedic applications 
Metallic materials are typically employed as load bearing members of a joint replacement for 
example (pins, plates and femoral stems for instance) in conjunction with a ceramic wear-
resistant surface; alumina or zirconia for example (Heimke, Leyen et al. 2002; Campbell, 
Shen et al. 2004). Hydroxyapatite is often used  
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Table 1.2 Classifications of biomaterials; metals, ceramics and polymers and their applications 
according to physical properties 
Class Sub-class Properties Common application 
+ - 
Metals Titanium Strong, load 
bearing 
Expensive, 
corrosive 
 Joint replacements 
 Orthopaedic fixation 
 Stents 
Cobalt-chromium 
Alloys 
316L 
stainless steel 
 
 
Ceramics 
 
 
Alumina Wear 
resistance, 
hardness 
Brittle; fail 
under tension 
 Dental implants 
 Joint parts 
Zirconia 
Carbon 
Hydroxyapeptite 
 
 
Polymers 
Polystyrene Cheap to 
manufacture 
and easily 
chemically 
modified 
Poor 
mechanically; 
lack rigidity 
and strength  
 Joint sockets 
 Sutures 
 Blood vessels  
Poylethylene 
Gortex 
Polyurathane 
for bone-bonding applications to assist implant integration (Chen, Wong et al. 2004; Porter, 
Buckland et al. 2006) and polymers such as ultra high molecular weight polyethylene 
(UHMWPE) are used as articulating surfaces against ceramic components in joint 
replacements (Davidson and Schwartz 1987; Davidson 1993). 
Dental applications 
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Metallic biomaterials have long been successfully employed as pins for anchoring tooth 
implants, mimicking the root of a tooth as well as in parts of orthodontic devices, whilst 
ceramics have found uses as tooth implants including alumina, zirconia and dental porcelains 
(Ozkurt and Kazazoglu), owing to their wear-resistant nature. Hydroxyapatite has been used 
for coatings on metallic pins and to fill large bone voids caused by disease or trauma. 
Likewise, polymers are also in used as orthodontic devices such as plates and dentures. 
Cardiovascular 
Many different biomaterials are used in cardiovascular applications depending on the specific 
application and design. For instance, carbon in heart valves and polyurethanes for pace maker 
leads (Stokes and Cobian 1982). Vascular grafts are typically made of 
polytetrafluoroeythlene (PTFE) (Peck, Gebhart et al.) and vascular stents can be made from 
titanium or polymers or both (Steinemann 1998; Stone, Ellis et al. 2004) depending on its 
function and longevity requirements. 
Cosmetic 
Silicones have been used in cosmetic surgery for applications such as breast augmentation 
(Duffy 1990; Duffy 2005) and chin and nasal replacement during maxillofacial surgery 
(Hinderer 1991). Polymers represent the optimal material for contact lens applications, owing 
to their sophisticated transparency, flexibility, hydrophilicity and oxygen-permeability 
properties (Wheeler, Woods et al. 1996; Nicolson and Vogt 2001; Goda and Ishihara 2006). 
This project is underpinned by the long-term goal of synthesizing and optimising a synthetic 
substrate to act as an artificial ECM for routine, long-term ESC expansion, thus replacing 
current animal-derived materials, which limit ESCs from reaching clinical phase.  
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Polymers represent a class of biomaterials which suit ESC scale-up applications; in terms of 
cost effective, simple manufacture and ease of chemical manipulation. The lack of 
mechanical strength does not influence their applicability here, since in vitro culture of ESCs 
does not involve the exertion of much force. 
Polymers, or ‘plastics’, represent chemical compounds consisting of repeating structural units 
created via polymerisation, which gives rise to a macromolecule of high relative molecular 
mass, consistent with natural, biological polymers, such as polyamides (proteins), 
polynucleotides (nucleic acids) and polysaccharides. A polymer of the same repeating 
monomer is termed a homopolymer, whilst variations in monomer backbone structures define 
a copolymer.  
Polymer properties and attributes are governed by the monomers which make up the polymer, 
the bonding between monomers, the physical arrangement of this monomer backbone and 
polymer chain length, which collectively gives rise to a specific microstructure and 
architecture, as a consequence of polymerisation. 
Polystyrene 
Discovered in 1839, polystyrene (PS) is a homopolymer comprised of styrene monomers, 
represented by a hydrocarbon backbone. PS properties are generally determined by relatively 
weak attractions between polymer chains, known as van der Waals attractions, which confer 
flexibility and elasticity. During manufacture, upon heating, PS chains slide past each other, 
underpinning the ability of PS to be easily softened and moulded to suit any shape or 
application (Figure 1.8). 
Tissue culture polystyrene (TCPS), commonly known as ‘tissue culture plastic’, has been 
used for the expansion of cells in vitro since the 1960s (Curtis, Forrester et al. 1983), largely 
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because it is cost effective to manufacture, clear and solid at room temperature and 
importantly, can withstand sterilisation involving high pressures and temperatures (Jayabalan 
1995; Sladowski, Grabska-Liberek et al. 2008). TCPS differs from PS only in surface 
treatment, since PS is modified to optimise electrostatic and hydrophobic cell-biomaterial 
interactions, necessary due to the non-adhesive nature of polystyrene (Maroudas 1977; Ward, 
Knox et al. 1977; Grinnell 1978). However, TCPS is often further modified, depending on 
application, using animal-derived materials to serve as an ECM, examples of which include 
collagen (He, Ma et al. 2005; Wojtowicz, Shekaran et al. 2010), fibronectin (Barrias, Martins 
et al. 2009; Maciel, Oliveira et al. 2012), laminin (Huber, Heiduschka et al. 1998; Huang, 
Huang et al. 2007), and gelatine (Goetz, Scheffler et al. 2006; Hosseinkhani, Hosseinkhani et 
al. 2008; Rao and Winter 2009; Sun, Huang et al. 2012). It is therefore clear that TCPS never 
truly interacts with any cells (cells sit on the cell-derived coating not the TCPS), but instead 
acts merely as a platform on which to build an animal-derived substrate. Thus, there such is 
an on-going effort to identify an entirely synthetic material to support ESC scale-up and 
eradicate the usage of animal products.  
 
Figure 1.8. Polystyrene application in cell culture. Styrene monomers represent the hydrocarbon 
polystyrene backbone, which can be easily softened and moulded to suit the application or shape. PS 
is often treated to enhance surface properties for cell-based applications and typical laboratory 
plasticware includes tissue culture dishes, culture plates, disposable pipettes and culture media bottles 
(from www.agc.com). 
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Since TCPS, what’s new? 
Since the discovery and common employment of TCPS for cell culture, many different 
polymers have been identified as biocompatible and now successfully function in an array of 
medical applications, outlined in Table 1.3. These polymers therefore represent great promise 
in the area of ESC scale-up too, and many are currently being explored as TCPS alternatives, 
as well as in tissue-engineering applications. 
Table 1.3 Uses of common polymers in medical applications and corresponding monomers 
Polymer Name Application 
 
PE 
 
(poly) ethylene 
 Catheters 
 Hip prostheses 
 
PET 
 
(poly) ethylene terephalate 
 
 Vascular grafts (Struszczyk, Bednarek et 
al. 2002) 
 Vertebrae disc prostheses (Ambrosio, De 
Santis et al. 1998) 
 
PMMA 
 
(poly) methyl methacrylate 
 Bone cement (Reichenberger, Stoff et al. 
2007) 
 Dental materials (Kaufmann, Jensen et al. 
2002) 
 
PTFE 
(GORE-
TEX) 
 
(poly) tertrafluoroethylene 
 Synthetic blood vessels (Sanchez, Wain et 
al. 1997) 
 Patches for tissue regeneration 
(Koschwanez and Broadbent) 
 Surgical sutures 
 
 
PEG 
 
 
(poly) ethylene glycol 
 Laxative 
 HMW PEG used as dietary preventative 
for colon cancer (Corpet, Parnaud et al. 
2000) 
 Suppressor of carcinogens(Borgens and 
Bohnert 2001) 
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PDMS 
 
(poly) dimethylsiloxane 
 Heart valve  
 Drug-delivery devices 
 Intravitreo implants 
 
HEMA 
 
(poly) 2- hydroxethyl 
methacrylate 
 Contact lens 
 Catheters 
 
1.4.2. Optimising polymer surfaces to enhance polymer-cell interaction 
Polymer properties and functionality in medical devices are not normally determined by bulk 
properties but instead related more to the micro and nano structures on the surface. Surface 
properties are usually underpinned by wettability, hydrophilicity, roughness and ionic charge, 
reviewed (Wang, Robertson et al. 2004; Ma, Mao et al. 2007) and manipulation of these 
features chemically, can provide the potential to tailor any polymer surface to suit a specific 
application.  
The importance of polymer surface properties is outlined by studies which demonstrate that 
the control of cellular behaviour can be attained using various polymer surface patterning 
techniques; for example neuron behaviour can be controlled by nano-patterned polymer 
surfaces (Murugan, Molnar et al. 2009) and similarly, nano-patterning has been shown to 
direct differentiation of hMSCs (Curran, Chen et al.). Furthermore, the performance of 
PDMS in microfluidic devices has been successfully enhanced via altering surface wettability 
(Zhou, Khodakov et al.) and osteoblast expansion for bone regeneration and engineering, has 
been enhanced via chemical manipulation of polymer surface properties (Saranya, Saravanan 
et al.). 
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1.5 Work leading to current studies 
Preliminary work from our group suggested that HS is required for the differentiation of 
extraembryonic endoderm (EEE) in mESC-derived EBs and that ESCs synthesise low levels 
of sulfated HS. Furthermore it was suggested that the loss of differentiation to EEE from 
mESCs, attributed to a lack of serum and feeders, cannot be rescued when cells were re-
plated onto heparitinase-treated feeders. Taken together, and considering the requirement of 
FGF in EEE differentiation, it is likely that EEE facilitates FGF signalling and vice versa, in 
an HS-dependent manner. 
This raised a number of questions to be addressed in the current study including; (i) is HS 
required for differentiation of mESCs to other lineages, (ii) is HS present in feeders and/or 
serum and if so (iii) what HS structures are present and finally, (iv) could this information be 
exploited to synthesize artificial substrates with stem cell regulatory properties? 
1.6 Project Aims 
1. Identify differences in mESC behaviour according to variations in culture conditions, 
and thus determine if feeder cells, or serum, or both are required for differentiation. 
2. Identify the requirement for HS in specific lineage commitment; primarily to 
endoderm differentiation. 
3. Identify differences in structure of HS from ESCs, according to culture condition. 
4. Determine if exogenous HS can rescue defects in EB development due to variant 
culture conditions. 
5. Evaluate novel polymers and polymer-HS conjugates for supporting the growth and 
differentiation of mESCs. 
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2. Materials and Methods 
2.1 Materials 
2.1.1 Solutions 
 
0.1 % w/v gelatine: 1 g porcine gelatine was added to 1 L distilled water and autoclaved. 
4 % (w/v) paraformaldehyde (PFA): 4 g PFA was added to 100 mL PBS in conical flask, 
heated to 60°C and agitated with magnetic flea in fume cupboard until PFA had dissolved 
and solution was clear. It was stored at 4 °C for 1 week. 
15 % sucrose: For 1 L, 150 g sucrose was added to 1 L 1 X PBS. 
7.5 % gelatine: For 100 mL: 7.5 g porcine gelatine and 15 g sucrose was added to 100 mL 1 
X PBS. 
Toluidine blue solutions 
Stock; 1 % toludine blue: For 50 ml: 0.5 g tolluidine blue in 50 ml 70 % EtOH. 
Working; 0.1 % toluidine blue: For 50 ml: 5 ml tolludine blue stock solution in 45 ml 1 % 
sodium chloride in water. 
Subbing solution: 500 mL distilled water was heated to 60°C and 2.5 g gelatine type A 
(bloom 300, Sigma) was added (0.5 % solution). The solution was mixed vigorously with 
magnetic flea (temperature not allowed to exceed 60°C), until completely dissolved and then 
allowed to cool to 40°C. Once sufficiently cooled, 0.25 g chromium potassium sulphate 
(CrKSO4.12H20) was added (0.05 % solution). 
BODIPY solution: 5 mg of BODIPY was freeze-dried and solid content was transferred to 
eppendorph tube. 1 ml of pre-chilled methanol was added to original viale.  
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2.1.2 Buffers 
10 X phosphate buffered saline (PBS): For 1 L, 80 g NaCl, 2.0 g KCl, 11.5 g Na2HPO4 and 
2.0 g KH2PO4 were added to 1 L distilled water and autoclaved (For 1X PBS 100 mL of 10 X 
solution was added to 900 mL dH20). 
5 X lyase buffer: 500 mM sodium acetate, 0.5 mM calcium acetate: For 10 ml, 0.4102 g 
sodium acetate, 1 ml of 500 mM stock, added to HPLC-grade water 
SAX – HPLC buffers 
A: 150 mM NaOH: For 1 L, 15 ml NaOH added to 1 L HPLC-grade water. 
B: 2 M NaCl 150 mM NaOH: For 1 L, 15 ml NaOH, 116.88 g NaCl added to 1 L 
HPLC-grade water. 
D: 2 M NaCl 300 mM NaOH: For 500 mL, 15 ml NaOH, 58.44 g NaCl added to 500 
mL HPLC-grade water. 
2.1.3 Cell lines 
STO cells, a mouse embryonic fibroblast cell line, were a gift from Dr Neil Smith, Cardiff 
University, Wales. 
E14 mESCs, a mouse embryonic stem cell line were a gift from Professor Mark Boyd, 
University of Liverpool, UK.  
EXT1
-/-
 mESCs, a HS deficient mouse embryonic stem cell line, were a gift from Dr Cathy 
Merry, University of Manchester, UK. 
KSCs-GFP, a kidney-derived stem cell GFP-expressing line, were derived by Dr Ranghini, 
University of Liverpool. 
 
64 
 
2.1.4 Biomaterials 
Polymers were synthesised in-house at SpheriTech (The Heath, Science Park, Runcorn), our 
CASE partner. Hydrogels and poly-Ɛ-lysine (PƐL) macroporous polymers were synthesised 
as outlined below in Table 2.1 and 2.2, respectively. 
Table 2.1 Synthetic SpheriTech hydrogels and corresponding compositional ratios. Sixteen 
different hydrogels were employed as potential biomaterials for ESC maintenance and support; their 
compositional ratios are outlined. 
 Methacrylic Acrylic PEG 360 
methacrylate 
PEG 526 
methacrylate 
2-hydroxethyl 
methacrylate 
M-N 
dimethyl 
acrylamide copolymer 
1 1  1    
3 1   1   
5 1    1  
6 1    15  
7  1 1    
9  1  1   
11  1   1  
12  1   15  
13  1    1 
14  1    15 
15 1     1 
16 1     15 
 
Table 2.2 Poly-Ɛ-lysine (PƐL) macroporous polymers composition 
Component 
Poly-Lys 
Dicarboxylic acid 
N-hydroxysuccinimide (NHS) 
Water soluble carbodiimide (WSC) 
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 2.2 Methods 
2.2.1 Cell Culture 
2.2.1.1 Preparation of gelatineised culture dishes 
0.1 % (w/v) gelatine solution was added to tissue culture dish and incubated at RT for 
approximately 15 min. The gelatine solution was aspirated and replaced with media when 
necessary. 
2.2.1.2 Medium 
STO/EB medium High glucose DMEM (Gibco, Invitrogen, UK) was supplemented with 10 
% fetal bovine serum (PAA), 2 mM L-glutamine (Gibco Invitrogen, UK), 1 % NEAA 
(Gibco, Invitrogen, UK), 1 mM 2-βmercaptoethanol (Gibco Invitrogen, UK). 
ESC medium Advanced
TM
 high glucose DMEM (Gibco, Invitrogen, UK) was supplemented 
with 1 mM β-mercaptoethanol (Gibco, Invitrogen, UK), 2 mM L-glutamine (Gibco, 
Invitrogen, UK), 1000 U / mL leukaemia inhibitory factor (LIF) (Millipore, UK) and 2% fetal 
bovine serum (PAA). 
Serum free medium Advanced
TM
 high glucose DMEM (Gibco, Invitrogen, UK) was 
supplemented with 1 mM β-mercaptoethanol (Gibco, Invitrogen, UK), 2 mM L-glutamine 
(Gibco, Invitrogen, UK) and 1000 U / mL leukaemia inhibitory factor (LIF) (Millipore, UK) 
2.1 Routine culture of E14 mESC 
E14 mESCs were cultured on 3.5 cm tissue culture dishes (Nunc, Thermo Scientific, 
Denmark) coated with 0.1 % gelatine in mESC medium. mESC medium was removed from 
confluent dish of E14 mESCs and cells were washed once with PBS. 1 x trypsin/EDTA 
(PAA, UK) was added for 3-5 min, and subsequently neutralised with STO medium, before 
centrifugation at 64g for 2.5 min. STO medium was removed and E14 mESCs resuspended in 
mESC medium depending on culture condition, outlined in Figure 2.1. Typically, E14 
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mESCs were sub-cultured every second day at a ratio of 1:3 and incubated at 37°C and 5 % 
CO2, unless otherwise stated.  
 
 
Figure 2.1 Schematic outlining the three distinct 2D culture conditions employed during E14 
mESC expansion, throughout this study. mESCs were maintained in the presence of 2% FBS and 
on a feeder layer (+F +FBS); a culture condition commonly employed for expansion and maintenance 
of mESCs. A second condition was feeder-free, whilst medium is supplemented with 2% FBS as 
before (-F +FBS). Thirdly, mESCs were maintained in a serum-free, feeder-free culture system (-F –
FBS). All three culture conditions were supplemented with LIF. 
2.2.1.4 Serum-free E14 mESCs culture 
mESCs were cultured in mESC medium, except that FBS was not added to medium. Under 
these conditions sub-culture technique is exactly as described previously, except mESCs were 
passaged every 3.5 days. 
2.2.1.5 Serum-free E14 mESCs culture supplemented with heparin 
mESCs were cultured exactly as described in 2.2.1.4, however dishes were supplemented 
with 1 µg/mL porcine mucosal heparin (Celsus, #HO-3105; www.heaprin.com) immediately 
prior to incubation. 
2.2.1.6 Routine culture of STO feeders 
STO cells were cultured in 10 cm tissue culture dishes (Corning) and coated with 0.1 % 
gelatine in STO medium. STO medium was removed from a confluent dish of STO cells and 
cells were washed once with PBS. 1 x trypsin/EDTA was added for 3-5 min, and 
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subsequently neutralised with STO medium, before centrifugation at 64g for 2.5 min. STO 
medium was removed and cells re-suspended in fresh STO medium. STO cells were sub-
cultured every second day at a ratio of 1:4 and incubated at 37°C and 5 % CO2. 
2.2.1.7 Preparation of STO feeders 
One confluent 10 cm dish of STO cells were inactivated with mitomycin-C (Gibco, 
Invitrogen, UK). 5 mL of total 10 mL of STO medium was removed from a confluent dish 
and 100 µL of 1 mg / mL stock of mitomycin-C (final concentration = 20 µg/mL) added. The 
cells were incubated for 2 h in 37 ° C and 5 % CO2. The medium was removed and cells 
washed thoroughly three times with PBS, then 5 mL 1x trypsin/EDTA was added for 3-5 
min. The trypsin was neutralised by transferring to 5 mL STO medium before centrifugation 
at 64g for 2.5 min. STO medium was removed and cells re-suspended in 9 mL STO medium. 
0.5 mL of cell suspension was added to 12 x 3.5 cm gelatineised tissue culture dishes. The 
volume was made up to 1.5 mL with STO medium and incubated at 37°C and 5 % CO2. 
2.2.1.8 Routine culture of mKSCs-GFP 
mKSCs-GFP were cultured in 10 cm tissue culture dishes (Corning) and coated with 0.1 %  
gelatine in medium supplemented with 10% FBS.  Medium was removed from a confluent 
dish of KSCs-GFP and cells were washed once with PBS. 1 x trypsin/EDTA was added for 3-
5 min, and subsequently neutralised with medium, before centrifugation at 64g for 2.5 min. 
Medium was removed and cells re-suspended in fresh medium. KSCs-GFP were sub-cultured 
every second day at a ratio of 1:4 and incubated at 37°C and 5 % CO2. 
2.2.1.9 Freezing cells 
Medium was removed from the culture dish and cells were washed once with PBS, followed 
by trypsinisation with 1 X trypsin/EDTA for 3-5 min, which was neutralised with equal 
volumes of STO medium, before centrifuging at 64g for 2.5 min. Medium was again 
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removed and cells were re-suspended in cell culture freezing medium (Gibco, UK), typically 
in 0.5 mL volume in a cryovial. The cryovial was placed in a freezing chamber containing 
isopropanol overnight at - 80°C. The cells were transferred to liquid nitrogen if long term 
storage was necessary. 
2.2.1.10 Thawing of cells 
The cryovial containing the desired cells was removed from liquid nitrogen and thawed 
rapidly in a water bath at 37°C. The cells were then transferred to STO medium and 
centrifuged at 64g for 2.5 min. Medium was removed and replaced with appropriate medium 
(depending on cells i.e. STO medium for STO cells), and cells were finally transferred to 
culture dish and incubated at 37°C 5 % CO2. 
2.2.1.11 EB formation 
Medium was removed from 3.5 cm dish of E14 mESCs and cells were washed once with 
PBS. 1 mL 1xtrypsin/EDTA was added for 3-5 min, and neutralised with 1 mL mESC 
medium, before centrifugation at 64g for 2.5 min. The medium was removed and cells were 
re-suspended in STO/EB medium (volume depends on number of dishes of EBs is required). 
If mESCs were previously cultured on plain tissue culture dishes, cells were counted using 
haemocytometer (cells/mL) and an appropriate density of mESCs were plated onto 
bacteriological dishes (Sarstedt) containing appropriate volume of STO/EB media (typically 
used 200 x 10
3
 cells/mL, total volume 1.5 mL). If mESCs were previously cultured on 
feeders, following re-suspension in STO/EB media after centrifuge, cells were transferred to 
gelatineised 6 cm dish and incubated for approximately 1 h to reduce the number of feeder 
cells. After incubation, cells remaining in suspension were counted and an appropriate 
density was seeded onto bacteriological dishes, as previously described. The medium was 
changed every 2 days by swirling the culture dish in circular motion until EBs gathered in 
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centre of dish, old medium was aspirated from edge and replaced with fresh STO/EB 
medium. 
2.2.1.12 Maintenance and expansion of KSCs-GFP on macroporous poly-Ɛ-lysine  based 
polymers 
Kidney-derived stem cells (KSCs) derived from mice expressing green fluorescent protein 
(KSC-GFP) were seeded at a density of 2 x 10
5
/mL onto PƐL-based polymers using a trans-
well insert, as outlined in Figure 2.2. KSCs-GFP were allowed to proliferate and medium was 
changed every second day, via aspiration from upper and lower chambers. 
2.2.1.13 Cell viability (Trypan blue) 
Cell suspension (1 x 10
5
 cells/mL) was diluted 1:1 with 4 % trypan blue solution and allowed 
to incubate at room temperature for 1 – 2 min. Cells were counted using a haemocytometer, 
whereby stained blue cells were counted as unviable and unstained cells were counted as 
viable cells. This was repeated in triplicate for each condition and time-point from more than 
three biologically distinct populations. 
2.2.1.14 Quantification of cell proliferation 
STO and KSC-GFP proliferation were analysed with regard to interaction with different PƐL 
macroporous polymers over time, using an MTS assay (Promega, CellTiter96 #G5421, UK). 
At appropriate time-points (dependent upon time-point of interest), the MTS compound was 
added to the upper chamber of the trans-well (1:5 MTS/PMS:medium, with final 
concentrations 333 µg/mL , 25 µM) and incubated for 4 hours at 37°C and 5 % CO2. 
Subsequently, 100 µL of MTS/PMH-medium solution was added to 96-well plate and 
absorption was measured at 490nm using nanodrop spectrometer (Nanodrop 2000, 
ThermoScientific, UK). Absorption readings were measured in triplicate for each condition 
and each time-point, from three biologically distinct culture dishes. 
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Figure 2.2 Schematic diagram depicting the trans-well set-up used to culture KSCs-GFP on 
PƐL-based macro porous polymers. KSCs-GFP were seeded onto PƐL discs which had been cut 
appropriately to fit the trans-well insert in a 6 well dish, where a Teflon disc and a polymer stabiliser 
were used to secure the polymer in position throughout culture. 3 ml KSC medium was added to the 
lower chamber and 0.5 ml added to upper chamber each time medium was added/replaced.  
2.2.1.15 Poly-Ɛ-lysine-based polymer synthesis 
PƐL macroporous polymers were synthesised via solubilisation of poly-Lys in distilled water, 
heat-induced linkage with NHS to form polymer backbone, and activation of polymerisation 
via carboxylic bonding with dicarboxylic (components of which were outlined in Table 2.3), 
generating a stable polymer with 100 % neutralisation (105% cross-linkage). However, in the 
case of PƐL polymer cross-linked with RGD, compositional ratios varied accordingly. 
Moreover in the case of PƐL polymers which were modififed with HS compounds via ionic 
interactions, cross-linking was reduced via reduction of NHS component. 
2.2.1.16 Sterilisation and preparation of polymers 
Polymers were washed three times in 100 % EtOH, followed by three washes with 1 X PBS 
and exposure to UV light for 1 hour prior to contact with KSCs-GFP. Similarly with Teflon 
discs and the polymer stabiliser rings used in the trans-well set up; both were soaked in 100 
% ethanol overnight and washed three times in 1 X PBS, followed by UV exposure for 1 hour 
prior to usage in culture system.  
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2.2.1.17 Surface modification of poly-Ɛ-lysine based polymers 
Six different HS-mimetic compounds, four of which are synthetic and made in-house* 
(University of Liverpool, UK), outlined in Table 2.4, were passively adsorbed onto surface of 
polymers via ionic interactions. 50 µg/mL of each HS compound was added to the surface of 
poly-Ɛ-lysine  based polymer discs, once the polymers had been secured into trans-well set 
up, and incubated for 1 h, followed by three washes with 1 X PBS. Gelatine and FBS were 
adsorbed in exactly the same manner, as positive controls. 
Table 2.4 HS compounds adsorbed to surface of poly-Ɛ-lysine macroporous. Six different HS 
mimetic heparin compounds were adsorbed to surface of PƐL via ionic interactions, as a method of 
discrete polymer surface modification. 
HS compound Sulfation 
PMH 
 
Heparin control – homogenous sulfation pattern 
PMHS 
 
HS control – heterogenous sulfation pattern 
NAc 
 
Unsulfated HS structure 
2OS 
 
Low sulfation at 2-O position only 
6OS 
 
Low sulfation, at 6-O position only 
Per 
 
Over-sulfated HS structure 
 
2.2.2 Immunochemistry and histology 
2.2.2.1 Fixation of cells (mESCs, STO, EXT1
-/-
 or KSC-GFP) 
The medium was removed and 4% PFA was added to the cells. The cells were incubated at 
RT for 5 min, before removing PFA and washing cells thoroughly three times in PBS.  Cells 
were stored for up to 7 days in 4°C until needed. 
2.2.2.2 Fixation of EBs 
EBs were transferred from 3.5 cm dish to 15 mL conical flask and allowed to settle to 
bottom. For relatively young EBs (i.e. 2/3 days) EBs were centrifuged at 64g for 1 - 2 min. 
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The medium was removed and replaced with 4% PFA, and cells were incubated with PFA at 
RT for appropriate length of time (1-3 d EBs -10 min; 4-7 d EBs – 20 min; 7d – 30 min). 
After incubation, PFA was removed and EBs were washed three times in PBS. Samples were 
stored at 4°C in PBS until needed. 
2.2.2.3 Gelatine embedding 
PBS was aspirated from EBs, and 10 mL 15 % sucrose was added. Cells were left to soak in 
sucrose solution overnight at 4°C. The sucrose solution was removed and replaced with 4 mL 
7.5 % gelatine solution (molten). Cells were incubated in a water bath at 37°C for 30-60 min 
(sometimes more) until EBs had dropped. During incubation, several mLs of molten gelatine 
was added to weighing boat and allowed to set. After water bath incubation, gelatine solution 
was removed from EBs, leaving 100 – 500 µL. Carefully, droplets of EB (within the gelatine) 
were plated onto the set gelatine in the weighing boat. Once gelatine droplets had set, EBs 
were cut from the weighing boat and mounted onto cork disc using cryoprotectant (OCT). 
EBs within the gelatine were covered in cryomount and, using forceps, they were transferred 
to a beaker of chilled isopentane. Once samples had turned white, they were transferred to 
liquid nitrogen (LN). Samples were retrieved from LN, wrapped in aluminium foil and stored 
at – 20 ° C until sectioning. 
2.2.2.4 Sectioning EBs 
Samples were cut using cryostat set at – 20°C and 10µm thickness. Once cut, sections were 
transferred to subbed slide. 
2.2.2.5 Preparation of subbed slides 
Slides were loaded into slide holder, soaked in 100 % EtOH for 10 – 15 min and washed five 
times in PBS. Slides were left soaking in distilled water whilst subbing solution was made up. 
Each slide was dipped in the subbing solution for 25 seconds and allowed to dry overnight. 
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2.2.2.6 Toludine blue stain 
Frozen EB sections were placed into a coplin jar containing 1 X PBS and incubated in a 
water bath at 37°C for 30 min to ensure EB sections were adequately thawed and that the 
gelatine had melted off. Slides were placed in a slide rack and submerged in dish containing 
toluidine blue working solution. The slide rack was removed and submerged in water for 
several seconds and repeated three times, immediately followed by submerging in 95 % 
EtOH for 2 min, followed by submerging in 100 % EtOH for a further 2 min. The slides were 
then transferred to xylene for 3 min before mounting with histomount, and applying a 
coverslip. 
2.2.2.7 Immunostaining of cells 
PBS was aspirated after fixation and washing step and blocking solution was applied (10 % 
fetal bovine serum, 0.1 % Triton X-100 in PBS). Cells were incubated with blocking solution 
at RT for 40-60 min. After incubation, the blocking solution was removed and the primary 
antibody solution was added, cells were incubated at 4°C overnight. After incubation with 
primary solution, cells were washed three times in PBS, the first two washes for 5 seconds 
and final third wash was left during preparation of secondary antibody. Secondary antibody 
solution was added to cells and cells were incubated at RT for 1 – 2 h. After incubation with 
secondary antibody solution, cells were washed thoroughly three times in PBS. When 
counterstaining with DAPI, DAPI solution was applied instead of third wash (1 mL DAPI: 1 
µL (1/100** working stock + 1 mL PBS) and cells were incubated at RT in dark for 5 min. 
Cells were washed three times in PBS and mounted on a slide with a coverslip and 
fluorescent mountant. Staining was visualised using an inverted microscope (Leica 
microsystems, 291185).  
All solutions were centrifuged for 5 min at 13,000 rpm. 
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2.2.2.8 Immunostaining of EBs 
Slides were placed in a coplin jar filled with PBS in water bath at 37°C for approximately 20 
min to ensure that the gelatine had melted off. A hydrophobic pen was used to highlight EBs 
location on slide. Staining procedure is as in the case of immunostaining of mESCs, except 
permeabilisation with Triton-X is unnecessary. 
Antibodies used were against pan-laminin (1:100, #L9393, Sigma-Aldrich, USA) laminin 
alpha 1 (1:200, #ab78287, abcam, Cambridge, UK) Oct4 (1:500 Santa Cruz Biotechnology 
Inc.), Nanog (1:400, #ab80892, abcam, Cambridge, UK), Gata6 (1:400, #AF1700 R&D 
Systems Inc.), 10E4 (1:100, Seikagaku Biobusiness Corporation, #370255), 3G10 (1:200, 
Seikagaku Biobusiness Corporation, #370260). Secondary antibodies were Alexa-488 
chicken-anti goat IgG (H+L), Alexa-594 chicken-anti goat IgG (H+L), Alexa 488 goat-anti 
rabbit IgG (H+L), Alexa-594 goat-anti rabbit IgG (H+L) (A11012, Invitrogen), Alexa-594 
goat-anti mouse IgG2b (γ2b). The negative controls for all antibodies can be found in 
Appendix I. 
2.2.2.9 Immunostaining of polymer sections 
After appropriate time of incubation with cells polymers were embedded in gelatine and 
sectioned, exactly as outlined in 2.2.2.3 and 2.2.2.4, respectively. Immunostaining was 
conducted as in the case of EB sections, again outlined previous, 2.2.2.7. 
2.2.2.10 Quantification of immunostaining 
Quantification of immunostaining was achieved by counting cells displaying positive 
immunoreactivity, typically conducted for four discrete regions on any one dish, repeated 
over three biologically distinct dishes. In the case of Nanog, whereby expression is typically 
represented by a gradient of immunoreactive intensities in any one population, only highly 
intensely positive cells, were counted as positive, exemplified in Figure 2.3. For 
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quantification of existence of basement membrane (laminin and LamA1 expression), a 
scaling system was used whereby EBs were counted as positive if a continuous BM was 
present in > 50 % of the EB circumference, outlined in Figure 2.4. 
 
Figure 2.3 Diagram outlining the quantification of a Nanog immunostain. Typically, Nanog 
immunoreactivity is represented over a range of intensities in any one cell population, therefore a 
system was used whereby only highly intensely positive cells were counted as positive (red circles) 
and counted in any quantification, whilst low intensely positive cells were not counted (blue circles). 
 
Figure 2.4 Diagram outlining the quantification of differentiating EBs with regard to Laminin 
expression. Quantification of adequately differentiating EBs was achieved in part by counting EBs 
with > 50 % circumference displaying positive Laminin expression, as shown with red boxes. EBs 
with < 50 % circumference Laminin expression were not counted blue boxes). 
2.2.3 Real Time Polymerase Chain Reaction 
2.2.3.1 RNA extraction 
EBs were isolated from bacteriological dish to 1.5 mL microfuge tube and centrifuged at 64g 
for 3 min. The medium was removed and replaced with 0.5 mL TRIzol, cells were 
homogenised and a further 0.5 mL TRIzol was added. 200 µL chloroform was then added to 
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the microfuge tube, which was shook for 20 seconds followed by centrifugation at 4°C at 
12,000 rpm for 15 min, during which time 1 µL glycogen was added to new 1.5 mL 
microfuge tube. After centrifugation, the upper aqueous phase was transferred to prepared 1.5 
mL microfuge tube (typically 500 µL) and an equal volume of isopropanol was added 
(typically 500 µL). The microfuge tube was inverted 4-5 times, to ensure gentle mixing, and 
EBs were incubated at RT for 10 min followed by centrifugation at 4°C at 12,000 rpm for 10 
min. The supernatant was discarded after centrifugation and remaining pellet was washed in 1 
mL 75 % ethanol, followed by centrifugation at 7.5,000 rpm for 5 min. Ethanol was removed 
and the pellet was allowed to dry (approximately 2 min). The pellet was dissolved in 10-50 
µL nuclease free water (usually 20µL as pellets are typically small). If RNA was to be stored, 
rather than used for cDNA synthesis immediately, the pellet was stored at – 20°C, in 1 mL 
75% ethanol. 
2.2.3.2 DNase treatment 
8 µL of the RNA solution was transferred into a 0.2 mL microfuge tube, and 1 µL DNase 
buffer and 1 µL DNase were added. Sample was incubated at 37 °C for 30 min. The reaction 
was stopped by adding 1 µL STOP buffer and the sample was incubated at 60°C for 15 min. 
Samples were placed on ice in preparation of reverse transcriptase reaction. 
2.2.3.3 cDNA synthesis  
cDNA was synthesised with SuperScript III First-Strand Synthesis System for RT-
polymerase chain reaction (PCR) (Invitrogen, UK) according to instructions. 6 µL DNase 
treated RNA was transferred to 0.2 mL microfuge tube and 5 µL nuclease-free water and 2 
µL 100 ng/µL stock of random hexamers were added and incubated at 65°C for 5 min. The 
sample was chilled on ice for 1 min, pulse centrifuged and 4 µL X 1st strand buffer, 1 µL 
DTT (0.1M), 1 µL dNTP mix (10 mM stock) and 1 µL superscript III reverse transcriptase 
(200 U/µL) were added. The solution was mixed gently by pipetting and incubated at RT for 
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5 min. A further incubation at 50°C for 60 min and inactivation was achieved by heating at 
70°C for 15 min.  
PCR was performed using KAPA Sybr Fast (Labtech, UK) and light cycler (Rotor-gene RG-
3000) was used. Values were normalised to GAPDH levels and the delta-delta ct method was 
used to calculate relative change in expression between different EB growth conditions, 
assuming primer efficiency. 
Relative change in expression compared to normal conditions =  2 
-∆∆Ct 
Normal conditions were considered to be EBs derived from E14 mESCs grown in presence of 
serum and feeders (+F +FBS). Treated samples were any conditions other than this; EBs 
grown in absence of feeders (-F +FBS), EBs grown in absence of serum and feeders (-F –
FBS), EBs grown in serum-free feeder-free conditions but supplemented with endogenous 
heparin (-F –FBS +1ug/ml heparin). 
Primer sequences are shown in Appendix II. 
2.2.4 Compositional disaccharide analysis of HS 
2.2.4.1 DEAE purification of HSPGs 
Medium samples were rotated with 0.1 ml DEAE-Sephacel beads (GE healthcare, UK) / 10 
mL sample overnight at 4°C. Samples were centrifuged at 2800g and the supernatant was 
removed. The beads were washed with 10 x volume PBS, followed by a 0.25 M NaCl wash; 
supernatant was removed after each wash. The sample was finally eluted with 10 x volume 2 
M NaCl. 
2.2.4.2 Desalting of eluted fractions  
Samples were desalted using HiPrep desalting columns on an AKTA purifier: 26/10 G-25 
superfine column pre-packed with Sephadex (GE Healthcare, UK) or DT G-25 superfine 
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column pre-packed with Sephadex (GE Healthcare, UK) , depending on sample volume. The 
fractions were injected into a 1 mL loop, using a Hamilton syringe, ensuring no air bubbles 
were injected into the circuit, and the flow rate was gradually increased to 1mL/min. Desalted 
fractions were freeze dried. 
2.2.4.2 Digestion of medium sample with heparitinase enzymes 
Recombinant Heparitinase I, II and III (Ibex; Ibex Technologies, Montreal, Quebec – Cat no. 
50-010, 50-011, 50-012 respectively) were employed to enzymatically digest HS from each 
medium sample, in accordance with previous data that showed usage of these enzymes in 
conjunction, is a most efficient for disaccharide analysis (Linhardt, Turnbull et al. 1990).  
Enzymes are generated from Flavobacterium heparinum (Galliher, Cooney et al. 1981) and 
each act on a different substrate, outlined in Table 2.5 to comprehensively digest the HS. 
Freeze dried samples were re-suspended in MilliQ H2O (typically 100 µL), 5 x lyase buffer 
and digested by addition of heparitinase enzymes: 2.5 mU of heparitinase I, heparitinase II, 
and heparitinase III enzymes per reaction. The samples were incubated at 37°C for 4 h and a 
further 2.5 mU of each enzyme was added and incubated overnight at 37°C. 
Unit definition; 1 international unit (IU) represents the amount the enzyme will liberate 1 
μmol of unsaturated oligosaccharides from HS per minute at 30 ° C and pH 7.5. 
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Table 2.5 Heparitinase enzymes for HS digestion to aid disaccharide analysis 
Enzyme Substrate 
Heparitinase I 
 
Broad specificity; cleaves linkages that have reduced density of sulfation and 
that contain beta-D-glucopyranosyluronic acid residues, typically N-acetylated 
or N-sulfated glucosaminido-glucuronic acid linkage. 
Heparitinase II 
 
Broad specificity; acts upon heparan sulfate producing disulfated, N-sulfated 
and N-acetylated-6-O-sulfated disaccharides, and small amounts of N-
acetylated disaccharide, preferentially upon N, 6-O sulfated glucosaminido-
glucuronic acid linkage. 
Heparitinase III Highly specific; cleaves highly sulfated polysaccharide chains containing 
linkages to 2-O-sulfated alpha-L-idopyranosyluronic acid residues. 
2.2.4.3 Purification of sample with C18 column 
High resolution separation and purification of samples was achieved using derivatised silica-
based C18 columns with cetyltrimethylammonium (CTA) hydroxide to provide the basic 
group for anion exchange (Mourier and Viskov 2004). Samples were freeze dried and re-
suspended in milliQ H2O (typically 500 µL).  
2.2.4.4 Fluorescent labelling of HS disaccharides 
5 µL BODIPY was added to freeze dried samples, followed by centrifugation at 64g and 
samples were speed vacuumed. DMSO:acetic acid (17:3 vol:vol) was added to each sample 
and incubated in dark adapted chamber for 4 h at room temperature. 5 µL 1M sodium 
borohydride was added to each sample, followed by centrifugation at 64g and incubation for 
30 min at room temperature. Samples were snap frozen in liquid N2, freeze dried and re-
suspended in 10 µL DMSO:milliQ H2O. 
2.2.4.5 Thin film liquid chromatography  
Butanol and filter paper were added to a beaker (butanol approximately 1-2 cm deep and 
filter paper standing in beaker) sealed with cling film, so to create a butanol atmosphere. In 
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the meantime, samples that had previously been suspended in DMSO:milliQ H2O were 
spotted onto TLC plates (Sigma Aldrich, cat # Z193275). TLC plates containing samples 
were then stood in the butanol-containing beaker (ensure that samples are spotted high 
enough on TLC plate so that when they stand in the beaker the sample spots are not 
submerged in butanol). Samples were incubated in the dark until butanol had carried 
unwanted components of the sample to top of TLC paper. TLC plates were hair-dryed and the 
process was repeated three times. 
Using a clean blade, spotted sample and immediately surrounding area on the TLC plate was 
scraped from surface of plate. Samples were added to an eppendorph, diluted with milli-Q 
H2O (approximately 200 µL) and vortexed. The supernatant (sample) was removed and 
diluted again in milli-Q H2O and further votexed (repeated three times). 
2.2.4.6 Strong anion exchange (SAX) purification 
Strong anion exchange (SAX) chromatography is a technique used to separate anionic 
molecules based on net charge – employed here to separate purified HS disaccharide 
structures based on their relative negative net charge via interaction with a positive column.  
A Propac column PA1 (Dionex, UK) was employed and represents a high resolution column 
specifically used for separation of HS/heparin, providing reliable elution times necessary for 
separation and disaccharide analysis. Positive charges on the matrix are due to a strong base 
derivatised onto a support medium which remains positively charged across pH 1-14. Upon 
introduction of a sample into the mobile phase, ionic binding to the column occurs and 
content of sulphate groups, carboxyl groups and strength of buffer underpins the strength of 
binding. Elution of the sample followed using a gradient salt wash between 0-100 % over 55 
min in B (Hold in A (150 mM NaOH in HPLC water) for 10 min to allow free BODIPY tag 
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to elute, 0-45 % B (2M NaCl 150 mM NaOH) for 40 min, 45-100 % B for 15 min for elution 
of sample, finally hold in D (2M NaCl 300 mM NaOH) for 10 min to wash the column).    
Elution of material from the column was achieved using a gradient salt wash over time and 
accordingly, disaccharides elute in a specific order as outlined in Table 2.6. 
Table 2.6 Order of disaccharide standards elution during HPLC-SAX analysis with time 
HS disaccharide standard Structure Elution time (min) 
1 
 
UA-GlcNAc 15.75 
2 
 
UA-GlcNS 21.0 
3 
 
UA-GlcNAc6S 23.0 
4 
 
UA2S-GlcNAc 24.75 
5 
 
UA-GlcNS6S 29.5 
6 
 
UA2S-GlcNS 31.25 
7 
 
UA2S-GlcNAc6S 37.0 
8 
 
UA2S-GlcNS6S 44.75 
2.2.5 Sample (polymer) preparation for SEM analysis 
2.2.5.1 Fixation 
All polymer samples were removed from the culture systems and incubated with 2.5 % EM-
grade gluteraldehyde for 30 min at room temperature, followed by three washes with distilled 
water.  
2.2.5.2 Dehydration 
After fixation, samples were dehydrated via incubation in 70 % EtOH for 30 min, followed 
by incubation in 90 % EtOH for 30 min and final incubation for 30 min in 100 % EtOH. 
2.2.5.3 Critical Point Drying (CPD) 
Dehyrdrated samples were loaded into CPD boat containing 100 % EtOH, ensuring that they 
were submerged fully in 100 %. EtOH. The CPD chamber was filled with liquid CO2 and the 
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chamber was allowed to cycle and displace EtOH for approximately 5 min, while vents were 
open. Once chamber was filled with CO2, all vents were closed and samples were left for 1 
hour. The CPD chamber was emptied of CO2 to a degree (level now just below the boat 
containing samples), and pressure within the chamber was increased via heating to 35°C, to 
ensure prevention of recondensing; critical point is 31°C 1500psi. Samples were removed 
once chamber was emptied and pressure reduced. CPD set-up is outlined schematically in 
Figure 2.6. 
 
Figure 2.6 Schematic of CPD set-up. Samples (represented by red squares) are contained within a 
closed system, under controlled pressure and temperature, during filling and emptying with CO2. 
2.2.5.4 Chromium sputter coating 
The inability of polymers to conduct electrons means that under SEM analysis without a 
metal sputter coating, polymers tend to ‘charge’. Charging is underpinned by the inability of 
the polymer sample to dissipate secondary electrons; electrons build up, induce a static 
electric field and therefore result in the deflection of electons thus generating 
unrepresentative, inconsistent contrasting image. Chromium (Cr) sputter coating was 
therefore employed. Samples were placed in vacuum whereby Ar gas was introduced, a 
potential was applied across target sample and therefore the Ar gas is ionized. Ar ions sputter 
off Cr atoms, producing a ‘cloud’ of Cr atoms, which subsequently coat the surface of the 
polymer.  
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2.2.6 Statistical Analysis 
Each experiment consisted of three replicates, statistical significance determined using 
Student t test, significance set to p < 0.05, unless otherwise stated. Error bars represent SEM, 
unless otherwise stated. 
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3. Variations in mESC culture condition influences behavior 
3.1 General Introduction 
ESCs are pluripotent cells with the ability to replicate indefinitely in an undifferentiated state 
whilst maintaining the ability to give rise to derivatives of all three embryonic germ layers. 
mESCs are routinely cultured in the presence of serum and on feeder cell layers (Evans and 
Kaufman 1981; Thomson, Itskovitz-Eldor et al. 1998). Under these conditions, the majority 
of cells within the population display the typical morphological characteristics of mESCs, 
including high nuclear:cytoplasmic ratio and prominent nucleoli, as well as a tendency to 
form compact, multilayered colonies (Matise 2000), and express mESC pluripotency 
markers, Oct4 and Nanog (Medvedev, Shevchenko et al. 2008; Orkin, Wang et al. 2008). 
However, little is known about the effect that the absence of serum and/or feeders has on 
mESC expansion, important given that the eventual implementation of ESCs in medicine will 
rely on xeno-free scale-up. Similarly, there is limited knowledge surrounding the affect 
culture condition (+/- feeders +/- serum) has on ESC differentiation capacity.  
A well established model of early development is the embryoid body (EB) model (Robertson 
1987), employed in this project to investigate differentiation according to 2D culture 
condition. Once grown in a suspension culture, mESCs clump together to form aggregates 
known as embryoid bodies (EBs). EBs were generated using several discrete 2D culture 
conditions and major hallmarks of EB development were monitored to assess differentiation 
capacity as a function of culture condition. Key stages of successful EB development include 
compact clustering by day 2, differentiation of primitive endoderm at the periphery of the EB 
by day 3 (Murray and Edgar 2000), visceral and parietal endoderm differentiation by day 4, 
and formation of the basement membrane (BM), which initially appears thin until parietal 
endoderm cells deposit a thick BM similar to Reichert’s membrane (Smith and Strickland 
1981; Gersdorff, Muller et al. 2005). Some inner mESCs, rather than differentiating to 
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columnar epiblast epithelium (CEE), undergo programmed cell death (Coucouvanis and 
Martin 1995), represented by the formation of a cavity, typically seen by day 7 (see Figure 
1.3 in chapter 1). 
As outlined in detail previously, BM is a highly organised structure composed of ECM 
molecules, which form an interface between many different cell types, provides mechanical 
stability and regulates cellular activity (Engvall 1995; LeBleu, Macdonald et al. 2007; Tzu 
and Marinkovich 2008). A key component of the BM is the non-collagenous trimeric 
glycoprotein laminin, which is essential for embryogenesis (Beck, Hunter et al. 1990; Huang, 
Hall et al. 2003; Miner, Li et al. 2004; Miner and Yurchenco 2004) and the molecule of 
choice when identifying BM synthesis in the EB throughout this project. Laminin is 
composed of three non-identical chains (alpha, beta, gamma) arranged in a cross-shaped 
structure, in which three short arms each form by a different chain, and one long arm is 
composed of the three assembled coiled chains, detailed previously. To date, it is suggested 
that only laminin trimers, not individual chains, are secreted extracelluarly, as identified in 
the case of laminin-111 and laminin-511 (Matsui, Wang et al. 1995; Yurchenco, Quan et al. 
1997); thus functional BM is only formed once all three chains are present and successfully 
configured.  
This chapter demonstrates: 
 That mESCs can be maintained in 2D culture with/without feeders and/or serum for > 
10 passages under all three conditions; mESCs retain typical morphological features, 
and the proportion of cells expressing Oct4 and Nanog is similar. 
 That mESCs maintained in serum-free feeder-free culture systems display 
significantly slower proliferation rates when compared to mESCs maintained in 
conditions containing serum +/- feeders. 
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3.2 mESCs maintained in the absence of feeders and/or serum, remain undifferentiated 
and display typical behaviour during 2D culture 
Before investigating the effect of feeder cells and serum on EB development, it was first 
necessary to confirm that mESCs cultured for > 10 passages in the absence of feeder cells 
and/or serum, remained undifferentiated and behaved typically with regard to morphology 
and proliferation. 
mESCs were maintained in three distinctly different 2D growth conditions; on feeders and in 
the presence of serum, without feeders but in the presence of serum and without feeders and 
in the absence of serum, demonstrated in Figure 2.1. mESCs maintained in all three culture 
conditions displayed typical mESC behaviour, irrespective of culture condition. Whether 
serum and/or feeders were present during ESC expansion for > 10 passages (> 24 days), 
mESCs maintained typical morphology, namely, high nuclear: cytoplasmic ratio and 
prominent nuclei. Furthermore there was evidence of multilayered colonies in all three 
conditions (Figure 3.1). To further confirm that the mESCs had not differentiated following > 
10 passages under the different culture conditions, co-immunostaining was performed for 
Oct4 and Nanog. mESCs remained positive for Oct4 and Nanog throughout expansion in all 
three conditions (Figure 3.2); moreover, quantification confirmed that proportions of Oct4 
and Nanog positive mESCs were not different between the three groups (Figure 3.3). 
The proliferation rate of mESCs during 2D expansion, however, was affected by culture 
condition. mESCs maintained in serum-free feeder-free culture conditions displayed a 
significantly lower proliferation rate detected by day 3, when compared to mESCs cultured in 
standard conditions, (in the presence of serum and feeders). The trend was consistent with 
time. mESCs expanded in the absence of feeders but in the presence of serum, displayed 
similar proliferation rates to mESCs expanded in normal conditions up to 2.5 days, however, 
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by 3 days the proliferation rate was significantly lower than mESCs cultured in the presence 
of serum and feeders (Figure 3.4). 
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Figure 3.1. E14 mESC display typical morphology in the absence of feeders and/or FBS. E14 
mESCs were maintained in vitro for > 10 passages (P16) in three different culture conditions using 
different combinations of with/without feeders (+/-F) and in the presence/absence of serum (+/-FBS): 
A) +F + FBS, B) –F + FBS, C) –F –FBS.  mESC morphology was similar under all three conditions; 
i.e., ESCs showed high nuclear:cytoplasmic ratio and prominent nucleoli (arrows) and could form 
multilayered colonies. In all three conditions, some cells without typical mESC morphology were 
present, suggesting that there was a degree of spontaneous differentiation. The experiment was 
repeated > 6 times and images are representative of for each condition. Scale bar represents 50 µm. 
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Figure 3.2 E14 mESCs express Oct4 and Nanog in the absence of feeders and/or FBS. E14 
mESCs were maintained in vitro for > 10 passages in 3 different culture conditions; with serum and 
feeders (+F + FBS), without feeders but in the presence of serum (–F + FBS) or serum-free feeder-
free (–F –FBS). mESCs maintained in all 3 conditions express the pluripotency markers Oct4 and 
Nanog. The experiment was repeated > 6 times and all images are representative of entire cell 
populations. The scale bar represents 100 µm. 
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Figure 3.3 The proportion of Oct4 
and Nanog positive E14 mESCs was 
comparable in all three culture 
conditions. mESCs were maintained in 
3 different culture conditions > 10 
passages; with feeders and serum (+F 
+FBS), without feeders but in the 
presence of serum (-F +FBS) or serum-
free feeder-free (-F –FBS). The 
percentage of cells that stained 
positively for Oct4 and Nanog was not 
statistically different between the three 
different culture conditions, n = 6; error 
bars represent SEM. 
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Figure 3.4 E14 mESC proliferation rate is dependent on culture condition. E14 mESCs were 
maintained in three different culture conditions; +F +FBS, -F +FBS and -F –FBS. Cell numbers were 
counted daily for 4 days to determine respective proliferation rates. mESCs maintained in serum-free 
feeder-free culture conditions had a significantly slower proliferation rate compared to that of mESCs 
maintained with feeders and/or serum. mESCs maintained in the presence of serum and feeders had a 
doubling time of approximately 18 h, feeder-free mESCs had a doubling time of 20 h and serum-free 
feeder-free mESCs displayed a doubling time of approximately 36 h. n = 12; error bar; SEM. 
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3.3 mESC development in the EB model is dependent upon 2D culture conditions prior 
to EB formation 
E14 mESCs were expanded in vitro in three different growth conditions (+F +FBS, -F +FBS, 
-F –FBS; Figure 2.1) for > 10 passages, essentially a 2D model, followed by growth in 
suspension, to induce EB formation. EB formation occurred via the removal of LIF, 
aggregation culture and in 10% FBS. The EB differentiation pattern was investigated, 
comparing the effect that the different growth conditions had on formation, development and 
differentiation of mESCs over time. Specifically, mESC differentiation to endoderm and BM 
formation was investigated, followed by evaluation of mesoderm and ectoderm 
differentiation. 
Quantification of differentiating EBs was achieved, as outlined previously (Materials and 
Methods, 2.2.2.10) using a scaling system, whereby EBs were counted as positive if a 
continuous BM was present in over > 50% of the EB circumference, an exmaple of which is 
shown in Figure 2.4. 
3.3.1 EB characterisitcs including morphology, size and cavitation all differ depending 
on 2D mESC culture conditions 
An initial observation was that –F –FBS conditioned EBs were significantly smaller in 
diameter when compared to EBs generated from mESCs cultured in the alternative two 
remaining conditions (+F +FBS, -F +FBS) as shown in Figure 3.5 and 3.6, respectively. 
Moreover, -F –FBS conditioned EBs appeared less compact, and generally disorganised 
when compared to EBs pre-conditioned in the presence of serum. There appeared to be no 
initial difference in the size or gross structure of EBs when comparing the presence or lack of 
a feeder layer. 
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EB morphology was further assessed using toluidine blue staining. At day 7, EBs conditioned 
in the presence of feeders and serum displayed signs of typical EB development, whereas 
serum-free conditioned EBs displayed obvious defects. In +F +FBS conditioned EBs there 
were tall cells on the periphery, probably representative of visceral endodermal cells, along 
with multilayers of round cells, which were likely to be  parietal endoderm.  -F +FBS 
conditioned EBs displayed fewer of the tall visceral endoderm-like cells on the periphery, and 
instead, almost all outer cells were round, like parietal endoderm cells, or squamous, like 
primitive endoderm cells. Nonetheless, EBs conditioned in the presence of serum (+/- 
feeders) displayed endoderm-like cell morphology, and in both cases displayed evidence of a 
BM represented by a space separating outer and  inner cells. In contrast, there was little 
evidence of BM deposition in –F –FBS conditioned EBs. Cavitation was detected and 
obvious in EBs conditioned in the presence of serum and feeders, although less apparent in 
EBs conditioned in the absence of feeders (+/- serum), as shown in Figure. 3.7.  
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Figure 3.6 Serum-free EBs are smaller than EBs conditioned with serum. Quantification of EB 
diameter showed that serum-free feeder-free EBs were significantly smaller than EBs conditioned 
with serum (+/- F); 200 µm in diameter, compared to 350 µm and 400 µm. n = 6, * p  < 0.05; error 
bars are representative of SEM. 
Figure 3.5 Serum-free 
feeder-free EBs are 
significantly smaller than 
EBs derived from mESCs 
cultured with serum +/- 
feeders. EB populations of 
day 7 EBs from serum-free 
feeder-free 2D pre-condition 
were represented by a 
relatively heterogeneous 
population compared to EB 
population from culture 
conditions containing serum 
and/or feeders. Moreover, 
serum-free feeder-free 
conditioned EBs were 
smaller in size, were less 
compact and appeared to 
lack outer endodermal cells 
(arrows) when compared to 
culture conditions where 
serum was present. Images 
are representative of entire 
EB populations for each 
condition. Scale bar 
represents 200 µm. 
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Figure 3.7 E14 mESCs EB development and morphology is different and dependent on 2D 
growth conditions prior to EB formation. E14 mESCs were maintained in three distinct culture 
conditions; +/- serum, +/- feeders for 7 days and stained with toluidine blue. –F –FBS  conditioned 
EBs lack compaction, any signs of cavitation, show few signs of  peripheral endoderm cells  and 
display little evidence of BM. EBs conditioned in the presence of serum (+/- feeders) show complete 
BM although feeder-free EBs lack cavitation, as shown with arrows. EBs shown are representative of 
the entire EB population for each growth condition. The experiment was repeated > 6 times. Scale bar 
represents 100 µm.  
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To further confirm morphological observations and identify and quantify any initial 
differences in the number of differentiating EBs between the three different conditions, EBs 
were co-immunostained with the PE marker, Gata6, and BM marker, LamA1. Quantification 
of the number of differentiating EBs, at least initially, suggested that EBs generated from –F 
–FBS conditions displayed delayed/atypical EB development. Such EBs had significantly 
lower proportions of EBs with > 50% LamA1 expression when compared to EBs generated 
from +F +FBS conditions (Figure 3.8 B). Similarly, proportions of Gata6 positive cells on the 
outer surface of –F –FBS conditioned EBs was significantly lower than those conditioned in 
+F +FBS conditions (Figure 3.8 A). The intermediate condition, -F +FBS conditioned EBs, 
displayed comparable results to +F +FBS conditioned EBs; proportions of Gata6 positive 
cells and LamA1 immunoreactivity were no different. Cavitation however, was detected in 
significantly fewer EBs (Figure 3.8 C). 
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Figure 3.8 EB development is 
influenced by 2D growth conditions 
prior to EB formation.  E14 mESCs 
were maintained in three distinct 
culture conditions; with serum and on 
a feeder layer (+F+FBS), without 
feeders but in presence of serum (-F 
+FBS) and serum-free feeder-free (-F 
–FBS). Serum-free feeder-free 
conditioned EBs display a 
delayed/restricted development pattern 
when compared to EBs conditioned in 
the presence of serum (+/- F). 
Specifically, serum-free EBs lacked 
extensive BM deposition by day 4 or 
day 7, characterised by > 50% of EB 
circumvented by LamA1+ BM (B). 
Furthermore, serum-free EBs showed 
fewer Gata6-positive cells on the EB 
periphery, again compared to EBs 
conditioned in presence of serum (+/- 
F), evident at both day 4 and day 7 
(A). Evidence of cavitation is detected 
at day 4 only in EBs conditioned in 
presence of serum and feeders. By day 
7, evidence of cavitation exists in all 
conditions, however the proportion of 
EBs displaying cavitation is 
significantly higher in EBs 
conditioned on feeders and in 
presence of serum (C). n = 20; error 
bar represents SEM, students T-test, 
** p < 0.01  
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3.3.2 mESC differentiation capacity is impaired in EBs generated from serum-free 
feeder-free conditions  
It is well known that the environmental cues dictate mESC behaviour however identifying the 
exact role of serum and/or feeders during in vitro differentiation is unclear. Oct4 and Nanog, 
common markers of pluripotency, were used to investigate the presence of undifferentiated 
mESCs within EBs comparing the three different growth conditions employed throughout. 
Typically, it is expected that the number of Oct4 and Nanog positive cells should reduce with 
time, as the EB differentiates (Pesce and Scholer 2001).  
EBs conditioned in the presence of serum (+/- feeders), displayed distinct loss of Oct4 
expression over time; specifically, by day 7, the percentage of Oct4 positive cells was 
represented by approximately 15% and 20% of the population of +F +FBS and –F +FBS 
conditioned EBs, respectively, compared with approximately 40% for that of serum-free 
feeder-free conditioned EBs (Figure 3.9). This was supported by Oct4 expression analysed by 
qRT-PCR (Figure 3.11). Localisation of Oct4 expression was limited mostly to a few inner 
cells in EBs conditioned in the presence of serum (+/- feeders), whereas Oct4 localisation of 
EBs derived from serum-free feeder-free conditions, was identified in outer cells as well as 
inner cells (Figure. 3.10). Nanog expression and distribution displayed a similar trend to that 
of Oct4 when comparing the three conditions. In serum-free feeder free conditioned EBs, 
Nanog positive cells represented approximately 30% of entire EB cell population, compared 
to approximately 15% for the other two conditions. Moreover, localisation of Nanog 
expression was detected across the entire EB for serum-free feeder-free, including outer cells. 
EBs conditioned in the presence of serum (+/- feeders), however, displayed Nanog positive 
cells localised centrally as well as in more outer cells (Figure 3.12).   
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Figure 3.9 Percentage of Oct4+ and Nanog+ cells within 7d EBs depends on prior 2D culture 
conditions. Serum-free feeder-free conditioned EBs displayed a significantly higher proportion of 
Oct4 and Nanog positive ESCs in 7d EBs compared to EBs conditioned in the presence of serum. 
Oct4 positive cells comprised approximately 15% and 20% of the population in +F +FBS and –F 
+FBS conditioned EBs, respectively. In comparison, approximately 40% of ESCs were Oct4 positive 
in serum-free feeder-free EBs. Similarly, Nanog positive cells were infrequent (approximately 8%) in 
EBs conditioned in the presence of serum with or without feeders, but comprises 30% of the 
population in serum-free feeder-free EBs. n = 6, * p < 0.05 student’s T-test, error bar, SEM. 
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Figure 3.10 Localisation of Oct4 positive mESCs EBs changes with different mESC culture 
conditions. Serum-free feeder-free conditioned day 7 EBs displayed Oct4 positive cells distributed  
across entire EB, with many Oct4 positive ESCs localised to outer edge of EB, as shown in magnified 
region. EBs conditioned in presence of serum displayed lower proportions of Oct4 positive cells 
moreover localisation was rarely identified in outer cells. –F +FBS conditioned EBs did display few 
Oct4 positive cells on outer edge of EB (magnified region) but generally were located more centrally. 
+F +FBS conditioned EBs Oct4 localisation was typical, whereby no outer ESCs were identified as 
Oct4 positive. Arrows indicate regions of Oct4 positive cells. EBs are representative of entire EB 
population, experiment was repeated 3 times. Scale bar represents 200 µm. 
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Figure 3.11 Oct4 mRNA levels are 
significantly higher for serum-free 
feeder-free conditioned day 7 EBs. 
qRT-PCR showed that Oct4 mRNA 
levels are significantly higher in 
serum-free conditioned EBs, whereas 
+/- feeders had no effect on Oct4 
mRNA levels. n = 6, * p < 0.05, 
student’s T-test, error bar, SEM. 
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 Figure 3.12 Localisation of Nanog differs depending on culture condition. Serum-free feeder-free 
conditioned day 7 EBs displayed Nanog positive cells localised to outer cells (magnified image) as 
well as inner cells, whereas EBs conditioned in presence of serum largely displayed Nanog positive 
cells localised relatively centrally in EB; magnified images show outer-most Nanog positive cells. 
Arrows indicate Nanog-positive cells. EBs are representative of entire EB populations and the 
experiment was repeated 3 times. Scale bar represents 200 µm. 
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3.3.3 Differentiation of extraembryonic endoderm and BM formation within EBs is 
influenced by mESC pre-culture conditions 
As mentioned previously, upon the removal of LIF, mESCs cultured in suspension form EBs 
and differentiate, giving rise to derivatives of the three germ layers. Extraembryonic primitive 
endoderm cells first start to differentiate at the EB periphery on day 2. They deposit a BM 
between themselves and the inner EB cells. By day 4, some primitive endoderm cells undergo 
further differentiation to generate visceral and parietal endoderm cells. Parietal endoderm 
cells secrete copious amounts of ECM proteins, resulting in the deposition of a thick 
Reichert’s-like BM (Smith and Strickland 1981). Visceral endodermal cells secrete alpha 
fetoprotein (AFP), the most abundant serum protein in the developing embryo in vivo 
(Tomasi 1977). Expression of Gata6 and AFP were therefore investigated, to determine the 
effect of different growth conditions (+/- F, +/- FBS) on extraembryonic endoderm (EEE) 
differentiation. Previous results showed that EBs generated from mESCs cultured in the 
absence of feeders (i.e., -F +FBS and –F -FBS) were less likely to cavitate than those 
generated from mESCs cultured on feeders. To investigate if reduced cavitation was due to a 
defect in primitive endoderm differentiation (and/or BM, investigated later) EB sections were 
stained for the EEE marker, Gata6. AFP immunostaining was also performed to detect 
differentiation to visceral endoderm. In addition to EEE, investigation into BM synthesis 
pursued, since EEE and BM synthesis are complimentary events, therefore EB sections were 
stained for laminin, using a pan laminin-111 antibody and an antibody specific for the 
LamA1 chain.  
Gata6 was expressed in the nucleus of cells located at the periphery of day 7 EBs conditioned 
in the presence of serum and feeders. These Gata6 positive cells were frequently present in a 
multilayer, suggesting that they were parietal endoderm cells, because of the three types of 
extraembryonic endoderm, only parietal endoderm cells are non-epithelial; both primitive and 
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visceral endoderm cells form a mono-layered epithelium at the EB periphery. In contrast to 
+F +FBS EBs, Gata6 positive cells in -F +FBS EBs were present in a single layer at the EB 
periphery, suggesting a lack of parietal endoderm differentiation in these EBs. In –F –FBS 
EBs, very few Gata6 positive cells were present at the EB periphery, suggesting that 
extraembryonic endoderm differentiation was inhibited in these EBs (Figure. 3.13). 
Quantification of Gata6 mRNA levels supported this result, since feeder-free conditioned 
EBs (+/- serum) displayed significantly lower Gata6 mRNA levels when compared to EBs 
conditioned in the presence of serum and feeders (Figure 3.14). AFP immunostaining in day 
7 EBs conditioned in the presence of serum and feeders showed that some, but not all 
peripheral cells expressed AFP, indicating that visceral endoderm cells had differentiated; the 
cells at the periphery of these EBs that lack AFP expression are likely to be parietal 
endoderm cells.  In -F +FBS conditioned EBs, AFP positive cells were mainly observed in a 
monolayer at the EB periphery, suggesting that only visceral endoderm and not parietal 
endodermal cells had differentiated in these EBs. In –F –FBS EBs, immunostaining showed 
that most AFP was present on the apical surface of peripheral cell, and weak expression was 
also observed within inner EB cells (Figure 3.15) mRNA levels of AFP between all 3 
conditions did not differ (Figure 3.16).  
Immunostaining for laminin-111 showed that a BM was present between the outer extra-
embryonic endoderm cells and inner EB cells in the +F +FBS and –F +FBS conditioned EBs, 
although a BM was barely detectable in –F –FBS conditioned EBs (Figure 3.17). On closer 
inspection, it appeared that laminin was only localised to the BM (not in any inner cells) in 
EBs conditioned with serum (+/- F) but in the case of –F –FBS conditioned EBs, there was 
little evidence of BM deposition, and instead, laminin was detected in central EB cells, and 
tended to be localised near the apical surface of cells at the periphery of the EB. Discrete 
laminin deposits were sometimes observed near the periphery of these EBs, but they were not 
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organised into a BM. (Figure 3.18). LamA1 immunostaining gave similar results, except that 
no staining was detected in central EB cells. As with laminin-111 staining, discrete LamA1 
deposits were sometimes observed near the periphery of –F -FBS EB cells but a continuous 
BM was rarely detected (Figure 3.19).  
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Figure 3.13 Gata6 positive cell numbers vary depending on culture condition. Gata6-positive 
cells, as indicated with arrows, represent a higher proportion in day 7 EBs conditioned in the presence 
of serum and feeders (+F +FBS), compared to EBs conditioned in the absence of feeders (-F +FBS) 
and/or without serum (-F –FBS). EBs are representative of entire EB population for each growth 
condition. The experiment was repeated 3 times. Scale bar represents 200 µm. 
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Figure 3.14 Gata6 mRNA 
levels differ depending on 
culture condition. Gata6 
mRNA levels relative to 
GAPDH indicate that feeder-
free and serum-free 
conditioned EBs display 
significantly lower Gata6 
positive endoderm cells 
when compared to EBs 
conditioned in the presence 
of feeders and serum, n = 4, 
* p < 0.05; error bar; SEM 
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Figure 3.15 Primitive endoderm marker, AFP levels vary depending on culture condition. AFP-
positive cells, highlighted with arrows, appear to represent a higher proportion of total day 7 EBs, 
from conditions where serum and feeders are present (+F +FBS) compared to EBs conditioned in the 
absence of feeders (+/- FBS). Serum-free feeder-free EBs displayed expression of AFP localised 
centrally in EB also, rather than solely to outer cells. EBs are representative of entire EB population 
and the experiment was repeated 3 times. Scale bar represents 200 µm. 
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Figure 3.16 AFP mRNA levels do 
not change between conditions. 
AFP mRNA levels relative to 
GAPDH indicate that there is no 
significant difference between 
growth conditions at day 7, n = 6, p 
> 0.05, error bar; SEM 
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Figure 3.17 2D mESC culture conditions affect laminin distribution in EBs. The pattern of 
laminin111 expression was consistent with  localisation within the BM underlying extraembryonic 
endoderm cells  of 7 day  EBs conditioned in the presence of serum (+/- feeders), and little 
immunoreactivity was detected elsewhere in the EB, as highlighted with arrows. Serum-free feeder-
free EBs (-F –FBS) displayed laminin immunoreactivity throughout the EB, rather than localised only 
to the BM, indicated with arrows. EBs are representative of entire EB population and the experiment 
was repeated 3 times. Scale bar represents 200 µm. 
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Figure 3.18 2D ESC culture conditions affect laminin distribution in EBs. Laminin-111 
expression was mainly localised to the BM of 7 day EBs conditioned in the presence of serum (+/- 
feeders). Serum-free conditioned EBs displayed laminin immunoreactivity throughout the EB,  as 
indicated with arrows. Images represent population, experiment was repeated > 3 times and scale bar 
represents 100 µm. 
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Figure 3.19 2D mESC culture conditions affect LamA1 distribution in EBs. The pattern of 
LamA1 immunostaining was comparable in day 7 EBs conditioned in the presence of serum (+/- 
feeders), and appeared to be localised to the BM between outer differentiated cells and inner EB cells. 
–F –FBS conditioned EBs displayed LamA1 localised in discrete regions only, as highlighted by 
arrows. Scale bar represents 200 µm. EBs are representative of entire EB population for each growth 
condition. The experiment was repeated 3 times. 
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Since, it has been shown that laminin trimer secretion is dependent on expression of the 
laminin A chain (Yurchenco, Quan et al. 1997). qRT-PCR was performed to investigate if the 
defect in BM deposition in –F –FBS conditioned EBs was due to reduced expression levels of 
Lama1. Indeed LamA1 mRNA levels were significantly lower in serum-free feeder-free 
conditioned EBs compared with EBs conditioned in the presence of serum (+/- F), whilst 
expression levels of LamB1 were similar in all three conditions (Figure 3.20). Furthermore, -
F +FBS conditioned EBs displayed reduced LamA1 mRNA levels compared to +F +FBS 
conditioned EBs, supported by a thicker BM identified in +F +FBS conditioned EBs 
compared to –F +FBS, described previous. 
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Figure 3.20 LamA1 expression 
levels differ depending on culture 
conditions. LamA1 mRNA levels 
were significantly lower in 7 day 
serum-free feeder-free EBs (-F –
FBS) compared to EBs conditioned 
in the presence of serum (+F +FBS, 
-F +FBS). LamB1 mRNA levels 
were no different when comparing 
the 3 conditions. n = 3; * p < 0.05, 
student’s T-test; error bars, SEM. 
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3.4 Differentiation of mesendoderm and ectoderm within EBs is influenced by mESC 
pre-culture conditions 
Brachyury (Bry) is expressed in mesendodermal cells that give rise to both definitive 
endoderm and mesoderm (Herrmann and Kispert 1994; Kispert and Herrmann 1994; Kubo, 
Shinozaki et al. 2004) . In the mouse embryo, following migration through the primitive 
streak, Bry is down-regulated and nascent mesoderm differentiates to form three subtypes: 
paraxial, intermediate and lateral plate mesoderm. Paraxial mesoderm is the first to form due 
to elongation of the primitive streak, and is marked by expression of Tbx6 and Foxc1 genes 
(Chapman, Agulnik et al. 1996; Fehling, Lacaud et al. 2003; Wilm, James et al. 2004). Given 
that expression of Bry is indistinguishable between definitive endoderm and mesoderm, 
expression of Tbx6 and Foxc1 can be explored. Intermediate mesoderm follows and finally, 
lateral plate mesoderm formation occurs.  
Differentiation to the third germ layer ectoderm is often classified into three subsections; 
external ectoderm, neural crest and neuroectoderm (neural tube). Pax6 is one of the earliest 
markers of ectoderm differentiation, know to be of great importance in development of the 
eye and neural epithelial of the forebrain (Li, Yang et al. 1994). The interaction of mesoderm 
and ectoderm differentiation is crucial for successful development therefore expression of 
Pax6 was also investigated (Ang, Conlon et al. 1994; Lawrence, Johnston et al. 1994; San 
Martin and Bate 2001). 
mRNA levels of the nascent mesoderm marker, Bry were shown to be significantly higher 
(approximately 100-fold higher) in serum-free conditioned EBs, when compared with EBs 
conditioned in typical ESC culture conditions in the presence of feeders and serum. A lack of 
feeders during mESC culture also affected Bry expression levels, which were 10-fold higher 
when compared to EBs conditioned in the presence of feeders (Figure 3.21). Investigation 
into paraxial mesoderm markers further supported the Bry expression data, since Tbx6 and 
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Foxc1 mRNA expression levels were also shown to be affected by ESC culture condition. 
Serum appeared to be most crucial; -F –FBS conditioned EBs displayed significantly higher 
levels of both Foxc1 (4-fold higher) and Tbx6 (10-fold) when compared to EBs conditioned 
in the presence of serum. –F +FBS conditioned EBs however, displayed similar levels of 
Foxc1, although Tbx6 was 2-fold higher than EBs conditioned in the presence of serum and 
feeders (Figure 3.22). 
Furthermore, levels of ectoderm marker Pax6 were significantly higher in serum-free EBs 
compared to EBs derived in the presence of serum and feeders. Interestingly the presence of 
feeders did not affect Pax6 expression providing serum was present, since Pax6 expression 
levels in +F+FBS and –F +FBS culture conditions were similar (Figure 3.23).  
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Figure 3.21 Levels of nascent 
mesoderm marker, Bry are 
significantly different for day 7 EBs 
depending on 2D culture conditions. 
Feeder-free EBs (-F +FBS) had 
significantly higher Bry levels, and a 
similar but more drastic trend for serum-
free feeder-free conditioned EBs (-F –
FCS) when compared to EBs conditioned 
in presence of serum (+F +FCS, -F 
+FBS).  n = 6, * p < 0.05, ** p< 0.001, 
student T-test, error bars; SEM 
Figure 3.22 Levels of paraxial 
mesoderm makers Foxc1 and Tbx6 in 
day 7 EBs significantly differ 
depending on 2D culture pre-
condition. Foxc1 and Tbx6 mRNA 
levels relative to GAPDH were 
significantly higher for serum-free 
feeder-free conditioned EBs when 
compared to EBs conditioned in 
presence of serum (+F +FBS).  n = 3, * p 
< 0.05, student T-test, error bars; SEM 
Figure 3.23 Levels of early ectoderm 
marker, Pax6 are significantly 
different between culture conditions. 
Pax6 mRNA levels relative to GAPDH 
indicate that serum-free feeder-free 
conditioned EBs (-F –FBS) display 
significantly higher Pax6 levels at day 7 
when compared to EBs conditioned in 
presence of serum (+F +FCS, -F +FBS).  
n = 6, * p < 0.05, student T-test, error 
bars; SEM 
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3.5 Discussion 
mESCs and hESCs have long been propagated using feeder cells and serum (Heath and Smith 
1988; Smith, Heath et al. 1988; Brook and Gardner 1997), although the exact mechanisms of 
their supportive roles are undetermined and undefined. STO feeder cells used in this study, 
like any fibroblast, secrete an array of cytokines, chemokines and proteins; their role in ESC 
maintenance is thought to be largely mediated by these secreted factors, but the mechanisms 
are unknown. Some years ago it was discovered that feeder cells secreted LIF  (Resnick, 
Bixler et al. 1992), which promotes mESC self-renewal (Smith, Heath et al. 1988), but more 
recently, other factors have been found to influence mESC self-renewal. Feeder cell secretion 
of BMP-4 was reported to be required for the maintenance of mESC pluripotency due to 
interactions with LIF and subsequent inhibition of the MAPK pathway (Qi, Li et al. 2004; Li 
and Chen 2012). Similarly, the importance of a feeder layer in the maintenance of hESCs has 
been linked to secretion of ActivinA (Jozefczuk, Drews et al. 2012), potentially underpinned 
by feeders displaying TGF-beta thus governing ActivinA, as demonstrated in one study 
(Chen, Lee et al. 2012). Characterisation of STO feeder cell conditioned media has shown 
that a variety of factors are present, including ActivinA and some FGFs whilst LIF is low or 
undetected (Van Hoof, Heck et al. 2008; Talbot, Sparks et al. 2012). The employment of 
serum during mESC culture is also very common (Cormier, zur Nieden et al. 2006), although 
again, the exact role is unknown. It is more than likely however, that the activity of serum is 
linked to the multitude of different proteins and growth factors present. Interestingly, one 
study has shown that serum-free ESC growth conditions however, can sustain pluripotent 
ESCs providing inhibitor of differentiation (Id1), a direct target of BMP-4, is over-expressed 
(Galvin, Travis et al. 2010; Romero-Lanman, Pavlovic et al. 2012). Likewise, another study 
demonstrated that the maintenance of mESCs in serum-free feeder-free conditions, can be 
sustained via over-expressing Blc-2, an antiapoptotic factor (Opferman and Korsmeyer 2003; 
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Yamane, Dylla et al. 2005). Results in this chapter have demonstrated that whilst a lack of 
feeder cells results in discrete alterations in ESC behaviour (a lack of cavitation and 
multilayered extraembryonic endoderm) they largely appeared dispensable during mESC 
expansion. Serum, however, was shown to be vitally important for normal ESC behaviour, 
both during 2D monolayer culture and in the 3D EB model in vitro, without which, ESC 
behaviour was drastically and significantly altered, outlined in Table 3.  
The absence of feeder cells or serum had no affect on Oct4 or Nanog expression during 2D 
culture. Despite variations in culture conditions, Oct4 and Nanog expression was consistent 
across all conditions (Figure 3.2, 3.3), suggesting that LIF supplementation is sufficient to 
maintain ESC pluripotency. Yasuda et al., showed that feeder cells do not influence hESC 
pluripotency, therefore mechanisms which underpin this could be consistent with mESCs 
(Yasuda, Tsuneyoshi et al. 2006).  However, the proliferation rate of mESCs was affected by 
culture condition; –F –FBS ESCs doubling time was 36 h, compared to 18 h for +F +FBS 
ESCs, and the absence of feeders was not shown to affect proliferation rate providing serum 
was present (Figure 3.4). Taken together, these results suggest not only that proliferation and 
pluripotency are independently regulated but also that serum, or a component of serum, 
affects proliferation. Interestingly, Faherty et al., investigated the interplay between FBS and 
LIF on mESC self-renewal and proliferation, and showed that variations in combinations of 
FBS and LIF resulted in correlation of low proliferation with increased self-renewal (Faherty, 
Kane et al. 2005), as seen in –F-FBS conditions. Over-expression of BMP-4 in STO feeder 
cells was shown to repress mESC proliferation (Kim, Lee et al. 2012); therefore, given the 
known interaction between BMP-4 and LIF, it was unsurprising that LIF was identified as the 
main factor for proliferation. 
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Table 3 Summary of 2D culture conditions prior to EB formation and the effects they have on 
subsequent EB development.  
 E14 +F +FBS E14 –F +FBS E14 –F –FBS 
 
 
2D monolayer 
culture 
Typical morphology: 
High nuclear: cytoplasmic 
ratio and prominent nucleoli. 
Proliferation :doubling 
time,~18 h  
Typical morphology, as in 
E14 +F +FBS. 
Proliferation: doubling time 
~20 h 
Typical morphology as 
in +F +FBS. 
Proliferation:  
doubling time, ~36 h 
EB 
morphology 
and cavitation 
Obvious cavitation by day 7 Occasionally, but not 
always signs of cavitation 
by day 7. 
Few signs of cavitation 
by day 7 
 
mESC self 
renewal in EB 
model 
Few Oct4+ Nanog+ ESCs 
centrally located in EB by day 
7 
Oct4+ Nanog+ ESCs low 
and mostly centrally 
located in EB by day 7 
Oct4+ Nanog+ ESCs 
represent significant 
proportion of cells in 
EBs and are located to 
outer surface of EBs at 
day 7 also 
 
EEE 
differentiation 
Gata6+ cells represented by 
multilayer on outer surface of 
EBs.  
AFP expression thick on outer 
surface of EB 
Gata6+ cells represented by 
a single layer on outer 
surface of EBs. 
AFP expression present, 
although less apparent 
compared to +F +FBS EBs 
Few Gata6+ cells on 
outer surface of EBs. 
AFP expression 
detectable, although 
levels lower than in +F 
+FBS conditioned EBs 
 
BM deposition 
Complete BM by  day 4/5 : 
correct localisation of Laminin 
and LamA1 between outer 
Gata6+ cells and inner cells 
BM present, as in +F +FBS 
conditioned EBs, although 
complete BM detected only 
from day 7  
Disorganised, 
incomplete BM. 
Laminin expression 
atypical, detected in 
inner regions of EBs, 
as well as few discrete 
outer regions. 
Differentiation 
to mesoderm 
and ectoderm 
Bry, Foxc1, Tbx6 and Pax6 
expressed  
Enhanced differentiation to 
mesoderm; increased Bry 
and Tbx6 compared to +F 
+FBS. No change in Pax6 
expression 
Increased expression 
of mesoderm and 
ectoderm markers at 
day 7; 100-fold 
increase in Bry and 
increased Foxc1, Tbx6, 
Pax6 levels 
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One study suggested that insulin and LIF positively affect mESC proliferation, whilst zinc 
and L-cystine reduce cell growth (Knospel, Schindler et al. 2010). It is therefore possible that 
a lack of serum is correlated with a lack of insulin, resulting in reduced proliferation, which is 
feasible since insulin-like factors are known to be present in serum (Hey, Browne et al. 
1987). Wnt has been shown to control stem cell proliferation in epidermal and hematopoietic 
systems (Reya, Duncan et al. 2003), and therefore, could also represent a major controlling 
factor here should Wnt signalling be down-regulated as a consequence of a lack of serum. 
Furthermore, Lianguova et al. showed that proliferation of mESCs is maintained by two 
separate mechanisms, one being a serum-dependent mechanism and the other a PI3K-based 
mechanism (Lianguzova, Chuykin et al. 2007). Interestingly, a long standing debate persists 
as to whether the tumour suppressor p53, restricts differentiation via repression of 
proliferation (Jain, Allton et al. 2012), which would also fit here. ZO-1, a tight-junction 
transmembrane protein known to affect cell proliferation, has also been shown to affect 
differentiation, since a lack of ZO-1 was shown to result in differentiation despite the 
presence of LIF (Xu, Lim et al. 2012). 
Perhaps a consequence of the slow proliferation rate detected in –F- FBS conditions, was the 
initial observation from corresponding EBs, which demonstrated that EBs conditioned in the 
absence of serum were smaller in diameter (Figure 3.5, 3.6) and lacked certain differentiation 
capabilities. EB size has been demonstrated to affect self-renewal and differentiation; 
specifically, smaller EBs have been shown to display more chondrogenic potential whilst 
lacking endoderm potential compared to larger EBs (Messana, Hwang et al. 2008). A second 
observation of EBs from morphological assessment was related to cavitation; a lack of feeder 
cells, irrespective of serum presence, was shown to affect the ability of EBs to cavitate 
(Figure 3.7, 3.8C). One study demonstrated that BM is required for cavitation since BM-
deficient EBs synthesise visceral endoderm but do not cavitate (Murray and Edgar 2000), 
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however one study demonstrated the dependency of visceral endoderm differentiation and 
subsequent cavitation on FGF-1 signalling (Esner, Pachernik et al. 2002). Perhaps a lack of 
STO feeder cells is correlated with a lack of FGF-1 signalling, although a lack of FGF-1 
signalling would be expected to cause more severe disruptions in differentiation than is 
actually identified in –F +FBS conditioned EBs. Cavitation represents the first wave of 
programmed cell death in the developing embryo and its importance has long been known 
(Bellairs 1961; Saunders 1966). Cavitation in embryoid bodies, is largely thought to parallel 
development of the pro-amniotic cavity in the developing embryo in vivo, moreover is 
thought to require apoptosis inducing factor (AIF) (Joza, Susin et al. 2001; Feraud, Debili et 
al. 2007). ESCs that over-produce catalase, an enzyme which degrades hydrogen peroxide, do 
not cavitate (Hernandez-Garcia, Castro-Obregon et al. 2008), therefore perhaps in the 
absence of feeders, ESCs lack AIF and/or are stimulated to over-produce catalase and 
although this trend is exaggerated in the absence of serum, serum alone cannot compensate 
for a lack of feeders with regard to cavitation.  
 
Variations in culture conditions were also shown to also affect ESC differentiation. Serum-
free conditions did not appear to support ESC differentiation but instead favoured self-
renewal, since –F –FBS conditioned EBs displayed significantly higher proportions of Oct4 
and Nanog positive ESCs (compared to +/-F +FBS) (Figures 3.9 – 3.12), and simultaneously 
lacked differentiation to primitive endoderm, identified via reduced Gata6 levels (Figure 
3.13, 3.14). This result, again suggests that serum, not feeders, is crucial for typical ESC 
behaviour, moreover in this instance, it appears that a component of serum regulates Oct4, 
Nanog or Gata6, or indeed all three. The interaction of Oct4, Nanog and Gata6 has long been 
studied. Interestingly, the loss of Nanog was shown to be a requirement for successful 
primitive endoderm differentiation (Hamazaki, Oka et al. 2004), although another study 
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suggested that initiation of primitive endoderm differentiation is independent of Nanog 
(Frankenberg, Gerbe et al. 2011; Filliers, Goossens et al. 2012). Oct4 and Gata6 interaction is 
more well studied although intracellular modulation of pluripotent and primitive endoderm 
factors is less defined. Knockdown of Oct-4 has been shown to result in the up-regulation of 
Gata6 (Hay, Sutherland et al. 2004), but there are many proposed regulatory factors. Myc, a 
proto-oncogene known to promote cell proliferation (Ifandi and Al-Rubeai 2003; Tamura, 
Hua et al. 2005) has been shown to control pluripotency (Oct4 expression included) via 
suppression of Gata6 (Smith and Dalton 2010; Smith, Singh et al. 2010). Another study 
showed that a target gene of Oct4, serine/threonine kinase40 (Stk40) links pluripotency and 
extraembryonic endoderm via activation of Erk/MAPK (Li, Sun et al. 2010). With this in 
mind, a lack of serum could stimulate a reduction in Myc, leading to slower proliferation and 
lack of Gata6 expression (as indentified in –F –FBS conditioned EBs), or indeed a lack of 
serum could affect the interaction between Oct4 and Stk40. Likewise, platelet derived growth 
factor alpha (PDGFα) has been shown to be essential for PE differentiation (Artus, Panthier 
et al. 2010), moreover it was shown that in serum-free conditions, only supplementation with 
PDGFα alongside other cytokines, can stimulate mesenchymal stem cells to differentiate to 
neuronal lineages (Tao, Rao et al. 2005). This suggests that that serum-free conditions lack an 
array of cytokines, of which PDFGα could be important. The feeder parameter however (+/- 
F) did not alter levels of Oct4 and Nanog positive cells in EBs, although it did affect 
differentiation to primitive endoderm. This is in contrast to work by Hamazaki et al., who 
showed that differentiation to primitive endoderm is achieved in mESCs without the presence 
of feeder cells (Hamazaki, Oka et al. 2004).  
 
Visceral and parietal differentiation was also lacking in -F- FBS conditioned EBs, detected by 
reduced AFP levels (Figure 3.15, 3.16) and identified with morphology studies. Visceral and 
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parietal endoderm are derivatives of primitive endoderm (Lehtonen, Lehto et al. 1983; Artus, 
Piliszek et al. 2010), moreover Gata6 null embryos fail to form visceral and parietal 
endoderm (Morrisey, Tang et al. 1998; Cai, Capo-Chichi et al. 2008), outlining the 
importance of primitive endoderm differentiation for parietal and visceral differentiation. Cell 
lineage is not the only influential factor though, since it has been shown that parietal 
endoderm differentiation is only successfully achieved in the mouse once adequate cell-
interactions with ectoderm cells occur (Hogan and Tilly 1981). A lack of serum, shown to 
affect differentiation to endoderm, could therefore be attributed to a lack of cytokine(s), or to 
a disruption in ectoderm differentiation, leading to insufficient cell-cell interactions and 
cross-talk. Nonetheless, results have shown that a lack of serum causes major disruptions in 
endoderm differentiation. Conley et al. showed that in serum-free media, hESCs do not 
differentiate to visceral endoderm (Conley, Ellis et al. 2007) and it is only upon the 
supplementation with BMP-4 that the visceral endoderm derivatives are reconstituted. 
Interestingly, it has been shown that the heterogeneous Nanog expression pattern, identified 
and true for all three culture conditions during monolayer culture, can dictate PE 
differentiation, furthermore Nanog is shown to directly repress Gata6 expression through 
binding to the proximal promoter region of Gata6 (Singh, Hamazaki et al. 2007). There is 
also growing evidence to suggest that differentiation to endoderm and primitive streak is 
governed largely by Wnt. Nakanishi et al. showed that in serum-free media, Wnt 
supplementation was necessary to stimulate primitive streak (PS) differentiation in hESCS 
and furthermore Wnt canonical pathway is essential for mESCs to differentiate into PS cells 
(Nakanishi, Kurisaki et al. 2009). It could be that –F –FBS conditions do not support the Wnt 
pathway. 
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BM formation was uncharacteristic in –F –FBS conditioned EBs also, attributed to atypical 
laminin expression and localization (Figure 3.17). BMs, as described previously, represent 
the earliest extracellular matrices produced during embryogenesis, of which laminin is a 
major component. Of the three chains which make up the laminin heterodimer, beta1 and 
gamma1 are detected at the 2 cell stage, whilst alpha1 is detected at the 8-16 cell stage 
(Cooper and MacQueen 1983; Dziadek and Timpl 1985). Disrupted BM synthesis, detected 
in –F –FBS conditioned EBs, is relatively unsurprising given the importance of endoderm 
cells, which are lacking in –F –FBS conditioned EBs, in the deposition of BM. BMs have 
been shown to play a role in endoderm differentiation and vice versa (Murray and Edgar 
2000) and one recent study demonstrated the importance of laminin in regulating ESC 
polarity (Li, Edgar et al. 2003), important in the organisation of differentiation. Although 
LamA1 is known to be expressed between endoderm and mesenchyme, in the early stage of 
BM formation, as in the early stages of EB development, LamA1 is found exclusively 
expressed by endoderm cells (Simo, Bouziges et al. 1992).  LamA1 chains are thought to 
drive secretion of laminin trimer regulated via beta1 integrins (Aumailley, Pesch et al. 2000). 
Studies have also shown that mESCs deficient in beta1 integrin, result in a lack of LamA1 
secretion to extracellular space (Aumailley, Pesch et al. 2000), moreover a deficiency in 
beta1 integrin is shown to interfere with BM self-assembly specifically Laminin-111 (Sasaki, 
Forsberg et al. 1998), similarly identified in –F –FBS conditioned EBs. It is possible perhaps, 
that this condition lacks beta1 integrin, so crucial in BM self-assembly.  
 
Expression of LamA1, commonly associated with BM secretion and functionality 
(Yurchenco, Quan et al. 1997; Miner, Li et al. 2004), was significantly lower in –F -FBS than 
+F +FBS conditioned EBs (Figure 3.20), and localisation was unusually central in EB rather 
than in an outer BM position (Figure 3.19). This would imply that LamA1 synthesis, 
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transportation and distribution is defective due to a lack of serum, suggesting that serum (or a 
component of serum) has a role in facilitating LamA1 transport. LamA1 domains have been 
shown to be essential for visceral endoderm differentiation (Akerlund, Carmignac et al. 
2009), lacking in –F –FBS conditioned EBs, suggesting a lack of serum influences this 
interaction. LamA1 has been shown to be dependent on Sonic hedgehog in muscle progenitor 
cells (Anderson, Thorsteinsdottir et al. 2009) furthermore TGF-beta, was shown to induce 
LamA1 (Nguyen, Bai et al. 2002). Either mechanisms of LamA1 control could be lacking in 
–F –FBS conditions, resulting in significantly lower LamA1 expression and inadequate BM. 
In comparison, EBs conditioned in the presence of serum (+/- feeders) displayed correct 
localisation of laminin, found in the BM position, and moreover the BM was typically thick, 
Reichert’s-like membrane. Research has shown that only once laminin is secreted (a 
consequence of LamA1 expression) can the different laminin trimers interact with each other 
and assemble into a functional meshwork (i.e. BM) (Urbano, Torgler et al. 2009). A lack of 
serum could potentially disrupt this process, whilst the presence of a feeder layer appears 
dispensable when considering BM synthesis and deposition.  
 
As outlined previously, ESC differentiation to mesoderm and ectoderm was also different 
depending on culture condition. –F –FBS conditioned EBs were stimulated to mesoderm and 
ectoderm, detected by a 100-fold increase in Bry and 15-fold increase in Pax6. Brachyury 
expressing-cells represent a transient population, therefore although Bry expression in day 7 
–F –FBS conditioned EBs was detected at significantly higher levels than +F +FBS 
conditioned EBs, it is known that under normal culture conditions, Bry is downregulated in 
EBs after day 4. Therefore, it is possible that the mesoderm markers had already peaked 
before day 7 in +F +FBS conditioned EBs, and therefore high Bry expression as detected in –
F –FBS conditioned EBs, could represent delayed mesoderm differentiation. Bettiol et al. 
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suggested that media supplemented with serum (fetal bovine serum) increases expression, 
markers of endoderm (AFP) and mesoderm (Bry) in hESCs (Bettiol, Sartiani et al. 2007). 
Unpublished observations (personal communication, Dr Patricia Murray, University of 
Liverpool) suggest that in hESCs, high levels of Bry are directly correlated with Oct4, since 
hESCs co-express Bry and Oct4. However, since Foxc1 and Tbx6, markers of paraxial 
mesoderm were also shown to significantly increase in –F –FBS conditioned EBs it would 
appear that differentiation to mesoderm is a true representation, since Foxc1, unlike Bry, is 
maintained in EB cultures following induction (unpublished observations of our Stem Cell 
group), therefore higher levels of this gene, are likely to truly represent enhanced 
differentiation to mesoderm in -F -FBS EBs. A lack of feeders was shown to affect mesoderm 
differentiation also (despite the present of serum); Bry expression increased 10-fold, 
compared to +F +FBS conditioned EBs, however differentiation to ectoderm, specifically 
Pax6 expression, was unchanged when comparing +/-F +FBS, implying that serum, not 
feeders, is more important for Pax6 expression. It has been shown that differentiation of 
hESCs to paraximal mesoderm in serum-free media is only achieved providing TGF-beta 
signaling is inhibited (Mahmood, Harkness et al. 2010) and in one study, disrupted 
polarisation within the EB, as demonstrated in –F –FBS conditioned EBs, results in 
differentiation predominantly along mesechymal lineage and spontaneously produces 
hematoendothelial precursors (Krtolica, Genbacev et al. 2007).  
Similarly, early ectoderm differentiation (detected by expression of Pax6) was significantly 
increased in serum-free conditioned EBs (-F –FCS) when compared to EBs conditioned in 
the presence of feeders and serum (+F +FCS) at day 7. Until a range of time points are 
investigated, it is unclear whether this result represents delayed ectoderm differentiation, or 
alternatively a definitive increase in ectoderm differentiation, as a result of different 
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environmental cues initiated by a lack of feeders cells or serum, compared to EBs grown in 
normal conditions, in presence of feeders and serum. 
Overall and in conclusion, these results suggest that EB differentiation patterns become 
disorganised if growth conditions prior to EB formation, lack serum and/or feeders. In – F –
FBS conditioned EBs, there is a lack of extraembryonic endoderm, BM deposition and 
cavitation, explained largely by a corresponding lack of Gata6 which has been shown to be 
required for LamA1 expression (Li, Arman et al. 2004). LamA1 is required for laminin trimer 
formation and secretion which in turn is required for BM deposition, known to be required 
for ectoderm polarisation and cavitation. Lonai et al., show that Gata6 induction is dependent 
on FGF signalling, therefore –F –FBS conditions could affect FGF signalling in the EBs, 
ultimately underpinning this disorganisation. 
The -F +FBS conditioned EB phenotype however, is less explicable. Primitive endoderm and 
BM deposition appeared normal, however these EBs lacked a multi-layering of cells and 
thick Reichert’s-like BM. This result suggests that there is an issue with parietal endoderm 
differentiation, attributed purely to a lack of feeders. This could be due to a lack of either a 
feeer cell-specific surface factor, or a soluble factor synthesised and secreted into the media, 
or both. A proteome study of STO feeder cell conditioned medium (CM) identified 136 
unique proteins, of these many were known to play a role in ESC differentiation and ECM 
remodelling (Lim and Bodnar 2002; Shi, Xie et al. 2005; Buhr, Carapito et al. 2007). 
Furthermore one study showed that CM from visceral-endoderm-like cell line was sufficient 
to induce parietal endoderm differentiation (Mummery, van Achterberg et al. 1991). Taken 
together these data suggest that a soluble factor that is missing when feeders are removed, is 
crucial for parietal endoderm differentiation. However, a role for substrate contact has also 
been suggested to be important for parietal endoderm differentiation in EBs from 
teratocarcinoma cells (Grabel and Watts 1987). This could represent a role for feeder-cell 
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specific surface molecules necessary for the stimulation of parietal endoderm differentiation. 
Differentiation to parietal endoderm is often thought to require over-expressing Gata6 cells 
(Kim and Ong 2012), which are lacking in –F +FBS conditioned EBs, and this is often 
attributed to the effect on the upstream transcription factor Sox7 (Futaki, Hayashi et al. 2004; 
Niimi, Hayashi et al. 2004). Nodal signalling has also been identified as crucial for 
extraembryonic endoderm differentiation, therefore a lack of feeders could result in a 
disruption in this signalling pathway (Kruithof-de Julio, Alvarez et al. 2011). 
Metalloproteinases have been highlighted as regulators of parietal endoderm differentiation 
also (Behrendtsen and Werb 1997) and studies have suggested that differentiation to parietal 
endoderm is a plastic event, varying in response to BMP (Paca, Seguin et al. 2012). A lack of 
feeder cells could be correlated with on or indeed all of these factors, although the exact 
mechanisms are difficult to isolate since the precise roles of the feeder cells in ESC culture 
have yet to be characterized in any great depth. 
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4. Heparan Sulfate is crucial for normal mESC behaviour 
4.1 General Introduction 
A master controller of regulatory proteins involved in mESC differentiation is heparan sulfate 
(HS) and as discussed previously, there is accumulating evidence for the importance of HS in 
an array of physiological processes governing embryogenesis via its interactions with a 
plethora of protein ligands (Klagsbrun 1990; McKeehan, Wang et al. 1998; Ornitz 2000; 
Fuerer, Habib et al. 2010; Mundy, Yasuda et al. 2011; Shimokawa, Kimura-Yoshida et al. 
2011). For example, mice lacking the HS biosynthetic enzyme, EXT-1, fail to gastrulate due 
to a major deficiency in HS synthesis (Lin, Wei et al. 2000).  
Expression levels and activity of a number of HS biosynthetic enzymes dictates the final 
sulfation pattern of a mature HS chain, therefore dictates function. HS synthesis is an 
enzyme-driven process whereby HS chain polymerisation is followed by step-by-step chain 
modification (Sasisekharan and Venkataraman 2000). However, each step in the process does 
not reach completion, giving rise to heterogeneity in HS chains and a variety of structures 
depending on cell type, environment and stimuli (Prydz and Dalen 2000). Little is known of 
what regulates the process; however, studies have shown that upon differentiation, HS 
biosynthetic enzyme expression does alter in mESCs (Nairn, Kinoshita-Toyoda et al. 2007). 
The proteins EXT1, EXT2, NDST1, Sulf1 and Sulf2 are some of the key enzymes involved 
in the biosynthesis and modification of HS chains, their precise roles have been outlined 
previously. The exostosin genes, EXT1 and EXT2, encode glycosyltransferases responsible 
for HS chain initiation and elongation (McCormick, Duncan et al. 2000; Busse, Feta et al. 
2007). N-deacetylase/N-sulfotransferase (NDST1) is involved in HS N-sulfation (Kjellen 
2003) and shown to be crucial in lung development, specifically for facilitation of BMP 
signalling (Hu, Wang et al. 2009; Ringvall and Kjellen 2010). NDST1 levels have been 
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shown to alter in mESCs depending on differentiation state (Dagalv, Holmborn et al. 2011), 
and varying levels of NDST1 and/or NDST2 collectively effects the HS species that is 
synthesised in mESCs (Pikas, Eriksson et al. 2000; Holmborn, Ledin et al. 2004), 
Interestingly, levels of EXT1 and EXT2 have been shown to affect the levels and activity of 
NDST1 (Presto, Thuveson et al. 2008). 6-O-endosulfatases 1 and 2 (Sulf1 and Sulf2) are 
extracellular enzymes which fine tune HS structure by removing 6-O-sulfate groups from 
HSPGs in the extracellular environment (Pempe, Burch et al. 2012). Loss of the sulf enzymes 
has been shown to feedback and alter the expression of other biosynthetic enzyme expression, 
thereby indirectly affecting HS sulfation pattern (Lamanna, Frese et al. 2008). During 
embryogenesis, the exact roles of Sulf1 and Sulf2 are unclear, with some suggesting that they 
exist mutually exclusively (Lum, Tan et al. 2007), whilst others suggest that their roles 
overlap (Holst, Bou-Reslan et al. 2007). Nonetheless they are important enzymes controlling 
HS structure and, therefore, function.  
HS chains synthesised by different cell and tissue types differ both structurally and 
functionally (Thomas, Clayton et al. 2003; Holmborn, Ledin et al. 2004; Nairn, Kinoshita-
Toyoda et al. 2007); every cell synthesises an array of structurally distinct HS chains. The 
structure of HS is also dynamic and directed by the extracellular environment. For example 
changes in HS chain length, sulfation pattern and domain organisation occur throughout lung 
development and brain development (Brickman, Nurcombe et al. 1998; Thompson, Connell 
et al. 2011). Furthermore, it has been shown that changes in HS species are a consequence of 
differentiation state and vice versa for mESCs as well as other cell types (Salmivirta, 
Safaiyan et al. 1998; Jackson, Murali et al. 2007; Smith, Meade et al. 2011). Conversely, HS 
sulfation pattern has been shown to affect differentiation of mESCs (Forsberg, Holmborn et 
al. 2012), for instance, to a neuronal lineage (Johnson, Crawford et al. 2007; Pickford, Holley 
et al. 2011). 
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Like all cell types, mESCs synthesise HS and present it as a HSPG either at the cell surface 
(Williams and Fuki 1997; Tumova, Woods et al. 2000) or secrete it into the ECM, regardless, 
either at the cell surface or in the ECM, HS is well positioned to control cell-cell interactions 
or cell-protein interactactions thereby facilitating numerous cellular processes, including the 
differentiation of mESCs (Johnson, Crawford et al. 2007; Lanner, Lee et al. 2010). Cell 
surface HSPGs can also be shed into the ECM via proteolytic cleavage of the protein core 
and/or endoglycosidic cleavage of the HS chains by extracellular heparanase (Bame 1993; 
Vlodavsky, Goldshmidt et al. 2002; Patel, Knox et al. 2007; Vlodavsky, Ilan et al. 2007) and 
it has been shown that these secreted proteoglycans govern proliferation of hESCs 
(Levenstein, Berggren et al. 2008). Interestingly, HS purified from a cell surface extract can 
be structurally distinct from HS in the cell conditioned medium, as identified in osteoblast 
cultures (Murali, Manton et al. 2009).  
In the previous results chapter variations in mESC culture conditions were shown to cause 
defects in EB development. In the absence of feeders (but presence of serum), although EBs 
can form thin BMs, there is an effect on extraembryonic endoderm (EEE) development, since 
there is a tendency for these EBs to develop a single layer of flat Gata6 positive EEE on the 
surface. This result implies that further differenitation of primitive endoderm to parietal and 
visceral endoderm might be effected. A reduced level of cavitation than in controls was also 
identified, although the reasons for this are unclear. In –F –FBS conditioned EBs, the 
phenotype is more severe. Primitive endoderm differentiation is inhibited, as evinced by few 
Gata6 positive cells, there is limited deposition of BM, and little evidence of parietal/visceral 
endoderm differentiation. These EBs also show little cavitation and  increased expression of 
mesoderm and ectoderm markers. An EXT1
-/-
 mESC line was exploited in this chapter, in 
order to investigate the specific role and source of HS in typical mESC behaviour, since it is 
known that HS specifically influences FGF and BMP-4 signalling (Ornitz 2000; Shimokawa, 
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Kimura-Yoshida et al. 2011), required for primitive endoderm differentiation and visceral 
endoderm differentiation, respectively, both lacking in the defective –F –FBS conditioned 
EBs. Furthermore, supplementation with exogenous PMH was investigated as a possible 
method of rescuing atypical mESC behaviour, as seen with –F –FBS conditions. 
EXT1
-/- 
mESCs have a genetic mutation in the EXT1 gene, which encodes a 
glycosyltransferase enzyme that catalyses HS chain polymerisation once the Xyl-linkage 
region is attached to the core protein. EXT1
-/-
 mESCs are, therefore, defective in the ability to 
generate endogenous HS (Lin, Wei et al. 2000), and as a result, are HS deficient (Lind, 
Tufaro et al. 1998; McCormick, Leduc et al. 1998).  
Should the role of serum/feeders be to supply a source of HS to the ESC culture, then HS-
deficient EXT1
-/- 
mESCs would be expected to develop normal EBs, comparable to wild-type 
EBs, providing serum and feeders are present. Alternatively, if the main effect of 
serum/feeders is to stimulate endogenous HS synthesis, then HS-deficient EXT1
-/- 
mESCs 
would be expected to develop EBs similar to wild-type EBs cultured in the absence of 
serum/feeders. Taking these together, it is hypothesised here that FBS and/or feeders might 
provide a source of HS that is required for the normal development of EBs. Accordingly, 
biosynthetic enzyme expression was investigated for each culture condition, together with a 
structural analysis of cell-surface HS and soluble HS shed into media. 
Results in this chapter demonstrate that:  
 Following heparin supplementation, –F –FBS conditioned EBs: 
o deposit a BM  
o  display Gata6+ EEE observed in regions of the EB periphery 
o  expression of mesendoderm, paraxial mesoderm and ectoderm markers and 
are not significantly different from controls 
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 EXT1-/- mESCs cannot be maintained in the absence of serum 
 HS structure and abundance differs depending on the origin/source 
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4.2. Defective EB development attributed to a lack of serum, can be rescued with 
exogenous porcine mucosal heparin (PMH) 
The common marker of pluripotency, Oct4 was used to determine localisation and levels of 
self-renewing cells within EBs, exploring the effect of porcine mucosal heparin (PMH) after 
supplementation of serum-free conditioned EBs with PMH. Upon the addition of exogenous 
PMH Oct4 expression was mainly localised to central cells of the –F –FBS conditioned EBs 
and further, Oct4 levels significantly reduced (Figure 4.1, 4.3). This was further supported by 
qRT-PCR data, which showed that Oct4 levels were no different from controls (EBs 
conditioned from +F +FBS) (Figure 4.6 A).  
Differentiation to primitive endoderm, was investigated using an antibody specific to Gata6 
to assess the potential of exogenous soluble heparin to rescue the lack of primitive endoderm 
differentiation previously identified in –F –FBS conditioned. Indeed, EBs derived from -F –
FBS conditions, supplemented with PMH, displayed increased percentage of Gata6 positive 
cells (Figure 4.4) and expression was more typically localization to outer cells compared to –
F –FBS conditioned EBs (Figure 4.2). Quantification of mRNA levels using RT-qPCR 
supported these findings (Figure 4.6 B); Gata6 levels were no different to controls. 
Additionally, supplementation of serum-free ESC cultures with PMH was also shown to 
rescue localisation of LamA1, which had previously been shown to be lacking and atypically 
localised in –F -FBS conditioned EBs (Figure 4.5). In addition, qRT-PCR showed that 
mRNA levels of Bry and Pax6, markers of nascent mesendoderm and early ectoderm markers 
respectively, were rescued in –F –FBS following supplementation with exogenous PMH (4.6 
C, 4.6 D).   
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Figure 4.1 Exogenous PMH affects the distribution of Oct4 positive cells within EBs. Serum-free 
conditioned day 7 EBs displayed Oct4 positive cells localised across the entire EB rather than in 
discrete central areas, as is the case for EBs conditioned in the presence of serum (+/- feeders). 
Serum-free conditioned EBs when supplemented with heparin, displayed Oct4 positive cells localised 
predominantly in central regions, as indicated with arrows. Images are representative of the EB 
population; the experiment was repeated > 3 times and scale bar represent 200 µm. 
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Figure 4.2 Exogenous PMH induces Gata6 expression in peripheral EB cells. Feeder-free and 
serum-free conditioned day 7 EBs contained fewer Gata6 positive cells than controls. Upon the 
addition of PMH for 3 passages prior to EB formation, Gata6 positive cells were observed at the EB 
periphery, comparable to +F +FBS conditioned EBs. Images are representative of the EB population; 
the experiment was repeated > 3 times and scale bar represent 200 µm. 
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Figure 4.3 Exogenous 
PMH significantly 
increases the percentage of 
Oct4+ mESCs in feeder-
free serum-free conditions. 
mESCs maintained in –F –
FBS conditions displayed 
significantly increased 
percentage of Oct4 positive 
cells when supplemented 
with 1µg/Ml heparin. N=4, 
**p < 0.01 student’s T-test 
and error bar represents 
SEM. 
Figure 4.3 Exogenous 
PMH rescues the 
percentage of Oct4+ 
mESCs in feeder-free 
serum-free conditions, now 
comparable to +F+FBS 
conditions. mESCs 
maintained in –F –FBS 
supplemented with PMH 
displayed significantly 
reduced percentage of Oct4 
positive cells, comparable 
with +F+FBS. n=4, 
**p<0.01 student’s T-test 
and error bar represents 
SEM. 
Figure 4.4 Exogenous PMH 
rescues the percentage of 
Gata6+ mESCs in feeder-
free serum-free conditions, 
now comparable to 
+F+FBS conditions. mESCs 
maintained in –F –FBS 
supplemented with PMH 
conditions displayed 
significantly increased 
percentage Gata6 positive 
cells, comparable with 
+F+FBS conditions. n=4, *p 
<0.05 student’s T-test and 
error bar represents SEM. 
134 
 
 
Figure 4.5 Effect of exogenous PMH on laminin expression. Serum-free conditioned day 7 EBs 
displayed LamA1 expression in discrete regions of EB on outer surface of the peripheral cells rather 
than in BM position, as indicated with arrows. Upon the addition of PMH for 3 passages prior to EB 
formation, LamA1 localised more typically to the BM position, again highlighted with arrows. Images 
are representative of the EB population; the experiment was repeated > 3 times and the scale bar 
represents 200 µm.   
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Figure 4.6 Exogenous PMH was shown to rescue a typical EB differentiation marker pattern 
expression in 7 day serum-free conditioned EBs. [Data for +F +FBS, -F +FBS and –F –FBS was 
reproduced from Figures 3.11, 3.14, 3.21 and 3.23, for corresponding Oct, Gata6, Bry and Pax6, for 
comparative purposes]. Serum-free conditioned EBs were shown to have significantly different early 
differentiation development profiles when compared to EBs conditioned in the presence of serum (+/-
F). Specifically, serum-free EBs had significantly higher levels of Oct4 (A), Bry (C) and Pax6 (D) and 
significantly lower levels of primitive endoderm marker Gata6, when compared to EBs conditioned in 
the presence of serum +/- F. Addition of soluble heparin (1 ug / ml) to the –F –FBS cultures for 2 
passages prior to EB formation, typical development was rescued; Oct4, Bry and Pax6 were all 
significantly reduced to levels now comparable to EBs conditioned in presence of feeders and serum 
(+F +FCS).  * p < 0.05, ** p < 0.001 ***p < 0.0001, n = 4, error bars, SEM. 
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4.3 HS-deficient EXT1
-/-
 mESCs require serum and feeders for normal behaviour  
Previously it was shown that supplementation with PMH rescued defects in E14 EB 
development attributed to a lack of feeders and more significantly, a lack of serum. This 
result suggested a deficiency in levels and/or species of HS, however, what remained unclear 
was the origin of HS; is it HS from feeders or serum, or both that is crucial in mESC 
behaviour? 
4.3.1 HS-deficient mESCs cannot be maintained in the absence of serum during 2D 
expansion 
HS-deficient EXT1
-/-
 mESCs were maintained in three distinctly different 2D culture 
conditions. Of these, only two conditions were able to support EXT1
-/-
 mESC expansion and 
viability long-term (> 10 passages). Serum-free conditions, although shown to previously 
support E14 mESCs during 2D culture, proved detrimental to EXT1
-/-
 mESCs; mESCs 
displayed a rounded cell morphology, and became detatched from the culture dish (Figure 4.7 
C). Quantification of viability confirmed this, since over 80 % of EXT1
-/-
 mESCs grown in 
serum-free cultures were no longer viable by 48 h (Figure 4.8). In contrast, providing that 
serum was present (+/- feeder layer), EXT1
-/-
 mESCs were maintained for more than 10 
passages and displayed typical morphology, proliferation and colony formation (Figure 4.7 A 
and 4.7 B).   
To further confirm that the EXT1
-/-
 mESCs had not differentiated after 10 passages under the 
different culture conditions, co-immunostaining of Oct4 and Nanog was performed, common 
markers of ESC pluripotency. EXT1
-/-
 mESCs remained positive for Oct4 and Nanog 
expression throughout expansion in both conditions (Figure 4.9). Quantification of Oct4 
positive EXT1
-/-
 mESCs confirmed that Oct4 expression was comparable to E14 mESCs, and 
additionally, there was no difference between culture conditions (+/- feeder layer). There was 
no difference in proportion of Nanog positive cells when comparing E14 mESCs and EXT1
-/- 
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mESCs cultured in the presence of serum and feeders (+F +FBS), however, in feeder-free 
conditions, HS-deficient EXT1
-/-
 mESCs displayed higher proportions of Nanog positive cells 
compared to E14 ESCs cultured in the same condition. In addition, comparing the effects of 
culture condition on EXT1
-/- 
mESCs pluripotency, Oct4 expression was unchanged, the 
proportion of Nanog-positive cells was however, significantly higher in EXT1
-/-
 mESCs 
cultured in the absence of feeders, compared to EXT1
-/-
 mESCs cultured with feeders (Figure 
4.10). 
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Figure 4.7 HS-deficient EXT1
-/-
 mESC expansion was not supported in serum-free and feeder-
free 2D culture conditions. EXT1
-/-
 mESCs were maintained in vitro for more than 10 passages in 
three distinctly different culture conditions in parallel; with feeders and serum (+F + FBS), without 
feeders but with serum (–F + FBS) and without feeders or serum (–F –FBS), as explained previous.  
EXT1
-/-
 mESC behaviour and morphology during monolayer culture varied depending on growth 
conditions. At 48 h EXT1
-/-
 mESCs cultured in the presence of serum (A, B, D and E) (+F + FBS, –F 
+ FBS) displayed typical behaviour; cells adhered to surface of dish and formed colonies. In contrast, 
EXT1
-/-
 mESCs cultured in serum-free conditions (C and F) (-F –FBS) displayed abnormal behaviour; 
cells adopted a rounded morphology and became detatched from the dish surface, highlighted with 
arrows. Long term, the cells were unable to survive in serum-free, feeder-free conditions. Images are 
representative of the entire population for each condition and the experiment was repeated over 6 
times. Scale bar represents 50 µm.   
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Figure 4.9 Oct4 and Nanog expression in HS-deficient EXT1
-/-
 mESCs cultured in the presence 
or absence of feeder cells. EXT1
-/-
 mESCs were maintained in two different culture conditions in 
vitro for more than 10 passages, with and without a feeder layer. After 48 h post sub culture, the 
expression of Oct4 was comparable between the two culture conditions (B and F). However, Nanog 
positive cells appeared to be more abundant in feeder-free cultures (G) compared to cells cultured in 
the presence of feeders (C). Furthermore Oct4 and Nanog co-expressing cells (yellow cells labelled 
with arrows in C and G) appeared more abundant in EXT1
-/-
 mESCs cultured in the absence of feeders 
(-F +FBS) (H) compared to cells cultured in the presence of feeders. Images are representative of the 
entire cell population and the experiment was repeated over 3 times. Scale bar represents 100 µm.  
Figure 4.8 HS-deficient EXT1
-/-
 mESC 
maintained in serum-free 2D 
conditions are not viable by 48 h.   
EXT1
-/-
 mESCs were maintained in 
parallel in 3 different culture conditions; 
with feeders and serum (+F + FBS), 
without feeders but with serum (–F + 
FBS) and without feeders or serum (–F –
FBS). The number of trypan blue-
positive-cells were counted daily. After  
96 h, EXT1
-/-
 mESCs  cultured in serum-
free, feeder-free conditions were almost 
completely non-viable (99 %), 
demonstrating that this condition cannot 
support long term EXT1
-/-
 mESC 
expansion. The experiment was repeated 
three times; error bars, SEM. 
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Figure 4.10 The percentage of Nanog positive mESCs is higher in HS-deficient EXT1
-/-
 mESCs 
compared to E14 mESCs but only in the absence of feeders. EXT1
-/-
 mESCs and E14 mESCs were 
maintained in parallel for more than 10 passages with or without feeders but in the presence of serum. 
The proportion of Oct4 and Nanog positive EXT1
-/-
 mESCs and E14 mESCs were comprable in +F 
+FBS conditions. However when cultured in the absence of feeders, EXT1
-/-
 mESCs displayed 
significantly higher proportions of Nanog positive mESCs than E14 mESCs cultured in the same 
condition. EXT1
-/-
 mESCs cultured in the absence of feeders displayed significantly higher 
proportions of Nanog positive cells when compared to EXT1
-/-
 mESCs cultured with feeders. The 
proportion of Oct4 positive cells was not significantly different when comparing cell type and 
conditions. n = 4, * p < 0.05, student T-test, error bars represent SEM. 
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4.3.2 HS-deficient EBs do not display characteristic morphological development 
Following expansion of HS-deficient EXT1
-/-
 mESCs in two different culture conditions for 
more than 10 passages, cells underwent growth in suspension to induce EB formation and 
differentiation upon the removal of LIF, as shown with E14 mESCs previously. The pattern 
of differentiation was investigated and compared to E14 mESC EBs and the effect of 
different growth conditions (+/- feeders) was also evaluated. EXT1
-/-
 mESCs differentiation 
to EEE and BM formation was central in the analysis, as was the case for E14 mESCs. 
One intial observation of HS-deficient EXT1
-/-
 EBs was that they were significantly smaller 
in diameter when compared to E14 EBs derived from the same culture condition. However, it 
appeared that culture condition (+/- feeders) had no impact on EB size, since there was no 
significant difference when comparing EBs with or without feeders (Figures 4.11).  
EB morphology was further assessed using toluidine blue, a basic dye which stains nucleic 
acids and polysaccharides. At day 7, HS-deficient EXT1
-/-
 EBs culture in the presence of 
feeders and serum displayed evidence for a number of outer cells becoming flattened in 
morphology, accompanied by a few signs of mutilayering parietal-like cells, indicative of 
differentiation to endoderm and thin spacing underneath these cells indicating some BM-like 
structure (Figure 4.12). EXT1
-/-
 EBs conditioned in the absence of feeders however, 
displayed fewer signs of typical EB development; very few flattened outer cells or 
mutilayering and a BM that was difficult to identify (Figure 4.12). All EXT1
-/-
 EBs, despite 
culture condition, lacked cavitation. Generally, one would expect day 7 EBs to display more 
advanced morphological developmental characteristics, shown previously for E14 EBs, 
whereby a thick Reichert’s-like membrane is apparent, outer cells are morphologically 
analogous to visceral and parietal endoderm cells and cavitation is evident. 
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Figure 4.11 HS-deficient EBs are significantly smaller compared to E14 EBs. EXT1
-/-
 EBs 
conditioned with feeders were significantly smaller than EBs derived from E14 ESCs cultured under 
identical conditions (+F +FBS). n = 6, * p < 0.05; error bars, SEM. 
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Figure 4.12 HS-deficient EXT1
-/-
 EBs display some signs of normal development but lack 
cavitation, irrespective of culture condition. EXT1
-/-
 mESCs were maintained in two distinct 
culture conditions (with or without feeders but in the presence of serum), for 7 days and stained with 
toluidine blue. In both conditions, EBs lacked cavitation, despite the fact there appeared to be 
evidence of some BM deposition (arrows) and visceral endoderm differentiation (cells in right panel 
positioned on EB periphery). EBs shown are representative of the entire EB population for each 
growth condition. The experiment was repeated over 6 times. Scale bar represents 50 µm. 
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To further confirm the morphological observations and quantify the differences in 
differentiation between EXT1
-/-
 EBs and E14 EBs, EBs were co-immunostained for the BM 
marker LamA1 and cavitation was assessed. Quantification of differentiating EBs was 
achieved, as outlined previously (Materials and Methods, chapter 2) using a scaling system, 
whereby EBs were counted as positive if a continuous BM (identified by LamA1 staining) 
was present in over 50 % of the EB circumference. HS-deficient EXT1
-/- 
EBs generated 
significantly fewer EBs with complete comprehensive EBs (> 50 % of EB circumference 
LamA1 +) compared to E14 EBs (Figure 4.13 A). In addition, there was little sign, if any, of 
cavitation compared to E14 EBs (Figure 4.13 B).  
 
145 
 
 
Figure 4.13 HS-deficient EBS lack cavitation and a complete BM.  EXT1
-/-
 mESCs were 
maintained with or without feeders and EB development was quantified to analyse the effect of 
different culture conditions, as well as make a direct comparison to E14 EBs at day 4 and day 7. The 
presence of LamA1 (A) was significantly lower in EXT1
-/-
 EBs compared to E14 cells. Cavitation was 
also significantly lower in EXT
-/-
 EBs (B). Results are consistent at day 4 and day 7. n = 6, error bar: 
SEM, students T-test, * p < 0.05.  
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4.3.3 HS-deficient EBs show restricted EEE differentiation 
The role of HS in mESC pluripotency is misunderstood and inconsistently reported. Some 
studies have suggested that HS is required for mESCs to remain in a self-renewing state 
(Sasaki, Okishio et al. 2008; Lanner, Lee et al. 2010; Helledie, Dombrowski et al. 2011), 
whilst in contrast and more often, studies have demonstrated the requirement of HS for 
mESCs to exit self renewal (Kraushaar, Yamaguchi et al. 2010; Helledie, Dombrowski et al. 
2011). The latter is supported by the studies in this chapter.  
Self-renewal, BM synthesis and EEE differentiation have all been analysed for HS-deficient 
EXT1
-/- 
EBs in order to demonstrate the differences when compared to E14 ESC EBs, which 
therefore highlights the need for HS in mESC differentiation.  
Despite EXT1
-/-
 mESCs being successfully maintained in 2D culture with or without feeders, 
it appeared from morphological studies that differentiation was impaired since EXT1
-/-
 EBs 
lacked cavitation and only a few cells displayed characteristic parietal endoderm morphology, 
despite the fact that the removal of LIF was disruptive. This was, therefore, the subject of 
further investigation. Oct4, a common marker of pluripotency, was used to investigate the 
presence of undifferentiated mESCs within EBs grown under different culture conditions. 
Typically, Oct4 positive cells reduce with time as the EB differentiates (Pesce and Scholer 
2001). The primitive endoderm marker Gata6 was also used to identify endoderm 
differentiation and the distribution of laminin was assessed in detail, using an pan laminin-
111 antibody and antibody specific for LamA1, to analyse the ability of HS-deficient ESCs to 
synthesise functional BM. 
EXT1
-/- 
EBs (+/- feeders) displayed significantly higher proportions of Oct4 positive cells 
compared to EBs conditioned from E14 ESCs +F +FBS, moreover, Oct4 positive cells were 
distributed across the entire EB, rather than localised exclusively to the centre of the EB, as 
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observed in normal E14 EBs (Figures 4.14). Culture condition affected this further, since 
feeder-free conditioned EXT1
-/-
 EBs displayed a significantly higher proportion of Oct4 
positive cells, compared to EXT1
-/-
 EBs derived from conditions containing feeders (Figure 
4.15). This was further confirmed with RT-qPCR data, which showed that EXT1
-/-
 EBs 
displayed significantly higher levels of Oct4 compared to E14 EBs conditioned under the 
same culture conditions (Figure 4.16).  
Investigation into the ability of EXT1
-/-
 mESCs to differentiate to EEE and synthesise 
functional BM, further highlighted that HS-deficient mESCs do not behave typically. 
Differentiation of EXT1
-/- 
mESCs to primitive endoderm, uncovered abnormal localisation of 
Gata6 and levels were significantly lower than those detected in E14 EBs derived from the 
same conditions (Figures 4.17, 4.18). This is in support of some recent studies which 
demonstrate the importance of HS for EEE differentiation, moreover propose the model is 
based on a lack of HS interactions with FGF (Lanner and Rossant 2010). In addition, day 7 
EXT1
-/- 
EBs displayed disrupted BM. Although some laminin expression was detected in 
EXT1
-/-
 EBs (comparable +/- feeders), localisation appeared to be intracellular, as identified 
using an antibody specific to laminin-111. This is in contrast to E14 EBs which displayed 
laminin expression in the BM-position of EB separating multilayered parietal-endoderm-like 
outer cells from inner cells (Figure 4.19). Furthermore, LamA1 expression for EXT1
-/-
 EBs, 
unlike E14 EBs, displayed LamA1 expression intracellularly, despite the identification of 
some outer primitive endoderm-like, flattened cells (Figure 4.20). Quantification of LamA1 
mRNA levels indicated that EXT1
-/- 
mESCs expressed significantly lower levels of LamA1 
when compared to E14 EBs derived from the same culture condition, although LamA1 levels 
did not change between EXT1
-/-
 EBs cultured with or without a feeder layer (Figure 4.21). 
Generally, these results suggest that defects in EXT1
-/-
 EBs, attributed to a lack of 
endogenous HS, is unable to be rescued by a feeder layer and/or the presence of serum.   
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Figure 4.14 The distribution of Oct4 positive cells is more extensive throughout HS-deficient 
EBs compared to E14 EBs and a lack of feeders enhances this effect. EBs derived from EXT1
-/-
 
mESCs displayed Oct4 positive cells in both outer and inner cells of the EB for both conditions (+/- 
feeders) (arrows), which is in contrast to the E14 EBs, which displayed Oct4 positive cells in the 
centre of the EB only. The presence of feeders appeared to negatively influence Oct4 expression by 
EXT
-/-
 EBs, since those conditioned with feeders and serum (+F +FBS) displayed fewer Oct4 positive 
cells than EXT1
-/- 
EBs conditioned without feeders but with serum (-F +FBS), (arrows). Images 
represent the entire cell population and the experiment was repeated over 6 times. Scale bar represents 
200 µm. 
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Figure 4.15 The percentage of 
Oct4 positive cells within HS-
deficient EBs is higher than in E14 
EBs. EXT1
-/-
 EBs displayed a 
significantly higher proportion of 
Oct4 positive cells compared to E14 
EBs cultured under the same 
conditions. EXT1
-/- 
EBs conditioned 
in the absence of feeders displayed 
significantly higher proportions of 
Oct4 positive cells compared to 
EXT1
-/-
 mESCs cultured without 
feeders. n = 3, * p < 0.05 student’s 
T-test, error bars represent SEM. 
Figure 4.16 Oct4 expression in day 
7 EBs is significantly higher in HS-
deficient EXT1
-/-
 EBs compared to 
E14 EBs. EBs were derived from 
EXT1
-/-
 ESCs and E14 ESCs after 
being maintained in parallel under 
different culture conditions (+/-
feeders). HS-deficient EXT1
-/-
 EBs 
displayed significantly higher Oct4 
levels compared to E14 EBs from 
the same culture conditions. EXT1
-/- 
EBs conditioned in the absence of 
feeders displayed significantly 
higher Oct4 levels compared to 
EXT1
-/-
 EBs cultured in the presence 
of feeders. n = 3, * p < 0.05 student’s 
T-test, error bars represent SEM. 
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Figure 4.17 HS-deficient EBs display abnormal localisation of Gata6 positive cells. EXT1
-/-
 
mESCs were maintained in two different culture conditions, with or without feeders, for more than 10 
passages prior to EB formation. EBs were then stained with a Gata6-specific antibody at day 7. In E14 
EBs Gata6 expression was localised to outer cells of EBs in a multi-layered fashion. In contrast, 
Gata6-positive cells in EXT1
-/-
 EBs (arrows) are poorly represented and incorrectly localised to some 
relatively inner cells in EXT1
-/-
 EBs as well as few outer cells, similarly when derived in the absence 
of feeders.  Images represent the entire EB population and the experiment was repeated more than 3 
times. Scale bar represents 200 µm. 
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Figure 4.18 HS-deficient EBs 
display significantly lower Gata6+ 
cells in day 7 EBs compared to E14 
EBs. EXT1
-/-
 EBs displayed 
significantly lower proportions of 
Gata6+ cells compared to E14 EBs 
cultured under the same conditions. n 
= 3, * p < 0.05 student’s T-test, error 
bars represent SEM. 
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Figure 4.19 Laminin is abnormally localised in HS-deficient EBs.  EXT1 
-/-
 mESCs were 
maintained in two culture conditions (with or without feeders) for more than 10 passages in parallel 
with E14 mESCs, prior to EB formation. EBs were stained with an antibody specific to laminin-111 
after 7 days. EXT1
-/-
 EBs, despite the presence of a feeder layer, displayed predominantly intracellular 
laminin (arrows) despite the presence of some endoderm-like cells on the outer surface of the EB 
(arrows in corresponding brightfield (BF) images). E14 EBs from the same condition displayed 
substantial laminin expression localised between outer parietal endoderm-like multilayered cells and 
inner cells, as shown in the BF image (arrows). The experiment was repeated > 3 times, images 
represent the population and scale bar represents 100 µm. 
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Figure 4.20 Abnormal intracellular LamA1 expression in HS-deficient EBs.  EXT1 
-/-
 mESCs 
were maintained in two culture conditions (with or without feeders) for more than 10 passages prior to 
EB formation in parallel with E14 mESCs, and stained with an antibody specific to LamA1 after 7 
days. EXT1
-/-
 EBs, despite culture condition (+/- F), LamA1 expression was abnormally localised 
intracellularly (arrows in 2
nd
 and 3
rd
 panels), despite the identification of some primitive endoderm-
like flattened cells shown in the corresponding BF images. This is in contrast to E14 EBs, which 
displayed typical LamA1 expressed discretely located to BM-position (arrows) beneath outer tall 
parietal endoderm-like cells identified in the corresponding BF image (arrows). The experiment was 
repeated > 3 times, images represent the entire population and scale bar represents 100 µm. 
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Figure 4.21 HS-deficient EBs display significantly lower LamA1 expression compared to day 7 
E14 EBs derived from the same culture conditions. RT-qPCR quantification of LamA1 expression 
showed that EXT1
-/-
 mESCs display significantly lower LamA1 levels compared to E14 mESC EBs 
derived from the same conditions. EXT1
-/-
 EBs conditioned in the absence of feeders did not display 
any differences in LamA1 expression when compared to EXT1-/- ESCs cultured in the presence of 
feeders. n = 3, * p < 0.05 student’s T-test and error bars represent SEM. 
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4.4 HS structure and abundance differs depending on mESC culture conditions 
Results in previous chapters have demonstrated that discrete variations in 2D culture 
conditions significantly influence mESC behaviour, and this is possibly linked to a HS-
dependent factor since exogenous PMH was shown to partially rescue these defects. 
Furthermore, HS-deficient mESCs do not differentiate to EEE and display uncharacteristic 
BM. Taken together, these results stress the importance of HS for normal mESC behaviour, 
therefore, a more in-depth characterisation and comparison of HS structures that are 
synthesised by cells under different culture conditions was investigated. 
Considering that levels and structure of HS has been shown to often depend on culture 
conditions (Robinson and Gospodarowicz 1983; Gordon, Conn et al. 1985), characterisation 
of soluble HS from mESC conditioned media (CM) and cell-surface HS could, therefore, 
prove important in unravelling the link between mESC behaviour, culture condition and HS. 
Proteomic studies of mESC and hESC CM has highlighted the difference that discrete 
variations in culture conditions (+/- feeder layer) has on proteins important for the 
maintenance of mESCs (Prowse, McQuade et al. 2005; Buhr, Carapito et al. 2007; Prowse, 
McQuade et al. 2007).  
HS structure and biosynthesis was characterised in mESCs cultured under different 
conditions (with or without feeders and with or without serum). HS shed by cells into their 
environment was analysed by purifying HS from mESC CM, digesting the HS to component 
disaccharides with heparinase enzymes, followed by separating the disaccharides using 
strong anion exchange (SAX) HPLC. Characterisation of cell surface HS was conducted 
using several different antibodies specific to structurally distinct HS-epitopes, and RT-qPCR 
was employed to quantify levels of HS biosynthetic enzymes, thus generating a comparative 
overview of HS levels and structures present within the different mESC culture systems. 
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4.4.1 mESC culture condition influences the structure of cell-surface HS  
Two HS-specific antibodies, 10E4 and 3G10 were employed to detect cell-surface HS for 
mESCs. 10E4 is a monoclonal antibody that has been shown to identify N-sulfated HS 
structures (van den Born, Salmivirta et al. 2005) and 3G10 recognises neo-epitope or ‘stub’ 
generated after digestion of HS from HSPG core proteins with heparitinase (David, Bai et al. 
1992).  
Feeder cells appeared to predominantly express the 10E4 epitope rather than the mESCs 
(Figure 4.22) during mESC culture in the presence of serum and feeders, further confirmed at 
high magnification which demonstrated that mESCs nuclei were rarely found surrounded by 
10E4 immunoreactivity (Figure 4.24 right panel). In contrast, in the absence of feeders (+/- 
serum) 10E4 HS epitope was expressed on the mESC surface in a relatively consistent, thin 
layer (Figure 4.22), further confirmed at higher magnification (Figure 4.24 right panel). 
Expression of the 3G10 HS epitope was identified localised to the surface of mESCs in all 
three culture conditions (Figure 4.23), however upon closer inspection, immunoreactivity 
appeared distinctly more intense on the surface of mESCs cultured in serum-free conditions, 
since expression was represented with by a thick layer, compared to relatively thin layers for 
mESCs cultured in the presence of serum (+/- feeders) (Figure 4.24 left panel). Both 3G10 
and 10E4 immunoreactivity was absent from EXT1
-/-
 +/-F mESC cultures, demonstrating the 
lack of cell surface HS synthesised by these cells. 
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Figure 4.22 Expression of 10E4 HS epitope was detected in all three conditions but localisation 
differed and primary expression was by feeder cells. E14 mESCs were maintained in three 
different conditions for more than 10 passages and 10E4 antibody was used to stain cells 48 h post 
sub-culture to detect N-sulfated cell surface HS structures. In +F +FBS conditions, immunoreactivity 
of the 10E4 HS epitope was predominantly localised to the surface of the feeders cells, whose nulei 
are highlighted with arrows, whilst mESCs displayed very little of the HS epitope. In the two feeder-
free conditions (+/- serum), 10E4 immuno-reactivity trend was comparable; expression was localised 
to the surface of mESCs. EXT1-/- ESCs displayed no specific immunoreactivity for 10E4, 
highlighting the lack HS on the surface of these mESCs. All images are representative of the entire 
cell population and the experiment was repeated 4 times. Scale bar represents 200 µm.   
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Figure 4.23 Levels of HSPGs on the surface of mESCs, identified by an antibody specific to the 
3G10 HS-epitope, differed in three different culture conditions. E14 mESCs were maintained in 
three different conditions in parallel with EXT1
-/-
 mESCs for more than 10 passages. 3G10, an 
antibody that identifies all HSPGs following removal of HS chains, was used to probe mESCs at 48 h 
post sub-culture. 3G10 immuno-reactivity was detected on the surface of mESCs in all three 
conditions, however, the levels differed between culture conditions. Highest HSPG expression was 
identified in –F -FBS conditions and expression appeared comparable between +/-F +FBS conditions. 
EXT1
-/-
 mESCs alone lacked any specific iummunoreacitivity, emphasising the lack of HSPGs on the 
surface of these mESCs. Images are representative of the entire cell population and the experiment 
was repeated over 4 times. Scale bar represents 200 µm.   
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Figure 4.24 10E4 and 3G10 epitope expression levels and localisation differs depending on the 
mESC culture condition. E14 mESCs were maintained in three different conditions for more than 10 
passages and HS-specific antibodies 3G10 and 10E4 were used to identify cell surface HSPGs and N-
sulfated HS structures, respectively, 48 h post sub-culture. 3G10 epitope expression was localised to 
the outer surface of mESCs in all three culture conditions, although mESCs cultured in serum-free 
conditions display a thicker layer of 3G10 immuno-reactivity compared to mESCs cultured in the 
alternative conditions (left panel, arrows). 10E4 expression was localised predominantly to feeders; 
mESCs displayed very little cell-surface immunoreactivity in this culture condition, however mESCs 
cultured in the absence of feeders (+/- feeders) displayed similar immunoreactivity trends; expression 
of the 10E4 epitope was localised to the outer cell surface in a constant, relatively thin layer (right 
panel, arrows). The experiment was repeated more than 3 times and the images represent the entire 
cell population. Scale bar represents 50 µm. 
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4.4.2 Culture conditions influence the structure of HS synthesised by mESCs 
Variations in culture conditions have been shown to affect mESC behaviour and also the 
localisation and abundance of cell surface HS, as detected using antibodies specific to N-
sulfated HS structures (10E4) and the neo-epitope generated on all HSPGs after digestion of 
HS chains (3G10). Consequently, we asked the question, do soluble HS structure and 
abundance also vary depending on culture condition? 
Preliminary SAX-HPLC analysis of HS purified from conditioned media (CM) and media 
components (Advanced DMEM and serum) demonstrated that HS levels and structures do 
vary depending on culture condition. Quantitation of HS was achieved by summing the peak 
areas for known disaccharides separated by SAX-HPLC and identified with respect to 
authentic standards. Firstly, total abundance of secreted HS purified from the different 
sources (CM and culture components) were different depending on the source (Figure 4.25). 
E14 –F –FBS CM contained the highest level of HS, 4-5-fold more than CM from E14 +F 
+FBS or E14 –F + FBS conditions. STO feeder cell CM displayed similar levels of HS to 
E14 + F +FBS. HS was also detected in Advanced DMEM, although levels were relatively 
low. HS-deficient EXT1
-/-
 ESCs +F +FBS CM was negative for sulfated HS (although there 
was a peak correlated with standard 1 (UA-GlcNAc) the presence of contaminant signal not 
corresponding to any standards made accurate quantification difficult) (Figure 4.29). 
A preliminary compositional analysis of the media components and CM suggested that HS 
species and sulfation patterns vary depending on source or conditions. HS purified from 
Advanced DMEM was largely composed of unsulfated UA–GlcNAc (approximately 81 %) 
with trace levels of sulfated structures including UA–GlcNAc6S, UA–GlcNS6S, and UA2S–
GlcNS6S as well as a significant amount of UA2S-GlcNAc. UA–GlcNS and UA2S–GlcNS 
were undetected (Figure 4.27). HS purified from FBS displayed a more typical profile of 
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sulfated disaccharides for a highly sulfated HS with UA–GlcNS6S (30 %) and UA2S-
GlcNS6S (16 %) major constituents of total HS (Figure 4.27). HS purified from STO feeder 
cell CM was a significant lower sulfated HS, with disaccharides; UA–GlcNAc (42 %) and 
UA–GlcNS HS (28 %)  being predominant (Figure 4.28). Accordingly, HS purified from 
FBS presents 1.60 sulfates per disaccharide on average, compared to 0.60 and 0.93 sulfates 
per disaccharide, from HS purified from Adv DMEM only and STO feeder cell CM, 
respectively (Table 4.2).  
HS species and levels varied between the three culture conditions that were shown previously 
to significantly affect ESC behaviour (chapter 3). Serum-free feeder-free CM displayed 
relatively high proportions of highly-sulfated HS structures; UA2S–GlcNS6S represented 
approximately 69 % of total HS abundance and UA2S–GlcNAc6S, undetected in the other 
E14 mESC growth conditions, represented approximately 5% of total HS abundance. HS 
purified from cultures containing serum (+/-F +FBS) displayed relatively low proportions of 
more highly-sulfated HS structures and generally, more low sulfated HS structures 
constituted a high proportion of total HS. Providing serum was present (+/-F +FBS) HS 
purified from +/- feeders CM was similar; the main difference was levels of standard 4 
(UA2S-GlcNAc; 29 % and 3 % for +F +FBS and -F +FBS, respectively) (Figure 4.28). 
Consequently, HS purified from –F –FBS CM contains on average 2.44 sulfate groups per 
disaccharide, comparable to heparin, a homogenous highly sulfated type of HS, which has 
approximately 2.5 sulfates / disaccharide. In comparison, +F +FBS and –F +FBS CM have, 
on average, 1.19 and 1.13 sulfates per disaccharides, respectively (Table 4.2). 
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Figure 4.25 Quantitation of HS detected from equal volumes of starting material demonstrates 
differences in HS levels depending on source or culture condition. Conditioned medium was 
collected from the five different cell culture conditions as well as controls from Advanced DMEM 
alone and FBS alone and 40 ml of each was prepared with pooled media from multiple cell cultures. 
HS was purified, subjected to digestion with heparin lyases and separated by SAX-HPLC. Levels of 
HS were calculated based on total yield of disaccharides (sum of peak areas). E14 –F –FBS 
conditioned media appeared to synthesize the most HS, almost 10-fold more than E14 +/-F +FBS CM. 
STO feeder CM displayed similar levels of HS as E14 +/-F +FBS, whilst HS-deficient EXT1-/- ESCs 
+F +FBS CM generated approximately half that of normal  E14 mESCs, comparable to levels 
detected in FBS alone. HS was detected in Advanced DMEM, although levels were relatively low. 
Sufficient material was only available for one experiment, although pooled media was collected from 
approximately 50 culture dishes. 
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Figure 4.26 HPLC-SAX analysis of soluble HS purified from CM suggests that different 
conditions provide different HS structures. CM was collected from mESCs maintained in distinct 
culture conditions and prepared for SAX-HPLC analysis. More highly sulfated HS structures were 
found in higher abundance in –F –FBS CM compared to CM from mESCs maintained with serum (+/- 
F); HS purified from -F –FBS CM was predominantly composed of UA2S–GlcNS6S (approximately 
70%). CM from mESCs maintained in the presence of serum (+/- feeders) displayed comparably 
lower levels of the more highly sulfated disaccharides; UA2S–GlcNAc6S was not detected and UA–
GlcNS6S represented approximately 15 – 20% of total HS. Standards were defined in Table 2.6. 
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Figure 4.27 HPLC-SAX analysis of soluble HS purified from media components, Advanced 
DMEM and serum (FBS), demonstrates the abundance of HS and disaccharide compositional 
make-up. HS purified from 2% FBS displayed a range of HS structures; major components were 
UA–GlcNS6S HS (approximately 30 %), UA–GlcNAc (approximately 29 %) and UA–GlcNS6S HS 
(approximately 16 %). HS purified from Advanced DMEM alone contained predominantly UA-
GlcNAc (approximately 81 %) with trace amounts of the other HS disaccharides.   
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Figure 4.28 Compositional disaccharide analysis using SAX-HPLC highlights HS 
structures purified from STO feeder cell CM and the lack of soluble HS purified from 
EXT1
-/-
 mESC CM. HS purified from EXT1-/- mESCs and STO feeder cells CM was 
collected, pooled and subjected to SAX-HPLC disaccharide analysis. STO feeder cell CM 
demonstrates the array of HS disaccharide structures, although is predominantly represented 
by low sulfated structures UA–GlcNAc (approximately 42 %), and UA-GlcNS (approximately 28 
%). More highly sulfated structures were identified, although levels were low (< 10 %). HS purified 
from HS-deficient EXT1-/- ESCs CM correlated with only unsulfated UA–GlcNAc, however the poor 
resolution of the peak suggests it is a contaminant and therefore this CM is negative for HS.     
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Table 4.1 HPLC-SAX analysis demonstrated differences in soluble HS purified from 
conditioned media, from different culture conditions. This table summarises data from SAX-
HPLC data in Figures 4.24, 4.25, 4.26 in terms of percentage abundance of each known disaccharide. 
STO feeder cell CM predominantly made up of UA–GlcNAc (68%) and UA–GlcNS HS (21%) whilst 
low abundance of UA–GlcNS6S (10%). 2 % FBS alone displayed low abundances of UA–GlcNS, 
UA–GlcNAc6S, UA2S–GlcNAc, UA–GlcNS6S, UA2S–GlcNS and UA2S–GlcNAc6S whilst UA–
GlcNS6S (30%) and UA–GlcNAc (30 %) were major constituents of total HS. HS purified from Adv. 
DMEM displayed low levels of UA–GlcNAc6S, UA2S–GlcNAc, UA–GlcNS6S, UA2S–GlcNAc6S 
and UA–GlcNS6S.UA–GlcNS and UA2S–GlcNS were undetected whilst UA–GlcNAc was a major 
constituent (74%) of total HS. E14 mESCs disaccharide profiles varied depending on culture 
condition; for ESCs cultured in presence of serum (+/- F) UA2S–GlcNAc6S HS was undetected, 
however present in –F –FBS CM (5%). UA–GlcNS6S constituted 69% of total HS detected in –F –
FBS E14 ESC CM, whereas levels were much lower in E14 ESCs cultured in the presence of serum 
(+/-F). 
   
   
Abundance of disaccharide standard relative to total HS (%) 
 
Standard 
number (in 
order of 
elution) 
HS disaccharide 
structure 
E14 
+F 
+FBS 
E14 
–F  
+ FBS 
E14 
–F  
-FBS 
STO 
only 
Adv. 
DMEM 
only 
2% 
FBS 
only 
 
EXT1
-/-
 
+F 
+FBS 
1 UA – GlcNAc 23.93 36.39 6.30 43.9 73.78 29.19 100* 
2 UA – GlcNS 14.58 12.66 1.94 20.63 0 7.95 0 
3 UA – GlcNAc6S 6.83 2.75 5.69 3.45 1.47 2.65 0 
4 UA2S – GlcNAc 29.10 7.91 5.46 1.11 2.48 1.89 0 
5 UA – GlcNS6S 3.09 26.74 5.94 8.14 5.16 15.80 0 
6 UA2S - GlcNS 5.60 3.61 0.97 7.65 0 5.59 0 
7 UA2S – GlcNAc6S 0 0 4.49 5.2 5.32 6.48 0 
8 U2S – GlcNS6S 16.87 9.03 69.21 9.92 11.79 30.46 0 
*unclear if this peak correlates with standard 1 alone, since the peak is unresolved 
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Table 4.2 An approximation of the number of sulfates per disaccharides corresponding to HS 
purified from discrete culture conditions and culture components highlights differences in 
degrees of HS sulfation depending on source.   
Culture condition/medium 
component 
 
Average number of 
sulfates/dp 
% 
  NS 2S 6S 
E14 +F +FBS 1.18 40.14 51.57 26.80 
E14 –F +FBS 1.12 52.95 20.56 39.42 
E14 –F –FBS 2.43 78.06 80.14 85.33 
Advanced DMEM 0.60 12.97 18.83 18.83 
2% FBS only 1.60 59.80 44.42 55.38 
STO feeder cells only 0.93    
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4.4.3 Levels of HS biosynthetic enzyme expression in E14 mESCs differs depending on 
culture condition 
Results thus far suggest that HS levels and structural composition varies depending on mESC 
culture condition, therefore an investigation into the expression of a number of HS 
biosynthetic enzymes (EXT1, EXT2, NDST1, Sulf1 and Sulf2) may further aid the 
understanding of why the final HS structures generated in the different conditions are distinct. 
EBs produced from mESCs maintained in -F -FBS media displayed significantly higher 
levels of EXT2 compared to EBs derived from mESCs maintained in the presence of serum 
(+/- feeders), whilst interestingly, EXT1 levels did not change between conditions (Figure 
4.29). NDST1 levels from –F +/-FBS conditioned EBs were significantly higher than +F 
+FBS conditioned EBs, suggesting that not only serum, but feeders affect NDST1 levels 
(Figure 4.30). Sulf2 levels did not change between the three culture conditions, however Sulf1 
levels were shown to be significantly higher in EBs derived from mESCs maintained in –F 
+FBS conditions. In contrast, Sulf1 levels were significantly lower in EBs derived from 
mESCs maintained in –F –FBS conditions (Figure 4.31).  
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Figure 4.29 EBs generated from mESCs cultured in the absence of serum express higher levels 
of EXT2 than EBs generated from mESCs cultured in the presence of serum.  Analysis of mRNA 
levels of HS biosynthetic enzymes EXT1 and EXT2 relative to GAPDH, indicated that although EXT1 
levels remain unchanged when comparing the effect of EB pre-conditions, EXT2 levels are 
significantly higher in EBs conditioned in serum-free feeder-free conditions (-F –FBS) compared to 
EBs conditioned in the presence of serum and feeders (+F +FBS). n = 3, * p < 0.05, student’s T-test, 
error bars, SEM.    
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Figure 4.30 Levels of the HS biosynthetic enzyme NDST1 are significantly different depending 
on mESC 2D culture condition. Levels of HS modification enzyme N-deacetylase/N-
sulfotransferase (NDST1) relative to GAPDH was investigated using qRT-PCR for day 7 EBs. 
Levels of NDST1 were significantly higher in –F +FBS and –F –FBS conditioned EBs compared to 
EBs conditioned in the presence of both serum and feeders (+F +FBS). n = 3, * p < 0.05, student’s T-
test, error bars, SEM.   
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Figure 4.31 Levels of the HS modification sulfatase enzyme Sulf1 are different depending on 
mESC culture condition but Sulf2 levels are unchanged. Levels of HS modification sulftransferase 
enzymes Sulf1 and Sulf2 relative to GAPDH were investigated using qRT-PCR for day 7 EBs. Whilst 
Sulf2 levels remained unchanged with varying culture condition, Sulf1 levels differed. Specifically, -F 
+FBS conditioned EBs displayed significantly increased levels of Sulf2, whilst –F –FBS displayed 
significantly reduced levels of Sulf2, compared to +F +FBS conditioned EBs. n = 3, * p < 0.05, 
student’s T-test; error bars, SEM.   
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4.5 Discussion 
We found here that substantial defects in mESC behaviour, largely attributed to a lack of 
serum, were rescued with exogenous PMH. Serum-free conditions supplemented with 1µg/ml 
PMH, displayed more typical Gata6 levels and localisation of laminin, indicative of 
successful EEE differentiation. Simultaneously, these mESCs cultures supplemented with 
PMH gave rise to EBs displaying relatively low numbers of Oct4 positive cells, now 
comparable to mESCs cultured in the presence of serum and feeders. This provides evidence 
in support of the hypothesis that a lack of serum and/or feeders is linked with a lack of HS 
structure important in mESC behaviour. PMH, like HS, is a sulfated polysaccharide, but is 
more homogenously sulfated in structure than HS (Roden, Ananth et al. 1992; Faham, 
Hileman et al. 1996; Casu and Lindahl 2001) and more readily available, thus it is often 
utilised as a model for the protein interacting S-domains of HS in biochemical assays. 
Interestingly, it was reported that exogenous heparin can rescue BMP signalling and restore 
hematopoietic differentiation in EXT1
-/-
 EB formation (Holley, Pickford et al. 2011) and 
furthermore in support of this, Conley et al. showed that in serum-free medium, BMP-4 
supplementation was necessary to reconstitute differentiation of hESCs to visceral endoderm 
(Conley, Ellis et al. 2007). Taken together and considering the importance of HS in 
regulation of BMP signalling (Fisher, Li et al. 2006; Hu, Wang et al. 2009), a lack of serum 
could indirectly disrupt BMP signalling via the lack of HS. One study has shown how serum-
free chemically defined media resulted in ESCs EBs displaying increased ectoderm 
differentiation, correlating with up-regulation of Pax6, commensurate with Bry expression 
(Wiles and Johansson 1999), this is similar to that seen in the present studies with –F –FBS 
conditioned EBs, the effects of which were rescued with exogenous PMH. Therefore, a 
highly sulfated, soluble HS-like structure could control/suppress this Pax6 up-regulation.  
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HS-deficient mESCs (EXT1
-/-
), unlike E14 mESCs, could not be maintained in serum-free 
culture conditions. This highlights the importance of HS and serum collectively in mESC 
cultures; which is unsuprising given the known importance of HS in embryogenesis. HS-
deficient ESCs were successfully maintained in monolayer and displayed characterisitic 
morphology providing that serum was present (-/+ feeders). However, Nanog expression was 
higher compared to E14 ESC cultures in the same conditions, suggesting a specific role for 
HS in regulating Nanog expression. Unlike Oct4, Nanog is shown to promote mESC self-
renewal independent of the LIF-STAT pathway (Chambers, Colby et al. 2003; Mitsui, 
Tokuzawa et al. 2003), and Kraushaar et al., have shown that HS inhibits Nanog expression 
via the FGF-signalling pathway (Kraushaar, Yamaguchi et al. 2010), therefore a disruption in 
FGF signalling via the lack of HS could result in up-regulation of Nanog. The involvement of 
Nanog specifically for FGF-4 regulation and vice versa has been highlighted, and N-sulfated 
HS structures are reported to be especially key (Kunath, Saba-El-Leil et al. 2007; Lanner, Lee 
et al. 2010; Shi, Gao et al. 2011), which is interesting since none of the N-sulfated HS 
structures (UA–GlcNS, UA–GlcNS6S, UA2S–GlcNS or UA–GlcNS6S) were identified 
either on the cell surface or from CM of EXT1
-/-
 mESCs cultures (Figure 4.28). A putative 
“HS” species purified from EXT1-/- mESC cultures was also identified, consisting only of 
UA–GlcNAc, suggesting the possible existence of the unsulfated HS precusor molecule 
heparosan. It was originally thought that heparosan (and subsequently HS) synthesis can only 
sufficiently occur upon the formation of the hetero-oligomeric EXT1-EXT2 complex, after 
some studies showed that targeted deletion of either EXT1 or EXT2 leads to a complete lack 
of HS synthesis (Lind, Tufaro et al. 1998). However, results in this chapter suggest otherwise, 
in support of work from Okada et al., who showed that EXT1
-/-
 mESCs do produce small 
amounts of HS (Okada, Nadanaka et al.), however since the peak  (UA–GlcNAc) is poorly 
resolved from other early-eluting contaminating material, further work (for example mass 
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spectrometry) would be needed to confirm this assignment. Nonetheless, the putative non-
sulfated HS structures synthesised by EXT1
-/-
 mESCs are clearly not sufficient to facilitate 
normal mESC behaviour, since EXT1
-/-
 EBs displayed restricted EEE differentiation and 
lacked a comprehensive BM. Nanog has been shown to block differentiation (Chambers, 
Colby et al. 2003; Niwa 2007), therefore it could be that sulfated HS structures, lacking in 
EXT1
-/-
 mESC, promotes Nanog indirectly restricting differentiation, despite the removal of 
LIF. EXT1
-/-
 mESCs displayed significantly higher levels of Oct4 and Nanog compared to 
E14 EBs from the same conditions. This result strongly suggests that a deficiency in HS is 
correlated with an increased capacity to self-renew. Inhibition of ECM-integrin interactions 
potentially via a lack of HS, have been shown to inhibit differentiation, thus promoting self-
renewal in mESCs (Hayashi, Furue et al. 2007), which could possibly have occurred here. An 
array of growth factor and cytokine-dependent pathways crucial in differentiation rely on HS 
(Grunert, Nurcombe et al. 2008), for example IL-5 requires HS with numerous N-sulfated 
domains (Lipscombe, Nakhoul et al. 1998), TGF-betas are localized specifically with 
perlecan in the developing brain (Grave 2000), modulation of hematopoeisis via TGF-beta1 
is partly due to GAG production (Luikart, Maniglia et al. 1990; Uhlman, Mooradian et al. 
1990), HSPG interaction with BMP-2 dictates chondrogenesis (Fisher, Li et al. 2006), 
furthermore decreased HS sulfation is shown to increase BMP-2 bioactivity (Jiao, Billings et 
al. 2007). Therefore, it seems highly likely that EXT1
-/-
 mESCs, despite the presence of 
serum and/or feeders, lack the network of growth factor and adhesion interactions required 
for typical behaviour. Interestingly, a lack of feeders during EXT1
-/-
 mESC expansion was 
shown to further exaggerate the increased pluripotent capacity, since –F +FBS EXT1-/- 
mESCs displayed significantly higher levels of Nanog compared to +F +FBS conditioned 
EXT1
-/-
 mESCs during 2D maintenance and in the 3D EB model. It would seem therefore, 
that feeders can compensate, to an extent, for HS-deficiency in EXT1
-/-
 mESCs, perhaps via 
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synthesis of factors necessary for the loss of pluripotency. Differentiation of HS-deficient 
EXT1
-/- 
mESCs to EEE was flawed and given the role of EEE in BM synthesis, it is 
unsurprising that EXT1
-/- 
EBs also displayed disrupted BM synthesis; interestingly laminin 
and LamA1 expression appeared to be intracellular, rather than localised to BM-position, 
despite the identification of some primitive endoderm cells from bright field and 
morphological studies using toluidine blue. The importance of HSPGs specifically in BM 
synthesis and endoderm differentiation is often highlighted (Higuchi, Shiraki et al. 2010), 
frequently attributed to its interactions with laminin (Li, Chen et al. 2001; Li, Arman et al. 
2004). Sulfation patterns of HS are further shown to affect BM synthesis, since inhibition of 
HS sulfation is proven to disrupt HS:laminin interactions and basement membrane assembly 
(Brauer, Keller et al. 1990). Furthermore, Yurchenco et al., showed how the binding of 
laminin to highly sulfated HS, drives laminin polymerisation and formation of BM 
(Yurchenco, Cheng et al. 1990). The data here, which showed that only unsulfated UA – 
GlcNAc HS structures are expressed on EXT1-/- mESC, both in CM and on the cell surface, 
support the view that sulfated HS is essential for normal assembly and function of laminin. 
Importantly, variations in culture condition observed here to affect mESC behaviour were, as 
hypothesized, correlated with variations in HS structures (with the caveat that these data are 
preliminary, being based on a single analysis). Both cell surface HS and soluble HS purified 
from CM, differed in species and abundance depending on culture condition.  The presence 
of feeders (+/-F), which was previously shown to have minimal effect on mESC behaviour 
(demonstrated in chapter 3), similarly had little effect on HS abundance and structure, 
suggesting that providing serum was present (+FBS) cells behave as normal. Analysis of 
expression levels of HS biosynthetic enzymes indicated that EXT1, EXT2 and Sulf2 levels 
were unchanged between +F +FBS and –F +FBS conditions and HS purified from CM were 
comparable (Table 4.1 and Figure 4.26). Consistent with the previous chapter however, –F –
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FBS conditions resulted in substantial effects, this time with regard to HS species and 
abundance. 
HS purified from -F –FBS ESC CM was in higher abundance compared to +/-F +FBS, and 
was quantified at levels almost 4-5-fold higher than HS purified from +/-F +FBS. This was 
supported by a significant increase in EXT2 levels in –F –FBS conditioned EBs compared to 
+/-F +FBS conditioned EBs. Furthermore, cell surface HS, as detected with 10E4 and 3G10 
antibodies, appeared more plentiful, suggesting that in the absence of serum, ESCs are 
stimulated to produce more HS than is typical. Detection of 3G10 immunoreactivity appeared 
to support quantification of HS abundance, since it was more prominently expressed on the 
mESC surface rather than on feeder cell surface. However, a lack of 3G10 staining on feeder 
cells could be attributed to incomplete digestion of HS chains, rather than a lack of HSPGs, 
and this is potentially caused by proteins bound to cell surface HS and a more extensive 
extracellular matrix preventing heparitinise enzymes from accessing the HS. 
Unlike +/-F +FBS CM, the major constituent of -F –FBS CM was UA2S – GlcNS6S 
(approximately 70 % of total HS abundance), which was supported by significantly decreased 
levels of Sulf1 compared to +/-F +FBS EBs. Accordingly, sulfation of –F –FBS ESCs HS can 
be estimated at 2.44 sulfates per disaccharide, which is a comparable level to that of heparin 
which has on average 2.6 sulfates per disaccharide. This indicates that HS purified from –F –
FBS CM is a highly sulfated, heparin-like structure. In comparison, HS purified from +F 
+FBS and –F +FBS CM, can be represented by 1.19 and 1.13 sulfates per disaccharide, 
respectively, indicating low sulfated HS structures. This was supported by lower levels of the 
more highly sulfated HS structures detected in CM of +F +FBS and –F +FBS culture 
conditions and was further correlated with unchanged levels of EXT1, EXT2, and Sulf2 (+/-
F). However, lack of a feeder layer during culture resulted in significantly increased levels of 
NDST1 and Sulf1 compared to cultures with a feeder layer. Over-expression of Sulfs have 
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been shown to influence Wnt, FGF-2, FGF-4 and BMP signalling (Sanchez, Silos-Santiago et 
al. 1996; Ai, Do et al. 2003; Lai, Chien et al. 2004; Viviano, Paine-Saunders et al. 2004), 
therefore increased levels of Sulf1, attributed to a lack of feeders, could potentially disrupt 
these signalling pathways. Furthermore, TGF-beta1 has been proven to increase Sulf1 
expression accompanied by a decrease in 6-O sulfated disaccharides (Yue, Li et al. 2008), 
and Pax6, upregulated in –F –FBS conditioned EBs, is also shown to regulate Sulf1 
(Genethliou, Panayiotou et al. 2009). This result suggests that feeder cells are not necessarily 
important for the synthesis of highly sulfated structures but in turn, maybe important in 
synthesising and secreting lower sulfated structures. One proteomic-based study suggested 
that the importance of feeders in hESC propagation is linked to the secretion of HSPGs, 
(Abraham, Riggs et al. 2010), although the exact HSPG species is unknown. Interestingly, 
HS purified from STO feeder cell conditioned medium was represented predominantly by 
unsulfated (UA–GlcNAc; 42 %) or low sulfated (UA-GlcNS; 28 %) structures; thus 
approximated sulfation represented by 0.93 sulfates per disaccharide. Therefore, although 
STO feeder cells synthesise more highly sulfated 6-O and 2-O sulfated HS structures in low 
abundances, unsulfated structures could underpin the role of feeders in regulating ESC 
behaviour.  
Advanced DMEM and serum, the other media components, contained HS with approximately 
0.60 sulfates per disaccharide and 1.60 sulfate groups per disaccharide, respectively. This 
implies that serum is associated with relatively highly sulfated HS structures, potentially 
underpinning its role as a culture component. HS purified from Advanced DMEM, was low 
in abundance and largely constituted by low sulfated HS structures, although this should be 
considered when employing this medium in ESC cultures where ‘well-defined’ conditions are 
paramount. HS purified from serum alone was represented by highly sulfated HS structures, 
for instance, UA2S–GlcNS6S HS constituted approximately 30 % of total HS abundance, and 
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other highly sulfated structures (UA–GlcNS6S, UA2S-GlcNS and UA2S–GlcNAc6S) were also 
well represented. It is possible that these structures are crucial for typical ESC behaviour, and 
if absent, as in –F –FBS conditions (these structures were largely under-represented in –F –
FBS conditions), ESCs behaviour is consequently uncharacteristic. Taken together, a serum-
free environment, as in –F –FBS conditions, perhaps presents an inadequate environment for 
the fine-tuning of HS, specifically for the removal of 6-O sulfate group by Sulfs. Decreased 
levels of Sulf1 we noted would be expected to result in enhanced 6-O-sulfation, consistent 
with the changes in HS composition observed.Like Sulf1, NDST1 was also significantly 
decreased in –F –FBS conditioned EBs. Interestingly, of the four N-sulfated structures (UA–
GlcNS, UA–GlcNS6S, UA2S–GlcNS and UA–GlcNS6S) all except UA–GlcNS6S were 
extremely low in abundance for –F –FBS conditioned media compared to +/-F +FBS 
conditioned media. It is interesting to speculate that decreased NDST1 might allow a greater 
influence of NDST2 on HS sulphation, since NDST2 has been associated with biosynthesis of 
highly N-sulphated HS species like heparin (Dagalv et al 2011). Attempts at evaluation of 
NDTS2 levels by RT-PCR failed (data not shown), but would be an interesting avenue for 
future work.The pattern of HS enzyme expression detected in cells from –F –FBS conditions 
appears unusual and overall will have some effect on the final HS structures present on the 
cell surface and in the CM. Increased EXT2 and significantly reduced Sulf2 and NDST1 
expression, suggests a possible relationship between these enzymes, as demonstrated by 
recent use of the term “GAGosome” discussed by Presto et al. (Presto, Thuveson et al. 2008), 
in which enzyme complexes clustered in specific Golgi compartments are proposed to result 
in production of divergent HS structures.  
It appears that serum (or a component of serum) is required to facilitate N-sulfation and/or 
the release of the N-sulfated HS structures into the ECM. Interestingly, cell surface HS 
structures however, appeared to be well represented in mESCs from –F –FBS conditions 
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since cell-surface HS, as detected with 3G10 and 10E4 antibody, demonstrated increased 
immunoreactovoty on the surface of mESCs from –F –FBS conditions compared to +/-F 
+FBS. N-sulfated cell-surface HS, identified with the 10E4 antibody, was predominantly 
localised to feeder cells in +F +FBS and since N-sulfated HS species constituted a large 
proportion of total HS in STO feeder cell CM, the importance of feeders during mESC 
expansion, as previously proposed, may be linked to the synthesis of specifically N-sulfated 
HS. Nonetheless, upon the removal of feeders, mESCs appeared to compensate and N-
sulfated cell-surface HS was also detected on the surface of mESCs. This result suggests that 
synthesis of N-sulfated HS in –F –FBS is supported, although shedding of these structures is 
lacking. 
Mechanistically it is possible that FGF signalling is disrupted due to the lack of serum. 6-O-
sulfation is required for FGF2 and FGF-4 signalling (Sugaya, Habuchi et al. 2008), therefore 
perhaps –F –FBS conditioned EBs lack adequate FGF-2 and/or FGF-4 signalling. Ablation of 
FGF-signalling is also correlated with a failure to assemble a BM and epiblast differentiation 
(Ekblom, Lonai et al. 2003). Therefore -F –FBS conditioned EBs, which fail to synthesise a 
functional BM, may lack the adequate FGF-signalling necessary, due to a lack of particular 
HS structures; for example UA–GlcNS6S, UA2S-GlcNS and/or UA2S–GlcNAc6S HS structures, 
identified in serum but lacking in –F –FBS CM. 
In conclusion, it would seem that a lack of serum is correlated with a lack of HS, specifically 
UA2S–GlcNS6S, UA–GlcNS6S, UA2S-GlcNS and UA2S– GlcNAc6S disaccharides. 
Ultimately, a deficiency in these structures could prove key, without which, mESC behaviour 
is abberant. 
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5. Optimisation of polymers for the expansion of mESCs and KSCs in vitro 
5.1 General Introduction 
The methodology utilised to expand cells in vitro depends on the downstream application. 2D 
expansion has long been achieved (since the 1960s) via the employment of tissue culture 
polystyrene (TCPS) dishes (Curtis, Forrester et al. 1983), usually with an appropriate surface 
treatment to optimise electrostatic and hydrophobic cell-biomaterial interactions, necessary 
due to the non-adhesive nature of polystyrene (Maroudas 1977; Ward, Knox et al. 1977; 
Grinnell 1978). TCPS is modified either via controlling distinct surface chemistry, thus 
presenting charged groups, using UV for example (Saha, Mei et al. 2011), or via coating of 
TCPS with animal-derived materials to serve as an ECM.  
Expansion of cells in a 3D environment using a synthetic scaffold is a more sophisticated 
process, owing to the dynamic nature of 3D bio-environments, and such expansion is often 
aimed at tissue-regeneration applications. Material choice, surface treatment and desirable 
bulk properties are carefully tailored to meet the specific application. For instance, a joint 
replacement will require material with good mechanical strength and wear properties, a 
muscular graft will primarily demand the material to support repetitive force exertion over 
time and potentially degrade over time upon the regeneration of healthy native tissue, any 
part of a kidney graft will require specific, well-controlled porosity to aid the diffusion of 
nutrients and waste (in and out, respectively) during filtration whilst being structurally sound. 
Exploiting any biomaterial for tissue regeneration purposes occurs in vitro firstly with 
endothelialisation and vascularisation, a consequence of maintaining healthy cells on the 
synthetic structure, followed by expanding cell numbers within the structure in 3D 
environment, culmilating with implantation in vivo to replace disease or damaged tissue. 
Such a demanding process has led to alternative avenues being investigated; one major one is 
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decellulisation of human tissue i.e. bone, so to generate a human-derived starting material as 
a way to overcome problems and issues with a synthetic structure. 
Nonetheless, the common feature of 2D and 3D expansion is that often an ECM/animal-
derived material is employed to improve performance, whether as a surface coating or 
incorporated during material synthesis. Common materials include, collagen (He, Ma et al. 
2005; Wojtowicz, Shekaran et al. 2010), fibronectin (Barrias, Martins et al. 2009; Maciel, 
Oliveira et al. 2012), laminin (Huber, Heiduschka et al. 1998; Huang, Huang et al. 2007), and 
gelatine (Goetz, Scheffler et al. 2006; Hosseinkhani, Hosseinkhani et al. 2008; Rao and 
Winter 2009; Sun, Huang et al. 2012) to name a few, largely attributed to their hydrophilicity 
(Li, Cui et al. 2005; Li, Mills et al. 2005) and ECM-derived nature (Nakajima, Ishimuro et al. 
2007; Flaim, Teng et al. 2008). Given that animal-derived products require elimination from 
in vitro expansion, bioengineers are focussed on generating synthetic alternatives, with 
specific attention focussed on exploiting physical and chemical attributes of potential 
alternatives, with regard to both surface and bulk properties.  
One material property specifically exploited and investigated has been porosity (and thus 
indirectly surface area to volume ratio), through investigating hydrogels and macroporous 
polymers (classified as such due to their respective differing surface area to volume ratios). It 
is interesting that Gustafsson et al. demonstrated that providing a polymer (PET) scaffold 
displayed sufficiently high surface area to volume ratio, neither cell proliferation or cell 
density was improved by the addition of animal-derived protein coating (Gustafsson, Haag et 
al. 2012).  
Through identification of HS as a factor in the need for serum in ESC maintenance and 
expansion (outlined in previous chapters), alongside the potential to couple compounds to 
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these hydrogels and macroporous polymers, suggest that there is much potential to generate a 
xeno-free culture system. 
Hydrogels  
Hydrogels present a promising field in regenerative tissue engineering, largely owing to their 
hydrophilic make-up, which underpin the highly absorbant properties and flexibility often 
compared to natural tissue. This, coupled with the proven ability to  tune copolymer synthesis 
to optimise hydrogel-protein interaction (Palacio, Schricker et al. 2010; Schricker, Palacio et 
al. 2010) for improved interaction with cells (Orilall and Wiesner 2011), make them an 
attractive option . Controlling physical and chemical properties, such as swell, however, can 
be difficult and in turn, has been shown to affect ESC behaviour (Engler, Sen et al. 2006; 
Park, Guo et al. 2009). Methacrylate-based hydrogels have been shown to support ESC 
attachment and proliferation also (dos Santos, Coelho et al. 2006; Nichol, Koshy et al. 2010), 
as have hydroxyethyl methacrylates (Horak, Kroupova et al. 2004). Acrylic based materials 
have also shown great promise as drug delivery systems (Ciardelli, Cioni et al. 2004) and 
acrylamide-based hydrogels are often utilised to bridge particles via their polymer chains. 
Poly(lactic-co-glycolic acid) (PLGA) is an excellent example of a successful, biodegradeable 
hydrogel, approved by the FDA and currently used in an array of medical applications 
including vascular grafts and drug delivery (Gunatillake and Adhikari 2003; Uematsu, Hattori 
et al. 2005; Makadia and Siegel 2011). Even so, coating with ECM proteins is often 
necessary to improve performance (Lees, Lim et al. 2007). 2-hydroxethyl methacrylate 
(HEMA), one of the hydrogel components investigated in this project, is a hydrosoluble 
monomer with long standing biocompatible performance (Chappard, Laurent et al. 1982; 
Chappard, Alexandre et al. 1986). HEMA-based hydrogel tubes have been shown to act as 
nerve guide channels (Dalton, Flynn et al. 2002), furthermore, HEMA-PEG hydrogels 
displayed great promise as subcutaneous biosensors (Quinn, Pathak et al. 1995). PEG-based 
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block hydrogels copolymers, another material investigated in this project, have displayed 
potential as synthetic ECM, having been shown to support fibroblast and MSCs expansion 
(Zhang, Skardal et al. 2008). Likewise for many different methacrylate-based copolymers 
(Brafman, Chang et al. 2010; Mei, Hollister-Lock et al. 2010), attributed in one case to 
adsorption of fibrinogin and albumin (Long, Clarke et al. 2003). In some cases, it is thought 
that the hydrophilic component of hydrogels, acrylic acid for example, is responsible for 
performance, attributed to swell factor (Schricker, Palacio et al. 2010). Poly (N,N-
dimethylacrylamide), used as a component in several of the SpheriTech hydrogels 
investigated, has been shown to be effective in the application and performance of amphillic 
copolymers in blood separation for example (Natori and Kurita 2007) and during modulation 
of fibrin clotting (Lai, Zou et al. 2010). Poly (N,N-dimethylacrylamide)-based hydrogels 
have also been shown to support chrondrogenesis, attributed to their low charge densities 
(Yang, Chen et al. 2010). Taken together, research suggests that combinations of these 
biocompatible monomers as hydrogels does, and therefore could, present novel materials as 
substrates for cell scale-up along with many drug-releasing applications, as outlined in Table 
5.1. 
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Table 5.1 Outlining some common hydrogels successfully employed as biomaterials 
Hydrogel Application 
HEMA-PEG 
 
Injectable antibiotic- releasing hydrogels (Arica, 
Tuglu et al. 2008) 
PEG-dimethylacrylamide 
 
Drug-releasing hydrogels (Diramio, Kisaalita et al. 
2005), quantum dot surface modification  
PEG-Methacrylate Drug releasing injectable hydrogels (Lutz and 
Zarafshani 2008; Wischerhoff, Uhlig et al. 2008) 
 
Macroporous Poly-Ɛ-lysine  
Aside from copolymer hydrogels, this project investigates the naturally occurring poly-Ɛ-
lysine (PƐL), as bulk polymeric material. PƐL is a small homopolymer, naturally synthesised 
by bacterial fermentation and employed as a food preservative. It is naturally biodegradable 
by protease activity and its’ protein-based structure impart biocompatibility (Hiraki, Ichikawa 
et al. 2003; Zhang, Feng et al. 2011; Kadlecova, Baldi et al. 2012). PƐL represents a 
polypeptide of 25 – 30 lysine residues, unique in the linkage of its residues. Unlike other 
polylysine analogues which have the alpha-carbon groups linked by a peptide bond, lysine 
residues in PƐL are linked molecularly via the amino and carboxyl groups (Yu, Huang et al. 
2010), the chemical monomer is outlined in Figure 5.1. The compound is water soluble and 
has been shown to function in many ways including, antiphage and antimicrobial action (Ni, 
Takehara et al. 2010; Chang, McLandsborough et al. 2012), endotoxin-removal activity 
(Yamanaka, Kito et al. 2010) and antiobesity due to inhibition of pancreatic lipase 
(Hirayama, Sakata et al. 1999). 
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Figure 5.1 Poly-E-lysine polymer, showing the monomer subunit, n = 25 - 30. 
Hydrogels incorporating PƐL have been shown to promote neural progenitor cell functions 
(Cai, Lu et al. 2012; Cai, Lu et al. 2012) and PƐL has demonstrated its ability to support 
functional vascular networks (Rauch, Michaud et al. 2008). Similarly, when employed as a 
hydrogel coating, PƐL has been shown to promote cell adhesion (Zhou, Li et al. 2011), 
likewise, Sprague et al., demonstrated that PƐL can support a dendritic cell response, 
comparable to Matrigel (Sprague, Muccioli et al. 2011), all suggesting that the charge-
enhancing abilities of PƐL, underpins its potential in supporting cell expansion. In contrast, 
the specific architecture of PƐL has been shown to massively influence cell adhesion and 
application. Park et al., showed that surface topography of titanium coated with PƐL resulted 
in enhanced cell adhesion and numbers, attributed to micro-texture (Park, Olivares-Navarrete 
et al. 2012). PƐL nano-spheres have shown great promise in drug delivery (Eom, Kim et al. 
2006; Eom, Park et al. 2007), again often attributed to shape rather than chemistry or ionic 
properties. Likewise, PƐL has been shown to influence and enhance biomimetics and porosity 
in silica materials (Gautier, Lopez et al. 2007), similarly in the case of hyaluranon-based 
hydrogels (Tian, Hou et al. 2005). Another study outlined that the high surface-area to 
volume ratio (achieved due to synthesis techniques of PƐL) rather than innate adhesion 
properties, is crucial in supporting proliferation and cell density of mesenchymal stem cells 
(Gustafsson, Haag et al. 2012), again suggesting that the architecture, as well as the specific 
components of an artificial microenvironment, is crucial. 
H 
N 
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Modification of PƐL with RGD and heparin 
The importance of HS in kidney organogenesis and function has long been demonstrated, 
therefore support of KSC-GFP expansion via synthetic HS-mimetic coatings on PƐL 
substrates could facilitate this in vitro, via acting as an artificial ECM. In some renal disease 
models, mesangial sclerosis for example, whereby rapid glomerularsclerosis occurs, changes 
in ECM composition and decreased HSPGs in the glomerular basement membrane, is 
correlated with renal failure (Yang, Zhang et al. 2001), highlighting the importance of HSPGs 
in renal function via the ECM. Cell surface HSPGs from renal-fibroblasts have been shown 
to be essential in nephrogenesis (Clayton, Thomas et al. 2001), and Shah et al., showed that 
2-O sulfated HS is of great importance for successful uteric bud branching (Shah, Sakurai et 
al. 2011) via presence of HS2OST (Shah, Tee et al. 2009; Shah, Sakurai et al. 2010). 
Furthermore, TGF-beta1, a target of HS, is shown to regulate ECM composition, outlined to 
be important specifically in the renal model (Douthwaite, Johnson et al. 1999). 
Investigation into the affect of treating biocompatible polymers with heparin or HS analogues 
on performance as an artificial ECM is proving fruitful. Heparin-carrying polystyrene for 
example, was shown to direct and select cell expansion (Ishihara, Saito et al. 2000). 
Polysaccharide-surface coatings, specifically immobilized GAGs, have been shown 
positively influence proliferation and differentiation of mesenchymal stem cells (Uygun, 
Stojsih et al. 2009; Almodovar, Bacon et al. 2010), compared to untreated polymers, such is 
the availability of commercial culture dishes treated with immobilized GAGs currently. 
Heparin-functionalized PEG gels are shown to enhance hMSCs cell adhesion, proliferation 
and differentiation, compared to PEG gels alone (Benoit and Anseth 2005). Moreover, 
identification and optimisation of specific HS structures as coatings for different applications 
is on-going. Since HS sulfation pattern is dynamic depending on cell type and stage of 
development, the sulfated structure of any HS coating material will depend on application, 
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and should be tailored accordingly, outlined in one study that 2-O sulfated HS coating was 
optimal in enhancement of osteogenic potential (Ratanavaraporn and Tabata 2012). 
Renal-applications for substrates 
Early kidney development represents a major area of research within our group. Given the 
advances in stem cell research and simultaneously the need for therapeutic treatments for 
both acute and chronic renal failure, it represents a fitting niche and one which is explored in 
this project.  
The kidney possesses an impressive regeneration capacity, often attributed to the contribution 
of native stem cells, found from stromal cells and bone marrow-derived stem cells within the 
adult kidney (Maeshima, Yamashita et al. 2003; Lin 2006). In ischemic injuries for example, 
it has been shown that bone-marrow-derived stem cells take part in renal regeneration via 
differentiation into resident renal cells (Kale, Karihaloo et al. 2003; Lin, Cordes et al. 2003), 
although this has since been disputed (Duffield, Park et al. 2005; Lin, Moran et al. 2005). The 
ability of the kidney to regenerate upon severe kidney damage though, during chronic kidney 
disease for example, which has now been recognised as a global health issue (Levey, Atkins 
et al. 2007), is elusive. Severe kidney damage leads to loss of kidney structure, in turn 
causing a complete loss of kidney function. The solution appears to require de novo 
development of the entire kidney, for which stem-cell based treatments display great promise. 
The employment of stem cells as a tool in the treatment of kidney failure has been 
investigated (Morigi, Imberti et al. 2004; Lazzeri, Crescioli et al. 2007; Guillot, Cook et al. 
2008), however little is known about optimal substrates on which initial expansion of kidney-
derived stem cells (KSCs) can be achieved before directed differentiation can be achieved or 
well controlled. Ultimately, de novo development of the kidney requires a synthetic substrate 
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to support initial KSC expansion so to achieve sufficiently high cell numbers, prior to 
directed differentiation. 
As discussed, surface properties often govern cell-material interactions; wettability, charge 
and topography for example, can influence cell-polymer interactions; employing a protein 
coating such as fibronectin and laminin, is a common example (Ito, Kajihara et al. 1991; 
Altankov, Grinnell et al. 1996). However more recently, cell-recognised peptide motifs have 
shown greater promise.  RGD (R; arginine, G; glycine, D; aspartic acid) is a cell-recognised 
peptide motif, specifically a sequence of fibronectin, identified many years ago as a minimal 
essential cell adhesion sequence (Pierschbacher and Ruoslahti 1984; Pierschbacher and 
Ruoslahti 1984). Since then however, it has been additionally identified in many other ECM 
proteins including laminin (Tashiro, Sephel et al. 1991), collagen (Taubenberger, Woodruff 
et al. 2010) and fibrinogen. Much work has been done in defining how RGD functions to 
increase cell adhesion; in the main it is thought that a subset of integrins, well established 
cell-surface proteins that act as receptors for cell adhesion, recognise the RGD (D'Souza, 
Ginsberg et al. 1991; Ruoslahti 1996).   
Polymers coated or coupled with RGD have been shown to outperform uncoated polymers in 
an array of applications, demonstrates a reproducible affect that is consistent across many 
different cell types and conditions. PLGA 3D polymers coated with RGD resulted in 
enhanced osteoblast in-growth (Eid, Chen et al. 2001), effective for orthopaedic applications. 
Likewise, RGD-modified polyethylene sutures displayed enhanced adhesion and proliferation 
of tenocytes compared to untreated polymers (Kardestuncer, McCarthy et al. 2006; 
Mazzocca, Trainer et al. 2012), an important feature in wound healing. PTFE treated with 
RGD caused accelerated endothelialisation in both vascular grafts and heart valves (Tweden, 
Harasaki et al. 1995). PEG-based hydrogels displayed increased biocompatibility and support 
for MSC expansion once RGD was incorporated into synthesis (Grover, Lam et al. 2012). 
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One study outlined how RGD-functionalised polymers exhibited robustly enhanced cell 
adhesion, proliferation and often differentiation too, irrespective of the underlying polymer 
(Joy, Cohen et al. 2011), again highlighting the massive potential that RGD-treated polymers 
have as biomaterials. Similarly, research has shown that the bio-application of poly-Ɛ-lysine 
can be improved via covalent attachment of RGD. Polylysine coupled with RGD was shown 
to promote attachment and spread of human dermal fibroblasts (VandeVondele, Voros et al. 
2003); similarly, titanium coated with polylysine that had been modified with RGD, resulted 
in expansion of osteoblasts, unlike RGD-free polylysine coatings, which displayed reduced 
cell attachment correlated with increased differentiation (Tosatti, Schwartz et al. 2004).   
SpheriTech, an SME based in Runcorn, UK, and collaborator on this CASE studentship 
project, have developed unique techniques for the synthesis of different 3D scaffolds based 
upon cross-linked PƐL, a number of which were investigated here. 
Results in this chapter cover: 
 Acrylic/methacrylic based copolymers do not support the attachment or spread of 
fibroblasts. 
 Poly-Ɛ-lysine polymers do support the attachment and self renewal of ESCs, or the 
proliferation and attachment of fibroblasts and kidney stem cells. 
 Poly-Ɛ-lysine polymers can be modified with HS analogues to enhance performance 
as an artificial ECM for ESC scale-up. 
5.2 Hydrogels for cell attachment or viability 
Twelve different hydrogels, outlined in Table 5.2, were synthesised in accordance with 
SpheriTech Ltd protocols. Hydrogel performance and the ability to support fibroblast 
adherence and spread were assessed.  
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Table 5.2 Ratios of hydrogel components. Twelve different hydrogels were synthesised in-house by 
SpheriTech Ltd, constituents of which were based on different ratios of methacrylic, acrylic, PEG 360 
methacrylate, PEG 526 methacrylate, 2-hydroxethyl methacrylate and M-N dimethyl acrylamide. 
 Methacrylic Acrylic PEG 360 
Methacrylate 
PEG 526 
methacrylate 
2-hydroxethyl 
methacrylate 
M-N 
dimethyl 
acrylamide copolymer 
1 1  1    
3 1   1   
5 1    1  
6 1    15  
7  1 1    
9  1  1   
11  1   1  
12  1   15  
13  1    1 
14  1    15 
15 1     1 
16 1     15 
 
Givent the novelty of these polymers and preliminary status at least initially, STO fibroblast 
cells rather than mESCs were employed to determine foremost, the biocompatibility of the 
polymers and secondly the ability of the polymers to support cell adhesion, given that 
fibroblasts are robust, anchorage-dependent cells which are maintained without the expensive 
LIF supplement. STO fibroblasts were seeded onto the hydrogels and allowed to proliferate, 
initially for up to 48 h, after which time morphology and proliferation were assessed. Of the 
six different methacrylic-based hdyrogels, only methacrylic: PEG 526 methacrylate 1:1 
(copolymer 3) displayed any signs of supporting fibroblast attachment and spreading, as 
detected by little evidence of fibrils and processes (Figure 5.2E). However, this elongation 
and spread was much less obvious when compared to fibroblasts seeded in optimum 
conditions on fibronectin-coated cover slips, which displayed extensive elongation and 
spreading (Figure 5.6C). Nonetheless, contact with this methacrylic: PEG 526 methacrylate 
1:1 hydrogel, unlike the other methacrylic-based copolymers, stimulated minimal cell death; 
trypan-blue positive cells represented less than 10 % of cell population after 48 h (Figure 
190 
 
5.7A). In contrast, the five remaining methacrylic-based hydrogels did not support any 
fibroblast attachment; fibroblasts were identified floating in suspension and adopted rounded 
cell morphology (Figure 5.2D, F, Fig 5.3D, E, F). In addition, fibroblasts seeded onto these 
hydrogels (methacrylic:2-hydroxethyl methacrylate 1:1 (copolymer 5), methacrylic:2-
hydroxethyl methacrylate 1:15 (copolymer 6), methacrylic:360 PEG 1:1 (copolymer 1), 
methacrylic:N,N-dimethylacrylamide 1:1 (copolymer 15) and methacrylic: N,N-
dimethylacrylamide 1:15 (copolymer 16)) were not viable by 48 h, moreover the majority of 
cells were not viable, as early as 2 h (Figure 5.7), compared to the negative control (Figure 
5.6 D). 
Of the acrylic-based hydrogels, acrylic: PEG 526 methacrylate 1:1 (copolymer 9) and acrylic: 
N,N-dimethylacrylamide 1:15 (copolymer 14) supported cell attachment by 48 h and there 
was evidence of typical fibroblast elongated morphology. This was demonstrated by evidence 
of processes, suggesting cell spread, similar to that of the positive control represented by a 
fibronectin-coated cover slip (Figure 5.6C), albeit to a lesser extent.  
In contrast, the remaining acrylic-based hydrogels; acrylic: 360 PEG 1:1 (copolymer 7), 
acrylic: 2-hydroxethyl methacrylate 1:1 (copolymer 11), acrylic: 2-hydroxethyl methacrylate 
1:15 (copolymer 12) and acrylic: M-N-dimethylacrylamide 1:1 (copolymer 13), appeared to 
discourage fibroblasts from adhering to the surface. Fibroblasts were identified floating in 
suspension and assumed a rounded morphology as early as 2 h and 48 h post-seeding 
(Figures 5.4D and F, 5.5D and F, respectively). Furthermore, more than 97 % of fibroblasts 
seeded onto these hydrogels were non viable after 48 h (Figure 5.7). Hydrogels that were 
seen to support fibroblast adhesion (acrylic: PEG 526 methacrylate 1:1 (copolymer 9) and 
acrylic: M-Ndimethylacrylamide 1:15 (copolymer 14)) displayed a largely viable fibroblast 
population after 48 h. 
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Of the twelve hydrogels therefore, only methacrylic: PEG 526 methacrylate 1:1 (copolymer 
3), acrylic: PEG 526 methacrylate 1:1 (copolymer 9) and acrylic: M-N-dimethylacrylamide 
1:15 (copolymer 14) showed any promise, not least because more than 90 % of fibroblasts 
seeded onto these copolymers survived after 48 h, but also because there was evidence in all 
three cases, of fibroblast adhesion to the copolymer surface and spread, attributed to 
elongated, fibroblast-like morphology.  
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Figure 5.2 Methacrylic-based hydrogels 1, 3 and 5 do not support fibroblast attachment or 
proliferation. Fibroblast cells were seeded onto copolymers after usual sterilisation procedures and 
allowed to attach for up to 48 h. Methacrylic:360 PEG 1:1 did not support cell attachment neither at 2 
h (A) or after 48 h (D); instead cells retained a rounded morphology and floated in suspension 
(arrows). Likewise, fibroblasts seeded onto methacrylic:2-hydroxethyl methacrylate 1:1displayed a 
rounded morphology at 2 hours (C) and after 48 h (F) (arrows). Methacrylic: PEG 526 methacrylate 
1:1 appeared to support some fibroblast attachment and spreading after 48 h (E) (arrows), displaying 
signs of fibrils, but cells were unattached and rounded after 2 h (B). The experiment was repeated 
more than 3 times, images are representative for each population, scale, 50 µm. 
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Figure 5.3 Methacrylic-based hydrogels 6, 15 and 16 do not support fibroblast attachment or 
proliferation. Fibroblast cells were seeded onto copolymers after usual sterilisation procedures and 
allowed to attach for up to 48 h. Methacrylic:2-hydroxethyl methacrylate 1:15 did not support cell 
attachment neither at 2 h (A) or after 48 h (D); fibroblasts displayed a rounded morphology (arrows). 
Methacrylic:M-Ndimethylacrylamide 1:1did not support fibroblast attachment neither after 2 h (B) 
nor after 48 h (E) as cells retained a rounded morphology. Likewise, methacrylic: M-
Ndimethylacrylamide 1:15, did not support any fibroblast attachment, instead, fibroblasts were 
identified in clumps floating in the medium with a rounded morphology. The experiment was repeated 
more than 3 times, images are representative of each population, scale bar, 50 µm. 
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Figure 5.4 Acrylic-based hydrogels 7, 9 and 11 display little evidence of supporting fibroblast 
attachment and spread. Fibroblast cells were seeded onto copolymers after usual sterilisation 
procedures and allowed to attach for up to 48 h. Fibroblasts seeded onto acrylic: 360 PEG 1:1 retained 
a rounded morphology at 2 h post seeding (A) and 48 h post seeding (D) (arrows). Likewise, upon 
seeding fibroblast cells onto acrylic:2-hydroxethyl methacrylate 1:1, cells did not attach but instead 
remained floating in suspension after 2 h  (C) and 48 h (F) (arrows). Fibroblasts seeded onto 
Acrylic:PEG 526 methacrylate 1:1 although rounded at 2 h (B), appeared to attach and display signs 
of spreading by 48 h (E) (arrows). The experiment was repeated more than 3 times, images are 
representative of each population, scale bar, 50 µm. 
 
  
195 
 
 
Figure 5.5 Acrylic-based hydrogels 12, 13 and 14 display little evidence of supporting fibroblast 
attachment and spread. Fibroblast cells were seeded onto copolymers after usual sterilisation 
procedures and allowed to attach for up to 48 h. Fibroblasts seeded ontoacrylic:2-hydroxethyl 
methacrylate 1:15 retained a rounded morphology at 2 h post seeding (A) and 48 h post seeding (D) 
(arrows). Likewise, upon seeding fibroblast cells onto acrylic: M-Ndimethylacrylamide 1:1, cells did 
not attach but instead remained floating in suspension with a rounded morphology after 2 h  (B) and 
48 h (E) (arrows). Fibroblasts seeded onto Acrylic: M-Ndimethylacrylamide 1:15 however, did 
support fibroblast attachment and spreading identified by 48 h (F), although the majority of cells 
remained rounded in morphology at 2 h (C). The experiment was repeated more than 3 times, images 
best represent each population and scale bar represents 50 µm. 
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Figure 5.6 Fibroblast morphology varies according to ability to spread. STO fibroblasts were 
seeded onto two different control conditions, one to encourage cell attachment and spread 
(fibronectin-coated cover slip) and another to discourage cell attachment (uncoated glass cover slip). 
Cell morphology was assessed accordingly, 48 h post seeding. The positive control, represented by a 
cover slip coated with fibronectin, resulted in fibroblasts attaching to the surface after 2 h (A) 
displaying some signs of cell spread, identified by elongated morphology and processes (A, arrows). 
After 48 h, the majority of cells were attached to the surface of the cover slip and appeared to be 
spreading, identified by typical, elongated fibroblast morphology (C arrows). In contrast, the negative 
control; an uncoated glass cover slip, caused fibroblasts to remain floating in suspension after 2 h (B) 
displaying a rounded morphology (B arrows). This was consistent also after 48 h, as cells were 
detected in clumps floating in suspension (D), all displaying a rounded morphology (D arrows). The 
experiment was repeated more than four times and images are representative of cell populations. Scale 
bar, 100 µm.  
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Figure 5.7 Fibroblast viability was completely lost in all but three hydrogels. Fibroblast cells 
were seeded onto twelve different hydrogels and incubated for 48 h, after which trypan blue was used 
to detect non-viable cells. Only copolymer 3, 9 and 14 supported fibroblast viability up to 48 h (A, C 
and D respectively). All other copolymers; 1, 5, 6, 7, 11, 12, 13, 15 and 16 resulted in loss of more 
than 95 % of cells, positive for trypan blue after 48 h. The experiment was repeated more than three 
times and error bars, SEM. 
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5.3 Poly-Ɛ-lysine based polymers support mESC viability and self renewal 
A range of copolymers investigated in section 5.2., generally proved unsuccessful in 
supporting fibroblast expansion. Consequently, investigations were pursued into an 
alternative polymer, poly-Ɛ-lysine as a synthetic substrate for cell expansion. The 
employment of polylysine in biomaterials represents a new, yet promising field within 
biomaterials.  
As mentioned previously, SpheriTech have developed a novel method to develop and 
synthesize 3D macroporous poly-Ɛ-lysine polymers with well controlled porosity and these 
were investigated here. 
mESCs were seeded onto SpheriTech PƐL polymers using a transwell system as described in 
Materials and Methods to assess the potential of these novel 3D macroporous polymers in 
ESC expansion and maintenance. Polymers were removed from the culture system after 10 
days and proliferation was assessed, as well as exploring the effect that contact with these 
polymers had on mESC self-renewal (via investigating alkaline phosphatase expression and 
Nanog expression, common markers of pluripotency).  
mESCs were identified adhering to the poly-Ɛ-lysine polymers after 10 days, as detected with 
DAPI (Figure 5.8A) and assessment of proliferation using an MTS assay, showed that, whilst 
proliferation of mESCs on these synthetic polymers was significantly slower compared to 
standard gelatine-coated tissue culture plastic, mESCs were proliferating in contact with these 
PƐL polymers (Figure 5.8D). Furthermore, mESCs in contact with PƐL polymers remained 
alkaline phosphatase-positive (Figure 5.8B and C). Similarly, mESCs maintained Nanog 
expression up to 10 days post seeding onto the polymers (Figure 5.9E and 5.9F). Closer 
inspection of the localisation of mESCs on the polymer, revealed that mESCs appeared to 
congregate on the periphery of the pores; moreover, cells were identified with a rounded 
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morphology and as single cells; there was no evidence of cells clustering together in colonies, 
as is often typical (Figure 5.9C and D). 
Scanning electron microscopy (SEM) was employed to investigate surface topography and 
corresponding mESC morphology. PƐL polymers displayed a distinctly spherical topography, 
attributed to the methodology of polymer synthesis (Figure 5.10). This topography therefore 
demonstrates high surface area: volume ratio, and well controlled porosity; both attributes 
ideal for cell scale-up in vitro and diffusion of nutrients through the polymer. 
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Figure 5.8 mESCs seeded onto poly-Ɛ-lysine polymers, attach, proliferate and retain alkaline 
phosphatase expression up to 10 days. E14 mESCs were seeded onto PƐL polymers and allowed to 
attach and proliferate for up to 10days, when polymers were stained for alkaline phosphatase. Cells 
were identified on polymers via DAPI stain (A), correlated with alkaline phosphatise stain (B) 
displaying alkaline phosphatise positive mESCs attached to polymer (C) (arrows). Cell proliferation 
quantification using an MTS assay showed that mESCs proliferate when in contact with PƐL  
polymer, albeit at a slower rate than compared to normal culture plastic, according to metabolic 
acitivity (D). All experiments were repeated more than three times, images are representative of the 
population and error bars, SEM. Scale bar represents 100 µm. 
 
201 
 
 
 
Figure 5.9 E14 mESCs maintain Nanog expression when seeded onto poly-Ɛ-lysine-based 
macroporous polymers and topography of polymer directs location of mESCs. E14 mESCs were 
seeded onto PƐL and allowed to proliferate during incubation for 10 days, after which polymers were 
frozen, sectioned and stained for pluripotency marker Nanog. Using bright-field (BF) microscopy, 
mESCs were identified on the periphery of pores within the polymer (highlighted by red arrows in A), 
as shown in magnified images from two different fields of view; dashed arrows in (C) and normal 
arrows in (D). mESCs were Nanog positive, as shown in B, highlighted at higher power (E and F). 
The experiment was repeated more than three times and images are representative of the cell 
population. Scale bars; 100 µm.  
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Figure 5.10 Poly-Ɛ-lysine 
topography and architecture. 
PƐL spherical topography 
demonstrates high surface area: 
volume ratio and well controlled 
porosity, ideal for expansion of 
cells and diffusion of nutrients. 
PƐL polymers were analysed 
under SEM after synthesis. 
Results show a high surface 
area: volume ratio and well 
defined pores. The experiment 
was repeated more than three 
times.  
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5.4. Growth of kidney stem cells on poly-Ɛ-lysine  
3D PƐL macroporous polymers were shown to support mESC adherence, proliferation and 
self renewal, attributed to its cationic surface and well controlled porosity (section 5.3). 
Considering the requirement for a synthetic substrate to be applied and the success of the PƐL 
for ESC culture, this section explores the potential to exploit this polymer in renal-based 
applications. Additionally, given the methodology of polymer synthesis, derived and 
modified by SpheriTech, and the very nature of PƐL, coupling functional groups to these 
polymers represents an exciting approach to further enhance polymer performance.  
The potential of PƐL and RGD-crosslinked analogues, to support KSC expansion was 
explored, for the eventual employment of these expanded KSCs as a kidney regeneration 
tool. The kidney-derived stem cell line was derived from mice expressing the green 
fluorescent protein (GFP), employed to increase the ease of tracking in vitro and to tailor the 
initial mESC-based investigation to suit a more renal, downstream application. 
5.4.1. Poly-Ɛ-lysine-based polymers +/- RGD support KSCs-GFP 
Kidney-derived stem cells derived from mice expressing green fluorescent protein (GFP) 
(KSCs-GFP) were seeded onto PƐL macroporous polymers, which had previously been 
shown to support mESC attachment, proliferation and self-renewal. KSC-GFP cells were 
identified adhering to the surface of the polymer using immunofluorescence detection of GFP 
in conjunction with DAPI at 4, 7 and 10 days (Figure 5.11 A, B, C, respectively). Similarly, 
PƐL coupled with RGD displayed KSCs on the polymer surface at 4, 7 and 10 days post 
seeding (Figure 5.11 D, E, F, respectively). Investigation of the proliferation of KSCs as a 
result of contact with these PƐL polymers (+/- RGD), demonstrated that PƐL coupled with 
RGD stimulated KSCs to proliferate significantly faster than that KSCs seeded on PƐL 
without RGD (Figure 5.12). However, both PƐL polymers (+/- RGD) displayed proliferation 
rates significantly slower than standard gelatine-coated tissue culture plastic (Figure 5.13).  
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Inspection of KSC-GFP morphology and interaction with PƐL polymers (+/- RGD) using 
SEM three days post seeding, revealed that KSCs appeared to be located within the pores of 
the polymer, although spreading appeared limited, due to lack of elongated fibroblast-like 
morphology detected both in the case of PƐL with and without RGD (Figure 5.13 A, B, C,D, 
respectively). In comparison, typical KSC-GFP morphology can be represented by elongated, 
fibroblast-like morphology, as shown by SEM images of KSCs-GFP cultured on gelatine-
coated tissue culture plastic (Figure 5.13 E and F). Evidently, KSCs-GFP coated the surface 
of the polymers with ECM molecules, as detected by a coating like surface on the surface of 
the polymers after culture with KSCs-GFP, and highlighted by the less distinct spherical 
topography. 
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Figure 5.11 Poly-Ɛ-lysine macroporous polymers (+/- RGD) support KSCs-GFP attachment and 
proliferation up to 10 days. KSCs-GFP were seeded onto macroporous PƐL polymers with and 
without RGD cross-linked. Cells were allowed to proliferate and at 4, 7 and 10 days, polymers were 
frozen and prepared for sectioning, followed by DAPI stain. After 4 days, low numbers of single cells 
were identified in any one field of view +/- RGD (A and D, respectively). After 7 days in culture, PƐL 
cross-linked with RGD appeared to display KSCs-GFP at higher density (E) compared to cells 
identified on PƐL alone (B). This was consistent and more apparent at 10 days, whereby PƐL alone 
displayed regions of relatively populated (C), however poly-Ɛ-lysine cross-linked with RGD 
displayed more highly dense cell populations (F). The experiment was repeated three times and 
images are representative of the cell population. Scale bar; 100 µm. 
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Figure 5.12 Synthetic poly-Ɛ-lysine coupled with RGD, supports KSCs-GFP proliferation at a 
higher rate than poly-Ɛ-lysine not coupled with RGD. KSCs-GFP were seeded onto PƐL polymers 
which were all 100% cross-linked (denoted 105%) with and without RGD (+/- RGD) and allowed to 
proliferate up to 10 days. At 2, 3, 7 and 10 days, MTS assay was used to determine cell proliferation 
with regard to metabolic activity and absorbance readings were taken at 490 nm. Metabolic activity 
increased over time for both polymers (+/- RGD) suggesting cell proliferation, however PƐL coupled 
with RGD, outperformed PƐL without RGD, displaying higher metabolic acitivty at every time-point. 
Both polymers (+/- RGD) displayed significantly lower absorbance values than standard culture 
conditions, however significantly higher than samples incubated with TritonX. The experiment was 
repeated more than three times and error bars, SEM. 
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Figure 5.13 KSCs-GFP populate the pores of the poly-Ɛ-lysine or on the surface of the spheres, 
and fibroblast-like processes appear to be lost compared to standard tissue culture plastic. 
KSCs-GFP were seeded onto standard tissue culture plastic coated with 0.1 % gelatine and PƐL  
polymers +/- RGD, allowed to proliferate and samples were then prepared for SEM, 3 days post 
seeding. KSCs-GFP displayed typical fibroblast-like morphology identified with fibrils and processes 
spreading across the dish (red arrows in C) when seeded onto tissue culture plastic coated with 
gelatine, further outlined in (F). PƐL polymers appeared to support KSC-GFP attachment in both +/- 
RGD samples, although interaction with the polymer was inconsistent; often KSCs-GFP were seen 
contacting the spheres of the structure of the polymer (A and B), but also seen to settle in the pores of 
the polymer structure (B and E). The experiment was repeated four times and the images are 
representative of the cell population. Scale bars ; 10 µm and 20 µm, respectively. 
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5.5 Poly-Ɛ-lysine-based polymers modified with HS analogues 
Results here have demonstrated that PƐL 3D macroporous polymers can support KSC-GFP 
attachment and proliferation, and moreover if coupled with RGD, polymer performance was 
shown to be enhanced (section 5.4). Additionally, results in chapter 2 outlined a role for 
soluble HS in maintaining typical mESC behaviour, potentially linked to the need for serum. 
Taken together, PƐL coated with synthetic HS structures could provide an artificial 
alternative to current in vitro cell expansion systems that typically involve animal-derived 
products, such as gelatine and serum for example. 
Accordingly, PƐL synthesis was modified to accommodate the binding of HS-mimetic 
structures via ionic interactions with free alpha-amine groups (Figure 5.1). Synthetic HS 
mimetic structures, chemically modified heparins with selectively reduced sulfation, were 
synthesised in-house (Yates, Guimond et al. 2004).  
Initially, the effect of these HS-mimetic heparin structures was tested by absorption onto the 
surface of standard tissue culture plastic simply via ionic adsorption. Investigation into the 
effect that different structures had on KSC-GFP adherence, proliferation and spread was 
pursued, with a view to employing the best-performing structures as alternatives to current, 
highly expensive synthetic plastics and/or animal-derived coatings. 
Per-sulfated (over-sulfated) heparin coating and PMH coating were demonstrated to have 
similar effects on KSC-GFP attachment and morphology, 48 h post seeding. KSCs-GFP 
cultured on PMH-coated tissue culture plastic (Figure 5.14A) and per-sulfated heparin-coated 
tissue culture plastic (Figure 5.14B) resulted in KSCs-GFP attachment to the surface, 
moreover there was evidence of cell spreading due to identification of processes and spindle-
like morphology, as in the control condition (gelatine-coated tissue culture plastic) (Figure 
5.14F).  
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Figure 5.14 Tissue culture plastic coated with per-sulfated heparin, outperforms other heparin 
analogue coatings, in supporting KSC-GFP attachment and spreading. KSCs-GFP were seeded 
onto tissue culture plastic coated with different HS analogues; per-sulfated, 6-O desulfated, 2-O 
desulfated, NAc heparin, PMH, and a gelatine-coated control and allowed to attach and proliferate for 
48 h, after which time morphology and spread was assessed. KSCs-GFP seeded onto per-sulfated 
heparin coated dishes, attached and spread displaying signs of processes and spindle-like morphology 
(A) (arrows), likewise for KSCs-GFP seeded onto PMH-coated dishes (B) (arrows). 6-O desulfated 
heparin-coating and 2-O desulfated coatings supported attachment and spreading also, highlighted by 
the presence of processes (C and D respectively) although less apparent spindle-like morphology. 
Dishes coated with NAc did not support KSC-GFP attachment and cells retained a rounded 
morphology (E). The experiment was repeated three times and images are representative of the cell 
populations. Scale bar represents 100 µm.  
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Tissue culture plastic coated with 6-O desulfated and 2-O desulfated heparin also displayed 
support of KSC-GFP attachment after 48 h, although there was less evidence of processes or 
elongated morphology (Figure 5.14C and D, respectively). Tissue culture plastic coated with 
NAc-heparin structures did not support KSC-GFP attachment; instead cells retained a 
rounded morphology and floated in suspension (Figure 5.14E). Investigation into 
proliferation of KSCs-GFP and the effect of different HS-mimetic coatings have on KSC-
GFP proliferation was investigated using an MTS assay, based on metabolic activity. PMH 
and per-sulfated heparin coatings stimulated KSCs-GFP to proliferate at a faster rate than 
KSCs-GFP seeded onto gelatine-coated dishes (Figure 5.15). 6-O and 2-O desulfated 
heparin-coated dishes displayed comparable KSC-GFP proliferation rates, but lower than 
gelatine-coated dishes. In contrast, NAc-heparin coated dishes did not stimulate any KSC-
GFP proliferation between 24 and 96 h (Figure 5.15).  
PƐL 3D macroporous polymers were coated with the same set of synthetic HS-mimetic 
structures and KSCs-GFP were seeded onto the polymers using the trans-well culture system 
employed previously. Interaction of KSCs-GFP with the polymers was investigated using 
SEM, and proliferation again assessed using MTS. 
SEM images of the polymers demonstrated that coating, whether with gelatine or any of the 
synthetic structures, altered the surface topography compared to that identified previous of 
the PƐL polymer alone (Figure 5.16). The most apparent change in surface topography was 
correlated with gelatine-coating; the distinct, spherical polymer surface was evidently 
covered, no doubt reducing surface area: volume. Furthermore, architecture also appeared to 
alter from a spherical, bead-like, porous structure to a more flattened, meshwork. Similarly 
for PMH-coated polymers; the existence of distinct spherical surfaces was reduced; instead 
the surface topography appeared more variable in heigh and overall polymer architecture 
seemed flattened and mesh-like (Figure 5.16). Per-sulfated, 6-O desulfated, 2-O desulfated 
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and NAc heparin structures appeared to induce fewer alterations in surface topography or 
polymer architecture. These four structures did display signs of coating the material, since the 
topography of the polymer appeared less homogenous when viewing the entire section, 
compared to polymer alone which displayed more uniformity. However on the whole, the 
PƐL polymers displayed spherical, bead-like topography and consistent porosity across each 
section (Figure 5.16).  
The KSC-GFP proliferation results demonstrated that per-sulfated heparin and PMH-coated 
polymers supported the highest level of cell proliferation and were comparable to each other. 
Polymers coated with gelatine, supported steady proliferation, but at a slower rate than per-
sulfated heparin-coated polymers and PMH-coated polymers. 6-O desulfated-coated 
polymers supported steady yet slower KSC-GFP proliferation compared to per-sulfated 
heparin-coated polymers for example, but higher than 2-O desulfated-coated polymers, which 
was relatively low. NAc heparin-coated polymers did not appear to support any proliferation 
up to 14 days (Figure 5.17).  
Further SEM analysis was conducted of the polymers which best supported KSC-GFP 
proliferation (PMH, per-sulfated heparin and 6-O desulfated heparin-coated polymers). 
KSCs-GFP detected on the surface of polymers treated with per-sulfated structures, displayed 
elongated morphology typical of KSCs-GFP. Similarly but often not as obvious, KSCs-GFP 
detected on the surface of poly-Ɛ-lysine polymers treated with 6-O desulfated heparin-
coating, displayed signs of spread, attributed to a flattened morphology (Figure 5.18).   
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Figure 5.15 PMH and per-sulfated heparin structures absorbed to the surface of tissue culture 
plastic best support KSC-GFP proliferation compared to tissue culture plastic coated with 6-O 
and 2-O desulfated heparin or NAc heparin structures. KSCs-GFP were seeded onto tissue culture 
plastic coated with five different HS analogue structures and an MTS assay was used to determine 
KSC-GFP metabolic activity compared to gelatine-coated tissue culture plastic. Per-sulfated heparin-
coated tissue culture plastic displayed the highest proliferation rate, comparable to PMH-coated 
dishes. 6-O desulfated heparin coatings and 2-O desulfated heparin coatings supported KSC-GFP 
proliferation also, at a rate comparable to gelatine-coated dishes but slower than per-sulfated heparin 
PMH coatings. The experiment was repeated more than three times and error bars, SEM. 
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Figure 5.16 Surface topography of poly-Ɛ-lysine macroporous polymers is affected by coating with different HS-mimetic structures. PƐL macroporous 
polymers were synthesised and different modified heparin (HS-mimetic) structures were absorbed to the surface following 2 h incubation. Topography was 
analysed using SEM after standard sample preparation.   
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Figure 5.17 KSC-GFP proliferation on poly-Ɛ-lysine macroporous polymers altered depending 
on heparin structure. KSCs-GFP were seeded onto PƐL polymers after 2 h incubation with synthetic 
HS-mimetic heparin structures; per-sulfated, 6-O desulfated, 2-O desulfated and NAc heparin, 
compared to PMH and gelatine coated polymers as controls. KSC-GFP proliferation was assessed 
using an MTS, where metabolic activity was measured. PMH and per-sulfated heparin coatings 
outperformed gelatine-coated polymers, supporting faster proliferation than any other coating 
material. 6-O desulfated heparin-coated polymers supported more proliferation than 2-O desulfated 
heparin-coated polymers, but lower than per-sulfated HS. NAc heparin-coated polymers did not 
appear to support any proliferation up to 14 days. The experiment was repeated three times and error 
bars represent SEM. 
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Figure 5.18 KSC-GFP-polymer interaction alters depending on the level/pattern of sulfation 
exhibited by the coating material; per-sulfated heparin-coated polymers support elongated 
KSC-GFP morphology. KSCs-GFP were seeded onto PƐL based polymers that had been coated with 
different synthetic heparin structures and allowed to proliferate for up to 10 days. SEM analysis was 
conducted in order to assess KSC-GFP morphology and interaction with polymer surface. Polymers 
were selected based on performance with regard to supporting the highest proliferation. Per-sulfated 
heparin-coating supported KSC-GFP attachment as highlighted with arrows, however, spindle-like 
processes are undetected. The experiment was repeated more than three times and scale bars represent 
10 µm. 
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5.6 Discussion 
 
 The original employment of biomaterials involved petroleum-derived synthetic polymers 
designed to be inert without interacting with the organism (Minoura, Aiba et al. 1989), 
categorized by low protein absorption and weak interactions with tissues. However more 
recently, there has been recognition for bioactive materials and as mentioned, polymers fit 
this role well (Langer and Vacanti 1993; Kim and Mooney 1998; Hench and Polak 2002).  
Of twelve different hydrogels synthesised using varying ratios of well established 
biocompatible materials (methacrylic, acrylic, PEG 360 methacrylate, PEG 526 methacrylate, 
2-hydroxethyl methacrylate and M-N dimethyl acrylamide), only three displayed any 
evidence of supporting cell viability, adhesion or spreading. This result alone highlights the 
difficulties faced in identifying optimised biomaterials.  
In order to assess these copolymer hydrogels, fibroblasts were initially employed. Fibroblasts 
represent anchorage-dependent cells, therefore adhesion and morphology not only provides 
indications of cell spreading behaviour, but also of polymer biocompatibility, specifically 
cytocompatibility. Moreover, fibroblasts are the most abundant cell in the stroma and are 
largely responsible for remodelling of the ECM (Grinnell 1994; Eastwood, Mudera et al. 
1998). 
Only methacrylic: PEG 526 methacrylate 1:1 (copolymer 3), acrylic: PEG 526 methacrylate 
1:1 (copolymer 9) and acrylic: M-Ndimethylacrylamide 1:15 (copolymer 14) displayed any 
potential to support fibroblast adherence and expansion. Fibroblasts incubated with the 
remaining copolymers resulted in cells assuming a rounded morphology and were identified 
floating in suspension, suggesting that these polymers did not promote or support attachment. 
It was shown many years ago that cells settle on a favoured surface within minutes (Curtis 
1964; Curtis, Forrester et al. 1983) and strong focal adhesions are seen within 24 h (van 
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Kooten and von Recum 1999), suggesting that these materials displayed unfavourable surface 
chemistries and/or topographies. Furthermore, considering, as mentioned, that fibroblast 
survival is dependent on adhesion, it was not surprising that of those hydrogels which caused 
fibroblasts to adopt a rounded unattached morphology, there was a corresponding lack of 
viability, measured using trypan-blue. More than 95 % of fibroblasts seeded onto hydrogel 
copolymers 1, 5, 6, 7, 11, 12, 13, 15 and 16 were non viable after 48 h, however, the rates of 
reaching complete non-viable cell populations, differed depending on the polymer surface. 
Where fibroblasts were identified as single floating cells (copolymers 5, 7 and 12 for 
example), a total unviable cell population was achieved much faster than when fibroblasts 
were clumped as cell aggregates initially. The instances were fibroblasts populations 
remained moderately viable after 24 h, were often correlated with cell aggregates. There are 
two forms of adhesion; cell adhesion to ECM (Harper and Juliano 1981), which is mimicked 
here in the case of these copolymers, or adhesion to another local cell (Harper and Juliano 
1981), therefore survival of fibroblasts was perhaps prolonged via adhering to other 
fibroblasts.  
Methacrylic: PEG 526 methacrylate 1:1 (copolymer 3), acrylic: PEG 526 methacrylate 1:1 
(copolymer 9) and acrylic: M-Ndimethylacrylamide 1:15 (copolymer 14) supported KSC 
adhesion and cells displayed typical, elongated and fibroblast-like morphology. Fibroblast 
morphology has long been outlined as diverse, largely dependent on substratum (Tajima and 
Pinnell 1981; Tomasek, Hay et al. 1982; Olmo, Lizarbe et al. 1988), therefore it would appear 
that these hydrogels, which were shown to support typical fibroblast morphology, present 
sufficient physical and/or chemical properties, to mimic natural ECM. Acrylamide-based 
hydrogels have been shown to affect cardiac fibroblast morphology and adhesion, as a 
consequence of hydrogel stiffness and topography (Al-Haque, Miklas et al. 2012), and 
fibroblasts have been shown to readily polarize, characterised by long actomyosin bundles 
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(stress fibers) and stable edges, on rigid but not compliant acrylamides (Prager-Khoutorsky, 
Lichtenstein et al. 2011). Accordingly, acrylic: M-Ndimethylacrylamide 1:15 (copolymer 
14), shown to support KSC elongation, could possess adequate stiffness and topographical 
properties, important for fibroblast polarization and response. The remaining two hydrogels 
shown to support KSC adhesion and spread; methacrylic: PEG 526 methacrylate 1:1 and 
acrylic: PEG 526 methacrylate 1:1, are similar in their building blocks; both are synthesised 
from PEG 526 methacrylate, and differ only in type of acrylic component 
(acrylic/methacrylic). PEG 526 methacrylate represents a high molecular weight component 
that will increase swell and has shown promise as hydrophobic drug delivery (Diramio, 
Kisaalita et al. 2005). However, overall analysis suggested that none of these hydrogels 
performed well enough to be investigated further, demonstrating the importance of selecting 
the correct polymer material. Wang et al., outlined precisely this, demonstrating that the 
choice of polymer is crucial and governs cell behaviour, showing that mesenchymal stem 
cells behave differently depending on material; polystyrene, polycarbonate and polyurethane 
stimulated distinctly different cellular responses (Wang, Ma et al.).  
In this project, attention was subsequently turned to PƐL; a small homopolymer synthesised 
from essential amino acid L-lysine. It therefore has excellent biocompatibility and 
consequently is being developed in an array of biomedical applications including wound 
healing dressings, delivery of nanoparticles (Jin, Yu et al.) and scaffolds for 3D tissue 
engineering (Crompton, Goud et al. 2007). This chapter investigates more the novel 
acrtictecture, surface topography and cross-linking capacity of these PƐL macroporous 
polymers, attributed to SpeheriTech technology and novel methodology during synthesis, 
given that biocompatibility is already well appreciated.  
SEM showed that these PƐL polymers presented a unique spherical, bead-like architecture 
with well-controlled porosity (Figure 5.10). It is well documented that surface topography 
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and polymer architecture can govern cellular behaviour, therefore porosity and the spherical 
nature of the polymer surface, could well underpin the cellular response identified in the 
work here. Alves et al., reviewed how cell behaviour can be controlled via carefully 
designing polymer surface properties (Alves, Pashkuleva et al.) and micro-geometries have 
been shown to be influential on hESC behaviour (Carlson, Florek et al.). In this chapter, 
mESCs appeared to congregate on the periphery of the pores and on the edges of spherical-
bead like structures, and adopted an unusually rounded morphology remaining predominantly 
as single cells (Figure 5.18C and D). There was no evidence of cells clustering in colonies or 
adhering and flattening to the polymer, as one would typically identify in culture dishes, 
suggesting that the surface did not support this, or that the cells did not adopt this behavior 
given alternative cues. Similarly, in the case of KSCs-GFP seeded onto these PƐL polymers, 
SEM images revealed that cells nestled in the pores of the polymer and rather than spreading, 
as is usual for fibroblasts, and KSCs-GFP remained as single cells.  
Interestingly, much research is being conducted regarding the influence of polymeric surface 
topographies on cell spreading, flattening and subsequent differentiation. Flattening of 
mesenchymal stem cells has been shown to be correlated with differentiation, according to 
geometric micro and nano-patterning of polymer substrates (Bucaro, Vasquez et al.; Song, Lu 
et al.). This is supported by another study which demonstrated that spreading of rat 
mesenchymal stem cells, attributed to the nanotopography of silicon columns, influenced 
differentiation capacity (Guvendik, Trabzon et al.), although to my knowledge, no work has 
been conducted with regard to mESCs specifically. Interestingly though, stiffness of a 
substrate (for example a stiff standard tissue culture plastic dish) has been shown to induce 
stress on mESCs and subsequently associated with a loss of pluripotency (Chowdhury, Li et 
al.). It could be that the elasticity of the PƐL, due to its hydrophobicity and swell, prevents 
stress-inducing cell polarization, therefore cells remain single and rounded rather than being 
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stimulated to flatten and potential differentiate. This suggests that the PƐL polymer is an ideal 
substrate for maintaining and expanding ESCs in a pluripotent (non-differentiated) state. 
Aside from flattening and spreading of cells to induce differentiation, many studies have now 
demonstrated that surface topography can solely dictate the fate on a cell, irrespective of cell 
cytoskeletal shape (Chen, Villa-Diaz et al.). Mattotti et al. demonstrated that entirely 
synthetic PMMA substrates were able to direct the differentiation of neural progenitors using 
carefully patterned nanotopography (Mattotti, Alvarez et al.) in the absence of any animal-
derived materials (often used in polymer bio-applications). Another study showed that 
roughened polymer surface topography, exploited to increase surface area: volume via 
solvent etching, increased the yield of human bone marrow-derived stem cells (hBMSCs) 
whilst stimulating controlled osteogenic differentiation, which was otherwise uncontrolled 
(Kumar, Waters et al.).  
The response of the mESCs to the poly-Ɛ-lysine polymers identified here could potentially 
highlight a niche to be exploited in mESC expansion. A spherical surface cleverly generates a 
high surface area: volume, substantially higher than that of a flat culture dish for example, 
therefore expansion of mESCs in this manner could produce considerably more cells per 
ppopulation, whilst using the same volumes of consumables (media and growth factors 
supplementation for instance), than would be used when culturing mESCs on a flat, single-
dimensional platform. Obviously, this would be extremely appealing commercially, since 
cost efficacy in the ESC field is a major factor. The use of beads and other spherical 
substrates with this cost-based rationale is developing in all fields of biosciences (Neurauter, 
Bonyhadi et al. 2007; Zhang, Zhang et al. 2009). The spherical, bead-like architecture gave 
rise to single mESCs often enclosed within pores and the spherical surface prevented the both 
mESCs and KSCs from flattening, although both cell lines did proliferate when in contact 
with the polymer. A rounded morphology and single-cell existence is not characteristic of 
221 
 
typical mESC populations however, does perhaps represent a method of expanding a pure 
homogenous mESC population. Currently, spontaneous differentiation is a problem in mESC 
cultures and hinders the isolation and expansion of pure mESC populations. Spontaneous 
differentiation has been shown to be induced by colony formation upon mESCs flattening 
(Zakany, Burg et al. 1984; Heo, Lee et al. 2005), therefore by preventing colony formation 
through culture with these PƐL structures, could limit spontaneous differentiation thus 
attaining a more pure mESC population. Many single-cell expansion systems are under 
investigation, with the same goal and rationale in mind – to optimise a pure cell population. 
One study demonstrated the use of a multi-well tissue culture plate to expand single cells; 
however this suffers significant inconvenience and is impractical since cell populations 
required dissociating and transferring to different wells over time (Greenberger, Goff et al. 
2000). Taken together, the porosity and spherical, bead-like architecture could potentially 
represent an excellent platform for expanding single mESCs at substantially higher density 
than that of standard expansion methods, which are costly and limited due to spontaneous 
differentiation in sub-populations. 
Further investigation here showed that the performance of these PƐL polymers to support 
KSC-GFPs could be enhanced using several different polymer modifications; a bulk material 
modification and a surface modification.  
Bulk material modification entailed cross-linking PƐL with RGD, a well-known protein-
binding motif (Ruoslahti 1996), during the polymer synthesis process. RGD has been used 
for several years in the biomaterials field to functionalize metals for example (Arosio, 
Manzoni et al.; Le Guillou-Buffello, Bareille et al. 2008) and more recently, RGD has been 
employed to modify biopolymers (Hersel, Dahmen et al. 2003). Examples of this include the 
improvement of PLGA substrates with RGD-coatings to improve in-growth of osteoblasts for 
bone regeneration applications (Eid, Chen et al. 2001). Similarly, the osseointegration on a 
222 
 
synthetic bone screw for implants, was improved using RGD coatings (Yang, He et al. 2009). 
In another example, RGD-coated hydrogels were shown to improve drug delivery efficacy 
compared to uncoated hydrogels (Chikar, Hendricks et al.) and polyurethanes engrafted with 
RGD motifs displayed improved adhesion and proliferation of human endothelial cells (Lin, 
Sun et al. 1994; Sagnella, Anderson et al. 2005). In this project, PƐL polymers cross-linked 
with RGD outperformed non-cross-linked polymers, since KSCs-GFP proliferated 
significantly more on these modified polymers, providing evidence for the importance of 
RGD.  
A second and novel modification of these PƐL polymers entailed surface modifications using 
synthetic HS-mimetic compounds. PƐL coated with per-sulfated synthetic HS structures, 
outperformed all other coating compounds and uncoated PƐL by stimulating enhanced 
adherence and proliferation. Although the usage of HS and HS mimetics as a coating material 
is relatively unstudied, the role of heparin as a coating material for improved substrate 
performance is not a novel idea. 
Many heparin-coated biomaterials are underpinned by the anticoagulant properties of 
heparin; therefore coating with heparin is often used to discourage cell adhesion, for example, 
in many eye-related treatments, including silicone-based intraocular implants (Fischer, 
Carstesen et al.) and to improve the performance of hydrogels as corneal replacements 
(Bourcier, Borderie et al. 1997). Heparin-coated polymer applications also include 
applications were a blood clot could negate the performance of the biomaterial and jeopardise 
the patients health, for example heparin-covered ePTFE stents for the treatment of occlusive 
legions in the superior femoral artery (Lensvelt, Fritschy et al.). 
According to results in this chapter, the KSC-GFP response to coating materials was 
structure-specific, since not all coatings positively affected KSC-GFP adhesion and 
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proliferation; NAc-heparin coating for example, performed poorly and did not stimulate 
adhesion or proliferation, emphasizing the importance of sulfation for this application. 
Furthermore, and interestingly, per-sulfated heparin coating outperformed other compounds 
with regard to stimulating KSC-GFP proliferation. Collectively these results highlight the 
importance of ionic cell-surface interactions often exemplified by many cell-polymer 
investigations (Lee, Jung et al. 1994); the results suggest that in general that providing an 
adequate degree of sulfation is presented to the KSC-GFP cells, specific sulfation patterns 
may be less important. Having said that, the results indicate that the loss of specific sulfates 
can induce different cell responses. 2-O desulfated polymers performed the worst of all the 
modified heparin coatings, therefore suggesting that 2-O sulfation is important for cell 
adhesion. Conversely, 6-O desulfated heparin coating performed the best of the compounds 
with reduced sulfation, suggesting that 6-O sulfation is not required for KSC-GFP adhesion 
and proliferation. It is interesting to note that 6-O desulfated heparin is typically low in 
activity to activate signalling by heparin-dependent growth factors such as FGFs (Guimond 
and Turnbull 1999). This property might be exploited in maintaining ESCs in maintaining 
ESCs in a pluripotent state. 
Since per-sulfated heparin coatings performed comparable to PMH-coatings and 
outperformed gelatin-coating, using these synthetic compounds could represent an attractive 
alternative to protein coatings. Gelatine-coatings represent the hallmark method of enhancing 
cell adhesion, for example a study relevant to this project showed that PƐL cross-linked with 
gelatin performed better than non-crosslinked PƐL in human epithelisation (Reno, Rizzi et al. 
2012). Although none of the other HS-mimetic modified heparins (desulfated) outperformed 
gelatine-coated polymers, according to the criteria of the limited studies carried out here, they 
may well provide interesting compounds for manipulating other aspects of ESC behaviour, 
especially selective differentiation, and this remains to be explored in future studies.  
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6. General Discussion and Future Directions 
 
Major findings from this project can be summarised as follows: 
 The culture conditions used to expand mESCs significantly influences their 
developmental potential when subsequently cultured in suspension as EBs; 
o A lack of serum during 2D expansion is correlated with disrupted EEE 
differentiation and uncharacteristic BM in subsequent EBs 
o A lack of feeders during pre-EB culture conditions affects mESC EB 
cavitation 
 HS-deficient mESCs were successfully expanded in 2D culture providing that serum 
was present, however, subsequent EB behaviour was substantially disrupted 
compared to normal E14 EBs 
o Soluble and cell-surface HS structures differed depending on culture 
conditions (those with serum and feeders displayed different HS structures)  
 Poly-Ɛ-lysine represents a promising biomaterial for mESC expansion  
o PƐL was shown to support attachment and proliferation.  
 This was further enhanced by surface treatment with synthetic HS 
structures 
 Per-sulfated HS structures out-performed other synthetic HS structures  
One caveat is that this project only investigated the behaviour of the E14 mESC line (Hooper, 
Hardy et al. 1987), and it is therefore possible that the observed responses of these cells to the 
different culture conditions are specific to this line. Every mESC line is genetically distinct, 
according to time of derivation and specific culture conditions used initially during 
derivation. Accordingly, results described throughout this project should be reproduced using 
several different mESC lines. E14 mESCs are a well established line, derived from the 
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embryo of a mouse at embryonic day 4.5 (Hooper, Hardy et al. 1987), however other mESCs 
are widely available, including D3 (Gossler, Doetschman et al. 1986), AB1 (McMahon and 
Bradley 1990), MBL-5 (Pease, Braghetta et al. 1990), EFC-3 (Nichols, Evans et al. 1990), 
BL/6-3 (Ledermann and Burki 1991), J1 (Li, Bestor et al. 1992), P55 (Johnson, Spiegelman 
et al. 1992) and TT2 (Saga, Yagi et al. 1992). 
Like many ESC projects, this project has employed mESCs as a model for human embryonic 
stem cells (hESCs), owing to their long established history, 40 years post-derivation. Taking 
a wider view, although the results emphasize the requirement for serum, feeders and HS 
during successful mESC propagation, reproducing this data with several hESC lines is 
absolutely necessary before hESC-related conclusions can be made. Nonetheless, the 
underlying message from this project is very likely transferable to hESCs; the need for a 
xeno-free, standardised system for ESCs expansion is a critical if hESCs are to fulfil their 
potential. 
Within the hESC field, depending on the laboratory and the nature of the research, expansion 
of these cells can occur with or without animal-derived products. Of those groups using 
animal products for the isolation and expansion of hESCs, problems related to downstream 
clinical applications are extensive. The use of serum and animal-derived products gives rise 
to variability in the culture system and thus presents huge challenges in long-term, robust 
hESC cultures. Furthermore, and perhaps more importantly, xenogenic factors used in these 
undefined hESC cultures may predispose hESCs towards a specific lineage, rendering their 
pluripotency. Ultimately, the importance of hESCs that have not contacted any animal-
derived components except those of human origin is critical for the eventual drug therapy and 
disease treatment in humans.  
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Several groups and private companies are investigating the expansion of hESCs in defined 
animal-free culture systems. Human-derived cells have been shown to effectively replace 
mouse-derived fibroblasts; Richards et al., reviewed many different primary cells for the 
support of hESCs, of which fetal muscle, fetal skin, neonatal foreskin fibroblasts and adult 
human fallopian tube epithelial cells were shown to maintain hESCs over 20 passages 
(Richards, Fong et al. 2002). Feeder-free conditions have also been achieved using MEF-CM, 
although often these systems employ Matrigel or fibronectin as dish coatings (Mallon, Park et 
al. 2006), and in some cases additional animal-derived growth factors, FGF for example, to 
compensate for the lack of feeders (Amit, Shariki et al. 2004; Amit 2007). Whilst the 
omission/replacement of animal-derived feeder layers for hESC maintenance is becoming 
attainable, the omission of FBS during hESC cultures is proving more difficult, which is in 
agreement with results in this project. This was demonstrated by one study, which showed 
that the replacement of FBS with human serum was unsuccessful in maintaining hESC in 
culture (Richards, Tan et al. 2003) emphasizing the importance of FBS during hESC 
propagation, albeit via undefined mechanisms. Furthermore, serum-free hESC cultures often 
require the presence of a fibroblast layer, exemplified by one study which showed successful 
expansion of hESCs for more than 10 passages was achieved providing human placenta 
fibroblasts were present (Genbacev, Krtolica et al. 2005). Similarly, serum-free commercially 
available media (StemPro and mTeSR1) were shown to support several hESC lines for more 
than 10 passages, although human-derived feeder layers were required in these serum-free 
systems (Chin, Padmanabhan et al.). 
Despite the progress being made in defining an animal-free hESC culture system, what 
remains unclear is the impact these systems have on the downstream differentiation capacity, 
which is a key emphasis of the project here. According to results in this project, pre-culture 
conditions for the maintenance of mESCs significantly affect the behaviour of mESCs in a 
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subsequent EB model. It would be interesting to identify if this is reproducible in hESCs and 
furthermore, the results support the views of some sceptics who suggest that exploiting 
hESCs in any clinical application is dangerous until the effects of prior culture conditions are 
known for hESCs (Mannello and Tonti 2007). 
Regardless, many companies are hoping to exploit niche, by synthesizing artificial substrates 
(using synthetic polymers for example) to replace and mimic natural ECM proteins, and this 
is a goal of our CASE partner, SpheriTech. Providing we can dispel the need for animal-
derived products in hESC scale-up via the employment of these synthetic substrates, which 
now appears feasible, hESCs offer great promise in studying development and also treating 
disease states (including Parkinson’s, Alzheimer’s, diabetes, blindness and cancers for 
example). RoslinCell, a regenerative-medicine based company based in Edinburgh, UK, has 
demonstrated the generation of clinical-grade hESCs using a xeno-free substrate, now 
commercially available via Invitrogen (CELLStart, Invitrogen). Currently, an array of 
different synthetic substrates are being investigated as alternatives (some of which have been 
outlined in this project), applicable to both 2D cell expansion and 3D tissue engineering 
application (Carletti, Motta et al.) restricted by biocompatibility, compatibility with 
sterilisation techniques, manufacture expense, scale-ability and efficacy in defined/xeno-free 
culture conditions. Hydrogels and macroporous polymers represent a large proportion of this 
research, and as the results in this project have suggested, substrate performance can be 
enhanced using chemical modifications in order to mimic protein-binding motifs, RGD for 
example, or to improve cell adhesion and proliferation. The latter was demonstrated with HS-
based compound surface treatments, since the performance of poly-Ɛ-lysine macroporous 
polymers shown to support ESC and KSC attachment was enhanced further by the coating of 
polymers with synthetic HS-compounds. 
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Despite the efforts to solve the problems that surround hESCs, a controversial debate engulfs 
this research, largely attributed to the nature of hESCs derivation and the potential by-
products, therapeutic cloning for example, and there are significant restrictions in hESC 
research.  
hESC lines, as outlined previously, are derived from a fertilized egg that has been grown in 
vitro for 5-6 days to form a blastocyst, of which the 30-40 inner most cells (ICM) are 
removed and expanded in vitro.  It is the origin of hESCs, which antagonises a ‘scientists 
versus ethicists’ debate. A classic model for this is the governing of hESC research in the 
USA. George W. Bush’s government epitomised a ‘pro-life’ view and in 2001, although 
National Health Institute (NIH) funding for already-underway hESC research (permitted by 
Clinton’s government in 1998) was allowed to continue, new and additional NIH funding for 
the derivation and long-term study of hESC lines was prohibited. This was thought by many 
in the science community to hinder the potential for any hESC-based theraputics. Such a 
bold, science-threatening, political decision, was largely based on religious views towards 
abortion, underpinned by the belief that an embryo has the same moral status as an adult 
since ‘human life begins at conception’, and therefore removing the ICM from a blastocyst of 
an aborted fetus to derive a hESC line, amounts to murder (1995; de Wert and Mummery 
2003). By 2009, Obama’s government had revoked these rules, supposedly ‘removing 
barriers in hESC research’ and allowing hESC to largely be governed by NIH rather than 
politics . Politics therefore no doubt affects hESC research, outlined by one study which 
showed that the rate of hESC-based publications by US-based authors specifically declined 
over the 2008-2010 period and accordingly, non-US authors are shown to publish more 
frequently and at a significantly higher rate. 
Nonetheless, the first clinical trial (phase I and II) using hESCs was approved by the FDA in 
November 2010, for the treatment of Stargardt’s Macula Dystrophy (SMD). SMD is a 
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hereditary disease, and a common form of macular degeneration detected in young adults. 
SMD is categorised by the death of retinal pigmented epithelial cells (RPEs) in the central 
region of the retina in the back of the eye (macula), and therefore loss of central vision 
persists, until eventual blindness occurs. The trial, funded by Massachusetts-based company, 
Advanced Cell Technology (ACT) is due to end in October 2013 and currently, two blind 
patients have been treated. The first report of this study is extremely positive, outlining no 
signs of hyperproliferation, tumourigenicity, ectopic tissue formation, or apparent rejection 
and encouragingly, one patient described visualising colour (Huang, McAlinden et al.; 
Schwartz, Hubschman et al.). 
As in this clinical trial, the potential of hESCs to be used in any clinical application is 
governed by the FDA (or equivalent bodies in other non-US countries) and encompasses 
three costly, exhaustive clinical trial stages; phase I, II and III. Phase I exists to determine if 
the treatment/application is safe for the human model and typically includes low numbers of 
participants over relatively short time periods. Phase II involves more participants and seeks 
to determine the efficacy of the treatment whilst the final phase III, establishes if this new 
treatment is superior compared to current treatments and typically involves many thousands 
of participants, usually in a double-blind study more longer-term.  
Several privately funded companies, unregulated by government bodies, are currently 
monitoring an array of other hESC-based clinical trials, all at different phases. One US-based 
company Geron, completed a phase I trial in October 2012, investigating the use of hESCs 
for spinal cord injury, where human embryonic stem cells have been directed to become 
neural progenitor cells (GRNOPC1). GRNOPC1 cells have been injected directly into a 
patient suffering with a spinal cord injury 7-14 days post injury, based on the hypothesis that 
these injected cells will contribute to healing. In Europe, on-going clinical trials are also 
underway. Glasgow University, Scotland, has been monitoring a phase I clinical trial since 
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June 2010, relating to the usage of a human neural stem cell line (CTX cells) derived from 
human fetal tissue, produced by the company ReNeuron, to treat stroke patients (Mack). All 
participants, disabled as a result of an ischemic stroke, have successfully been injected 
directly into the brain with CTX cells and a report in August 2011 outlined that no adverse 
effects had been observed. Furthermore, reductions in neurological impairment and spasticity 
were observed in all participants compared with pre-treatment. According to the success, a 
phase II trial is expected to begin mid-2013. Balgrist University, Zurich, Switzerland, is 
involved with a phase I clinical trial using human CNS stem cells (HuCNS-SCs) as a 
treatment for spinal-cord injury since December 2010, in conjunction with the company Stem 
Cells Inc.  
Much of the promise of hESCs however, lie in the potential for ‘personalised medicines’, as a 
consequence of somatic nuclear cell transfer (SNCT) using hESCs (Byrne, Pedersen et al. 
2007; French, Adams et al. 2008). However, the concept of ‘personalised medicine’ is now 
more recently governed by the field of induced pluirpotent stem cells (iPSCs) and interest in 
SNCT has therefore decreased. 
iPSCs, as their name suggests, are pluripotent stem cells which have been derived from non-
pluripotent stem cells and represent a favourable source of pluripotent stem cells, given that 
ethical issues associated with hESCs do not exist in iPSCs. In 2006, Yamanakas’ laboratory 
at Kyoto University, Japan, optimised conditions that enabled the ‘reprogramming’ of murine 
fibroblasts to express a ‘embryonic stem cell-like’ fate, via forcing these adult cells to express 
genes important for embryionic stem cell self-renewal, initially Oct4, Sox2, Klf and c-Myc 
(Yamanaka and Takahashi 2006). Since then other groups have optimised the conditions for 
iPSCs using a combination of different embryonic stem cell genes (Takahashi, Okita et al. 
2007; Yu, Vodyanik et al. 2007) and for many different species, including rat (Liao, Cui et al. 
2009) and monkey (Liu, Zhu et al. 2008). The employment of iPSCs as a medical tool is 
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therefore extremely promising, but like hESCs, some issues still need to be addressed. 
Foremost, the efficacy of creating iPSCs must be greatly improved, as must the 
understanding of the mechanisms which govern reprogramming. However, aside from their 
origins, iPSCs can be categorized as hESCs, and therefore have an equally exciting future.  
In conclusion, the employment of hESCs clinically undoubtably represents an area with 
massive potential if the science community can resolve some key issues and the political 
community can refrain from over-regulating this field of research (Owen-Smith, Scott et al.). 
However, insights into the effect of culture conditions on the downstream behaviour of 
mESCs as outlined in this project, is one of many concerns surrounding the usage of hESCs 
in the clinic. This could pave the way for iPSCs, which has just as much promise but 
conveniently does not harbour the burden of ethical hysteria and associated restrictions, and 
can practically be generated from a patients own cells.  
Future directions 
The results from this project, like most research, led to an array of further questions, which 
represent potential future directions and follow-up experimental lines, some of which include: 
 Are the effects identified in the serum-free, feeder-free conditions irreversible? 
Serum-free conditioned mESCs were shown in results here, to display severely 
uncharacteristic behavior, recognised during 2D monolayer culture but most obvious during 
3D expansion in suspension culture upon the removal of LIF. For example, serum-free 
conditioned EBs appeared to lack the ability to transport the laminin trimer after synthesis 
(LamA1 was down-regulated compared to EBs conditioned in normal mESC cultures (with 
serum and with feeders), whilst LamB1 remained unchanged between conditions). But how is 
this linked to a lack of serum? Are these effects irreversible? If these cells were placed back 
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into normal culture conditions (i.e. in the presence of serum), would downstream self 
renewal, differentiation and BM functionality be rescued? If yes, a further question to 
confirm the link between serum and HS would be whether, if these defective mESCs are then 
replated back in conditions containing serum and heparitinase enzymes/chlorate-treated cells 
(STO feeders and/or mESCs) are the effects still rescued (via digesting soluble HS/cell 
surface HS)? Furthermore, medium collected from serum-free mESC cultures displayed 
highly sulfated HS structures (comparable to heparin) and high levels of sulfated HS were 
detected on the cell-surface (mESCs cultured in the presence of serum with/without feeders 
displayed typically low levels of low sulfated HS structrues). This raises the question; do 
these conditions stimulate mESCs to synthesise more highly sulfated HS, which effects 
subsequent mESC self renewal and differentiation? Or conversely, do these serum-free 
culture conditions repress the ability of the mESCs to ‘fine-tune’ HS structure for example by 
the action of Sulfs to remove 6-O-sulphation, and in fact there was a lack of Sulf2 in serum-
free conditioned mESCs. Mechanistically, it is possible that serum-free culture conditons lack 
adequate support for FGF-signalling, known to be crucial in mESC differentiation. This could 
be directly linked to inadequately sulfated species of HS, as a consequence of aberrant culture 
conditions. 
 PMH was shown to rescue defects due to a lack of serum, how and why? 
PMH, a homogenously sulfated HS-model molecule, was shown to rescue the lack of serum. 
What signaling pathway was this linked to; perhaps FGF signalling? One could use western 
blots to assess activation of FGF signaling (FGFR phosphorylation) and other downstream 
events, for their dependence on culture condition. ELISA could be employed also to detect 
activation of FGF through specific receptor dependence.  
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o Since PMH was shown to rescue uncharacteristic mESC phenotype (attributed 
to a lack of serum), one further question would be, can exogenous HS 
mimetics reproduce this affect?  
If yes, what structures can substitute for serum and can they be produced in animal-free 
systems? Recent studies have shown that defined heparin/HS structures can be produced both 
chemically (Schworer, Zubkova et al.) and chemoenzymatically (Deangelis, Liu et al.), 
supporting the view that tractable production of non-animal derived heparanoids is possible. 
 Poly-Ɛ-lysine was shown to support mESCs, and this action was further enhanced 
with synthetic HS structure surface coatings. Can this approach be optimised further? 
o Can this system be used to control and direct differentiation of ESCs and is 
this dependent on specific HS structures?  
Overall, it is clear that the work presented here has opened up a number of avenues for 
potential exploitation of HS in stem cell self-renewal and differentiation, to support 
applications for regenerative medicine. It is hoped that in the future such applications can be 
realised in practice as new treatments for the benefit of patients with conditions such as 
Alzeimers and Parkinson’s disease. 
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Appendices 
Appendix I 
 
Figure A1. Negative controls for all antibodies used throughout this project. Primary 
antibody controls for Oct4, Nanog, Gata6, laminin, LamA1, AFP, 3G10 and 10E4.  
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Appendix II 
 
Table A1. Details of primers used throughout this project for RT-qPCR 
 
Gene Primer Sequence Ampli
con 
size 
(bp) 
Temp 
C/cycle 
number 
Source 
Pluripotency 
Oct4   
 
F 5’TGGAGACTTTGCAGCCTGAG3’ 188 56/33  
R 5 CTTCAGCAGCTTGGCAAACTG3’  
Endoderm 
GATA6 F 5’CAAGATGAATGGCCTCAGCAG3’  64/33  
R 5’TGGTGGTGGTGTGACAGTTGG3’  
AFP F 5’ACATGAGTGTCTGCTGGCAC3’ 461 63/33  
R 5’AGCGAGTTTCCTTGGCAACAC3’  
Mesoderm 
Bry F 5’CATCGGAACAGCTCTCCAACCTAT3’    
R 5’GTGGGCTGGCGTTATGACTCA3’  
Foxc1 F 5’TCAGAGCGGAAATTGTAGGA3’ 226 58/33  
R 5’GTATTTGTTCATGTGCCAACTC3’  
Tbx6 F 5’GCCTCCTTCCGATTTCCT3’ 141 62/33  
R 5’CATCCCGCTCCCTCTTAC3’  
Ectoderm 
Pax6 F 5’GAGAAGAGAAGAGAAATGAGGAAG
GAGA3’ 
201 63/33  
R 5’ATGGGTTGGCAAAGCACTGTACG3’    
Basement membrane 
Lam-
111 
F     
R     
LamA1 F     
R     
LamB1 F     
R     
HS biosynthetic enzymes 
EXT1 F     
R     
EXT2 F     
R     
NDST1 F     
R     
Sulf1 F     
R     
Sulf2 F     
R     
Reference 
GAPDH F 5’TGAAGCAGGCATCTGAGGG3’ 102 56/33  
R 5’CGAAGGTGGAAGAGTGGGAG3’  
 
